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Michael I. Schimerlik
During catalysis the flavoprotein domain of neuronal nitric-oxide synthase (nNOS)
shuttles NADPH-derived reducing equivalents from FAD to FMN and then to the
P450-heme enabling heme-based oxygen activation and subsequent NO-synthesis. The
binding of Ca2-activated calmodulin (Ca2tCaM) to nNOS alleviates inhibition of
flavin mediated electron transfer within the diflavin domain, which is demonstrated by
the increase in the rate of 2,6-dichioroindoiphenol (DCIP) reduction by 2 to 3 fold and
that of cytochromec3by 10 to2O fold. To investigate the effect of the Ca2-CaM on
the nNOS reductase activity, the steady-state kinetics of basal and CaM-stimulated
reduction of these two substrates was studied.Parallel initial velocity patterns
indicated that both substrates are reduced in a ping-pong mechanism. Product and
dead-end inhibition data with DCIP as the electron acceptor were consistent with a di
iso ping-pong bi-bi mechanism. In contrast, product and dead-end inhibition studies
with cytochromec3as the second substrate were consistent with an iso (two-site) ping-
pong mechanism. Ca2-CaM did not alter the proposed kinetic mechanisms;however,
Redacted for Privacyit did effect to varying degrees the(kcat/Km) for the various substrates.The pH-
dependence of basal and CaM-stimulated reduction of DCIP revealed that ionizable
groups involved in the binding of substrates and catalysis are notaltered by Ca2-CaM.
However, the activated cofactor does influence catalytic rate constants and/or ionizable
groups involved in cytochromec3reduction. nNOS was found to abstract the pro-R
(A-side) hydrogen from NADPH. Primary deuterium isotope effects (NADP(D)) and
solvent isotope effects (SKIE) suggests that of the two half reactions, the reductive half
reaction involving NADPH oxidation limits the overall reaction rate, but that hydride
transfer to FAD is not the slow step. A small value ofD(v/K)NADpH(1.2-1 .6) suggests
hydride transfer is not the rate-limiting step within the reductive half-reaction. Large
solvent kinetic isotope effects (SKIE) were observed on(V/K)for basal and CaM-
stimulated reduction of cytochromec3suggesting that proton uptake from the solvent
limits the rate of the oxidative half-reaction. A small SKIE on V and(V/K)NADPH
indicates that proton uptake does not limit the overall reaction rate. Proton inventory
analysis revealed multiple transition-state protons contributed to the observed SKIE.Copyright by Kirsten R. Woithers
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Chapter 1
Introduction
Nitric oxide, NO, is a wide spread mediator of a vast number of physiological and
pathophysiological processes (1, 2). A family of three isozymes, the nitric-oxide
synthases (NOS; EC 1.14.13.39), catalyze NO biosynthesis via the five-electron
oxidation of L-arginine (Figure 1.1; 3, 4;). One reaction cycle consumes 1 .5 NADPH
and two02to produce NO, L-citrulline and two H20 (5, 6).In the first step,°2and
NADPH-derived electrons convert L-arginine to the intermediate N-hydroxy-arginine
(NHA) and H20 in a mixed-function oxidation reaction (7, 8). The unique second step
uses 0.5 NADPH and02to oxidize NHA forming NO, L-citrulline, and H2O (5, 9).
All three isoformsneuronal (nNOS), inducible (iNOS) and endothelial (eNOS)-
are homodimers with each subunit consisting of three conserved domains (Figure 1.2; 3,
10). An iron protoporphyrin IX heme, (6R)-5,6,7,8-tetrahydo-L-biopterin (H4B), and L-
arginine bind to the oxygenase domain located at the N-terminal half of the polypeptide
subunit (11-14). The C-terminal reductase domain contains two flavins, FAD and FMN,
and the binding site for the substrate NADPH (15). During catalysis the flavins transfer
NADPH-derived electrons to the heme iron enabling it to activate oxygen and catalyze
NO synthesis. Dimer formation is necessary for NO synthesis because flavin to heme
electron transfer proceeds exclusively between adjacent subunits (16, 17). Binding of
calmodulin (CaM) to the third conserved site connecting the oxygenase and reductaseNH2 NH2
I
NH3
2
HO-N NH2 0 NH2
.NO
NADPH/02NH 0.5 NADPWO2 NH
HO HO
NH3 COO- NH3 COO
Figure 1.1 The NOS-catalyzed two-step conversion of L-arginine to L-citrulline. In
the first step,02and NADPH-derived electrons convert L-arginine to H20 and the
intermediate N-hydroxy-L-arginine (NHA) in a mixed-function oxidation reaction.
The second step uses 0.5 NADPH and02to oxidize NHA forming NO, H20, and L-
citrulline.3
Figure 1.2 Functional elements of the NOS sequence. The sequences for the PDZ
domain of nNOS, the fatty acylation sites in eNOS are shown at the N-terminus (4).
Site-directed mutagensis identified the cysteine axial heme ligand, the cysteine
involved H4B binding and a glutamate participating in L-arginine-NOS complex
formation; these are shown in the oxygenase domain. Consensus sequences for
CaM-binding and the putative contact sites for the isoalloxazine rings and
phosphate portions of FMN and FAD and the ribose and adenine portions of
NADPH are also depicted by the black boxes.N-termin
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domains facilitates electron transfer between the flavins and heme (18). Neuronal and
endothelial NOS require elevated intracellularCa2levels to initiate the binding ofCa2-
activated CaM (Ca2-CaM) required for NO synthesis (19, 20).However, CaM is a
tightly bound to iNOS even at basal intracellularCa2levels; therefore, this isoform will
continually generate NO in a Ca2-independent manner (21-23).
This introductory chapter is divided into four sections. The first section will
review the structure of NOS, comparing each of the isoforms with each other and with
the cytochrome-P450 system. The mechanism of NO synthesis, the control of protein-
mediated electron transfer, and the role of various substrate/cofactors during catalysis
will be discussed in the second section. The third section will review the properties,
cellular distribution and control of the expression of the NOS isoforms. The major
physiological roles of NO in the nervous, immune and circulatory systems will be
addressed in the last section.
1.1 Structure of NOS
1.1.1 Quaternary and tertiary structure
The three isoforms of NOS share 50-60% amino acid sequence similarity. nNOS (160
KDa; (24) is larger than eNOS (-130 KDa; 25) and iNOS (-133 KDa; 26) due to an
additional 220 N-terminal amino acid residues (27). Evidence suggests that both the
monomeric and dimeric forms of NOS are elongated proteins. The elution profile for
eNOS from an FPLC column with a set of globular proteins reveled that eNOS eluted
immediately after apoferritin (443 KDa) and the eNOS monomer eluted very close toamylase (200 KDa; 28). Furthermore, velocity sedimentation experiments with nNOS
dimer revealed that the quaternary structure of the enzyme also appears to be an
elongated homodimer (29).
The polypeptide subunits of NOS have a bidomain structure. Limited trypsin
proteolysis of nNOS in the absence of CaM cleaved the enzyme into an N-terminal and
C-terminal half, each approximately 80 KDa (30). The absorbance spectrum of the C-
terminal-half showed shoulders at 450 nm and 550 nm representing the enzyme-bound
FAD and FMN (30). This domain was labeled the reductase domain as it exhibited
cytochromec3reductase activity analogous to cytochrome P450 reductase (CPR; 31).
The absorbance spectrum of the nNOS N-terminal half had a small shoulder at 420 nm
with broad bands at lower extinction coefficients centered near 538 nm and 650 nm
attributed to the heme chromophore (30).The pyridine hemochrome assay
demonstrated that the enzyme contains two mols of iron protoporphyrin IX/mol of
enzyme homodimer (12, 14).
Although all three isoforms function as homodimers, the protein structural
components required for subunit association and the cofactor and substrates needed for
inducing and stabilizing dimerization are different. Subunit association in eNOS and
nNOS involves head to head interactions of the oxygenase domain, tail to tail
interactions of reductase domain, and head to tail interactions between the oxygenase
and reductase domain (32).In contrast, iNOS subunit association involves only
oxygenase domain interactions (33).Low-temperature SDS-polyacrylamide gel
electrophoresis revealed that the binding of H4B and L-arginine synergistically convert
nNOS and iNOS into stable homodimers (29).For these two isoforms, dimer7
dissociation was accompanied by a concerted loss of NO synthesis activity and the
release of bound H4B from the protein (34, 35).Reif et at. determined that the
endogenous addition of H4B prevented monomerization (35). In contrast, dimerization
in eNOS is controlled by the intracellular availability of the heme, not the binding of
H4B or L-arginine (36, 37). A set of chimeras in which the reductase and oxygenase
domains where swapped between the isoforms demonstrated that the structural
components in the eNOS oxygenase domain facilitate H4B-independent dimer formation
(38).
Evidence suggests the binding of H4B and L-arginine induces large
conformational changes in the iNOS and nNOS oxygenase active site. Large bulky
nitrosoalkane derivatives are able to react with distal-side of the heme in the absence the
cofactor and substrate. However, the binding of L-arginine and H4B inhibits the binding
of even the smallest nitrosoalkane ligand (CH3NO; 39). Exposure of the distal side of
the heme to the solvent in monomeric H4B-free and L-arginine-free iNOS also permits
DTT to form a bisthiolate complex (34). The hyperporphyrin spectra emitted by the
bisthiolate complex will disappear with addition of L-arginine and H4B indicating that
structural changes are occurring in the oxygenase domain (40). Comparison of the H4B-
free and H4B-bound crystal structures of the iNOS oxygenase domain show that the
binding of the cofactor, which binds at the dimer interface, induces large conformational
changes in this isoform to stabilize the dimeric form of the enzyme (41). In contrast, the
crystal structure for the H4B-free and H4B-bound eNOS reveals that the presence of the
cofactor does not induce dimerization and fails to induce any large conformational
change (42).F:]
1.1.2 Oxygenase domain
Spectral analyses of the heme ligand environment in NOS indicated that the
coordination to heme was similar to that of cytochrome P450 enzymes. Similar to
cytochrome P450, the binding of CO the heme results in the inhibition of substrate
oxidation suggesting that the NOS-heme participates in catalysis (11).The nNOS
reduced CO-difference spectrum with a X maximum at 444 nm provided the initial
evidence for a proximal thiolate linkage to the heme iron (11).Site-directed
mutagenesis verified the position of the proposed thiolate donor in human eNOS, rat
nNOS, and human iNOS as cysteine-184 (43), cysteine-415 (44, 45), and cysteine-200
(46), respectively.All cysteine mutants were unable to bind heme or carry out NO
synthesis. The nNOS cysteine-415 mutant and iNOS cysteine-200 mutant were also
unable to bind H4B or L-arginine despite the circular dichroism (CD) spectra indicating
the mutants were folded properly (44, 46).
Although both the NOS oxygenase domain and the cytochrome P450 contain
cysteine thiolate-ligated heme and share several spectral properties, there is a lack of
primary sequence similarity between the two enzymes, particularly within the conserved
residues neighboring the distal cysteine heme ligand. The three-dimensional structures
of the NOS oxygenase domains and cytochrome P450 are different in both their tertiary
structure and active site geometry (42, 47). The distal heme pocket of iNOS primarily
consists
1structure opposed to a variety of other heme containing enzymes such as
oxygenases, oxidases, peroxidases, and catalyases, which largely have a-helicaldistal
heme pockets (47). The orientation of the cysteine proximal ligand also differs betweenthe two families of proteins. The cysteine-194 of iNOS lies at the carboxy-terminal end
of the helix and proceeds an extended strand, whereas the cytochrome P450 cysteine lies
at the N-terminal of the helix and follows an extended strand.The two cysteine
thiolates also bind opposite faces of the iron protoporphyrin IX in the two proteins (47).
In the absence of substrate, the heme iron of cytochrome P450 exists as a
hexacoordinate heme, four bonds to the pyrole nitrogens, one to the sulfur atom of the
proximal cysteine, and the one to the sixth axial ligand, which is most often H20. The
addition of substrate displaces the sixth axial ligand and the heme converts to the high-
spin pentacoordinate state (48-50). The conversion of the heme to the high-spin form
can be observed spectrally, since it coincides with a blue shift the heme Soret maximum.
Unlike the majority of the cytochrome P450s, all three full-length H4B-containing ferric
NOS isoforms are predominately pentacoordinate high-spin even in the absence of
substrate (51). The visible spectrum of purified nNOS displays a broad peak at 406 nm,
which arises from the coalescence of a high-spin peak with an absorbance maximum at
389 nm and a low-spin peak with an absorbance maximum at 416 nm.Electron
paramagnetic resonance (EPR) data on the nNOS heme confirmed that the iron exists as
a population of high and low-spin heme, with the majority (>85%) in the high-spin
pentacoordinate state (12). During catalysis, the sixth coordination site is occupied by
02;however, at rest, the sixth coordination site of the heme in these enzymes is
occupied by H20 (52). The addition of L-arginine results in the conversion of the
remaining fraction of hexacoordinate heme iron into the high spin-state (53).This
substrate perturbation results in "type I" difference absolute spectra with a peak at 396
nm. A "type II" substrate perturbation occurs when a strong heme ligand such as10
imidazole binds to the sixth axial heme ligand position and converts the heme from a
high-spin pentacoordinate state back to a low-spin state hexacoordinate state. The "type
II" absolute spectra has absorbance peaks ranging between 420 and 438 nm.
Imidazole inhibits NOS-catalysis formation by preventing oxygen activation
(54).The binding constant for imidazole, 160 IIM, was determined by following
spectral changes as the ligand was titrated with the heme. The direct binding of L-
arginine to NOS induces a relatively small spectral perturbation compared to imidazole;
therefore, the binding constant for the substrate could not be determined by following a
direct substrate-dependent shift in the heme spin equilibrium. Instead the L-arginine
binding constant, 0.6 jiM, was determined by following the heme absorbance change
back to the high spin form accompanying imidazole displacement with the substrate
(55).
If nNOS or eNOS are expressed and purified in the absence of H4B, the heme is
primarily low spin (45, 56). EPR demonstrated that the low-spin heme forms a
bisthiolate complex with a cysteine thiolate located in distal heme pocket that likely
becomes available to a population of the heme protein through collapse or deformation
of the distal site in the absence of pterin. Prolonged incubation with H4B (24 hrs) in the
presence of dithiothreitol converts the heme of either isoform to the high spin-state. The
thiol (DTT) requirement for H4B and L-arginine binding suggests that a cysteine residue
is involved in the restoration of the pterin- and substrate-binding, possibly through
reductive cleavage or rearrangement of the intersubunit disulfide bond (56, 57).
In contrast, the eNOS heme is primarily high-spin in the absence of H4B and L-
arginine (28). Through a series of deletions aimed at modulating the eNOS distal heme11
site, Rodriquez-Crespoet at.demonstrated sequence at the N-terminus stabilizes the
binding of L-arginine, sequesters the heme from the bulk solvent, and retains the heme
in the high-spin state even in the absence of L-arginine and H4B. Therefore, the N-
terminal portion of eNOS participates in eNOS dimerization, since these same
properties are attributed to the stability of the eNOS dimer in the absence of
substrate/cofactor.
Stabilization of the NOS dimers may also be attributed to the presence of a zinc
tetra-thiolate in the oxygenase domain. Although the initial crystal structure of the
iNOS oxygenase domain published by Craneet at.did not show any zinc associated
with this domain, subsequent crystal structures of the oxygenase domains of all three
isoforms revealed a zinc tetra-thiolate(ZnS4)(41, 42, 58, 59).The zinc atom is
tetrahedrally coordinated to two pairs of symmetry related cysteine residues located in
the phylogenetically conserved CXXXXC motif present in each NOS monomer (42,
58).It is situated at the bottom of the dimer interface, 14Afrom each pterin ring and
21.7Afrom each heme iron (42, 60). In the first published crystal structure of the iNOS
oxygenase domain, the cysteine ligated to the zinc, Cys-109, formed a self-symmetric
disulfide bond with the Cys-109 of the adjacent subunit at the dimer interface (59). A
more refined structure of the disulfide-bridge showed that an N-terminalJ-hairpin hook
was swapped between adjacent subunits (59). Removal of the3-hairpin hook disrupted
the H-bond and packing interactions within the N-terminal and caused permanent
defects in homodimer formation, H4B binding, and enzyme activity.Thus the N-
terminal hook in iNOS is thought to stabilize the dimeric structure by increasing the
number of surface area contacts in the dimer interface.In the single zinc-ligated12
structure, the residues on the N-terminal hook interact primarily with amino acids in the
same subunit, rather than with the adjacent subunit (58).However, eight hydrogen
bonds are created by the formation of the zinc tetrathiolate, which may also contribute to
dimer stabilization. The formation of a disulfide between symmetry related Cysl 15 of
eNOS in the zinc free form weakens the hydrogen-bonding to H4B; therefore, the
presence of the zinc tetrathiolate is strategic in this isoform for maintaining the integrity
of the H4B binding site (58, 59).
The presence and absence of the zinc tetrathiolate in the crystal structures of the
iNOS and eNOS oxygenase domain may have arisen from the contrasting methods for
expression and purification of the enzymes (60). Crane et al. crystallized the purified E.
coli-expressed heme domain of iNOS, which contains only -20 % of the theoretical zinc
content based on one atom of zinc for two hemes (41). In contrast, the zinc content of
the trypsin cleaved heme domain of iNOS and eNOS derived from the full length iNOS
or eNOS holoenzyme contains 90% of the theoretical zinc (42, 58). Metal analysisof
eNOS, nNOS and iNOS indicates that zinc is present in the eNOS at the highest ratio of
0.6 relative to the total iron.For nNOS and iNOS the ratio falls to 0.3 and 0.2,
respectively. Interestingly, the ratio of zinc content roughly correlates with the stability
of the homodimer, since the eNOS homodimer is the most stable and the iNOS
homodimer is the least stable among the isoforms. Although the zinc binding site is
conserved among all isoforms where it may contribute to stability of the homodimer,
most notably for eNOS, it is not required for NO synthesis (60).
The crystal structure of eNOS and iNOS oxygenase domains also revealed that
H4B lies perpendicular to and on the proximal side to the heme (41, 42). The pterin13
makes hydrogen bond contacts with the propionate of the heme, which in turn is H-
bonded to the amino group of the substrate L-arginine (42). The pterin cofactor also lies
at the interface of the dimer and is involved in extensive H-bonding with both subunits,
which attests to its unusual high affinity (Kd 10 nM; 42). The binding of H4B to iNOS
oxygenase induces a conformational rearrangement of the domain in which the heme
becomes sequestered from the bulk solvent and a 30Adeep funnel-shaped channel to
the active center is created (41).
Although the crystal structures show the dimer associated with two pterins,
nNOS will typically purify with one molecule per dimer. This is attributed to the first
molecule having a dissociation constant in the low nanomolar range (- 10 nM), while
the second molecule has a dissociation constant three orders of magnitude larger (61).
Purified nNOS containing H4B in the high affinity binding site is partially active, and
the endogenous addition of micromolar concentrations of H4B will saturate the second
site and lead to an increase in NOS activity (62-64). The binding of H4B to a pterin-
deficient nNOS follows biphasic association kinetics. The Kd values obtained from
radioligand binding studies are 147 ± 24.1 nM and 52 ± 9.2 nM for the binding of H4B
to eNOS in the absence and presence of 0.1 mM L-arginine, respectively (37). The
positively co-operative effect of L-arginine was due to a pronounced decrease in the rate
of H4B dissociation (from 1.6 ±0.5 toO. 3±0.1 mm1; 37).
1.1.3 Reductase domain
The three dimensional structure of the NOS reductase domain has not been solved; thus,
any structural information on this diflavin domain is based onits close sequence14
similarity with other related dual-flavin enzymes. The NOS reductase domain belongs
to a subset of related reductases that contain an FMN-containing flavodoxin-like module
linked to an NADPH and FAD-binding ferridoxin-like module (FNR) (15, 65).
Members of the family include CPR (66), sulfite reductase (67), and methionine
synthase reductase (68). The NADPHIFAD and FMN modules of these proteins appear
to fold separately and function when expressed independently or after being separated
by proteolysis (69, 70). The two flavins are sandwiched between aromatic residues and
are positioned end to end with the two isoalloxazine rings at1500 angle with respect to
each other. The closest distance separating the two flavins, about 4A,is through the 7-
and 8- methyl groups on the isoalloxazine rings.. This close arrangement suggests that
electron flow between the two flavins is not mediated by amino acid residue atoms, but
occurs by direct transfer between the flavins. This structural information is consistent
with kinetic data which demonstrates that electron transfer between the two flavins is
rapid (69).
In the absence of NADPH, NOS maintains an air-stable one-electron reduced
state (FAD-FMNH.) (71), which is unable to reduce the heme or cytochromec3(72).
The donation of two electrons through the oxidation of NADPH reduces both NOS and
CPR to the three-electron reduced state. The midpoint potential for the reduction of the
FAD semiquinone lies at 280 mV, suggesting that facile reduction by NADPH
(reduction potential 320 mV) can occur (73).Saturation of the nNOS reductase
domain with NADPH does not fully reduce the flavins (the flavins have the ability to
accept 4-electrons), although full reduction of the flavins is possible with dithionite. The
incomplete reduction of the flavins by NADPH could result from the binding of NADP15
or NADPH stabilizing the FAD semiquinone by shifting the reduction potential to a
more negative value. Similar effects have been observed for P450 BM3, adrenodoxin
reductase and cytochrome b5 reductase (73). During turnover NOS, like CPR, cycles
between the one and three-electron reduced states (74).
NOS and CPR are also able to reduce 2,6-dichloroindolphenol (DCIP),
ferricyanide (FeCN), and cytochromec3with electrons derived from NADPH oxidation
(31, 75). However, nNOS is unique in that the binding of Ca2-CaM to the enzyme
stimulates a 2 to 3 fold increase in DCIP and FeCN reduction and a 10 to 20 fold
increase in cytochromec3reduction (30, 76).The Ca2-CaM stimulation of these
activities is independent of electron transfer from the flavins to the heme since the same
level of stimulation of ferricyanide and cytochromec3reduction occurs with nNOS
devoid of its oxygenase domain (74, 76, 77). Stopped-flow studies indicate that the
binding of Ca2-CaM increases the pre-steady state rate of electron transfer from
NADPH to the flavins (76, 78). The increase in electron transfer may be facilitated by
the ability of Ca2-CaM to induce a conformational change in the enzyme (30, 74, 79,
80). Bound FMN is essential for the fluorescence change associated with CaM binding
to nNOS suggesting the CaM induced conformational change is restricted to the FMN
module (74). Stopped-flow kinetic analysis demonstrated that FMN suppresses FAD
reduction by NADPH, and the suppression is relieved by CaM binding or FMN removal
(81).Potentiometric analysis of the flavin couples revealed that Ca2-CaM does not
influence the thermodynamic driving force of electron transfer (73).
The FMN oxidizedlsemiquinone has the highest midpoint potential of 49 mV in
nNOS (73), thus electron transfer from the hydroquinone state of FAD is16
thermodynamically favorable.Due to the close proximity of the of the
semiquinone/hydroquinone midpoint potentials for FAD (-280 mV) and FMN, (-274
mV) the two flavins can exist as a stable neutral semiquinone, and in the three-electron
reduced state of the enzyme, the FMN will fluctuate between the semiquinone and
hydroquinone states.Only the hydroquinone form of FMN ispoised to
thermodynamically deliver the first electron transfer to the ferric iron(E'm,7is 239mV
for Fe (11)/ Fe(III)]. The midpoint potential of the semiquinone form of FMN can be
accessed by the ferric-superoxy species; therefore, this intermediate may provide the
second electron to heme required to generate the oxyferryl intermediate. The redox
cycle of the reductase domain is completed with electron transfer from the FAD
semiquinone to the oxidized FMN, generating the air-stable FMNH..
The reductase domain of NOS also has additional amino acid sequences that are
not found in CPR. nNOS and eNOS contain an additional 40-50 amino acid insert
located in the FMN-binding subdomain (82).This insert is thought to be an
autoinhibitory domain since it was shown to promote the dissociation of CaM from
nNOS at low intracellularCa2concentrations and to inhibit electron transfer in the
absence of Ca2-CaM (82).Both iNOS and the constitutive isoforms possess an
additional 21-42 amino acid-tail at the C-terminus, which is not present in CPR. This
sequence is proposed to modulate electron transfer betweenthe flavin moieties or
between FMN and cytochromec3(83).
The crystal structure of the INOS oxygenase domain suggests that interaction
with the reductase domain occurs through electrostatic interactions. The heme edge on
the side opposite to the active site channel becomes exposed to the solvent upon17
dimerization of the iNOS oxygenase domain (41) and may interact with the reductase
domain as it contains residues which are highly conserved among the NOS isoforms. In
addition, the electrostatic potential of these residues and the shape of the domain are
complementary to the structure of the putative NOS reductase domain, which is based
on the structure of the CPR (41). The crystal structure of the eNOS oxygenase domain
revealed a lysine residue in this area, which is exposed to the solvent and lies in the
region where the heme is close to the protein surface. The conversion of this lysine to a
glutamic acid results in a mutant that is unable to produce NO with either L-arginine or
NHA as substrates. Furthermore the low rate of electron transfer from the reductase
domain to the heme iron under both aerobic and anaerobic conditions exhibited by this
mutant suggests the lysine residue forms ionic interactions with the reductase domain.
1.1.4 Calmodulin-binding domain
The CaM binding domain for all three isoforms consists of a stretch of approximately 30
amino acids residues. The hydrophobic and basic composition of these amino acids
along with their propensity to form an alpha helix is a diagnostic feature among CaM
binding sites on target proteins. To initially demonstrate that CaM forms a complex
with nNOS, a 30 amino acid synthetic peptide corresponding to the putative CaM-
binding domain was used to compete for CaM and inhibit its stimulatory effect on two
other CaM target proteins, cyclic nucleotide phosphodiesterase and adenylyl cyclase
(84). The synthetic residue bound to CaM at an elevatedCa2concentration, with a 1:
stoichiometry, and a binding affinity of I nM, typical for CaM binding targets proteins
(30, 84).18
A similar experiment was conducted for iNOS in which a synthetic thirty amino
acid residue peptide corresponding to the putative CaM-binding domain this isoform
was used to compete with full-length iNOS for CaM (21). The iNOS-peptide inhibited
90 % of iNOS activity when present in 12-fold excess. Unlike the nNOS-peptide, the
presence of 5 mM EGTA only caused a 30 % maximal inhibition of activity. The
addition of exogenousCa2restored activity in a concentration-dependent fashion,
demonstrating that the binding interaction between CaM is tight but reversible and
requires basal concentrations ofCa2for full activity. As a result of this tight binding,
CaM co-purifies with iNOS. Circular dichroism (CD) and 1H-NMR studies on the
structure of the iNOS CaM binding-peptide in solution or complexed with CaM further
demonstrated that the INOS peptide retained the ability to bind CaM both in the
presence and absence ofCa2(85). The 2D-NMR and CD spectra also showed that
peptides corresponding to the CaM-binding domain of all three isoforms assume a-
helical structures in aqueous solution and when complexed with CaM (85, 86).
To determine if the structural features that facilitate theCa2independent CaM
association lie within the thirty amino acid stretch of the iNOS CaM-binding domain or
in protein sequence outside this domain, chimeric proteins were constructed in which
the canonical CaM-binding domain was swapped between iNOS and nNOS. Chimeras
containing the nNOS oxygenase and reductase domain tethered by the iNOS CaM-
binding domain required intermediate levels of freeCa2to bind CaM and generate NO
(87). Truncation analysis of iNOS suggests that residues within oxygenase domain are
also required forCa2independent binding (38).Chimeras of the two isoforms
constructed by Lee et al. showed that Ca2tindependent activity of iNOS requires19
sequence in all three domains (88).The dissociation ofCa2from the CaM-nNOS
complex was studied to determine the specific interactions betweenCa2and CaM that
lead to association and activation of NOS (89).Tryptic fragments of the C- and N-
terminal lobes of CaM were bound to NOS in the presence ofCa2and the dissociation
ofCa2from CaM-nNOS complex with either lobe was determined through stopped-
flow fluorescent measurement using a fluorescentCa2chelator. Fast dissociation (1000
i)ofCa2from the N-terminal lobe corresponded to inactivation of NOS, while slower
Ca2dissociation from the C-terminal lobe (1 s1) was coupled to dissociation form the
CaM-nNOS complex. The bidentate glutamic acid residues, which coordinateCa2in
each of the fourCa2binding sites on CaM were changed to glutamine to examine the
specific role of eachCa2in CaM-nNOS complex (90).The mutational analysis
demonstrated thatCa2binding at site I is critical for all electron transfer reactions. In
contrast, mutation at site III in the carboxy-terminal lobe activated NOS to similar level
as wild type and mutations at sites II and IV exhibitedintermediate effects on electron
transfer between the flavins and heme.All single point mutations of CaM had
nanomolar binding constants for nNOS, suggesting that the binding of CaM to target
proteins does not necessarily lead to activation of the target protein, but rather that target
activation requires specificCa2dependent interaction between the two proteins (90).
Su et at. created a series of chimeras between the CaM and cardiac troponin C to
determine which structural features of CaM control association and activation of nNOS
(91).Although CaM and troponin C belonging to the same superfamily ofCa2
signaling proteins and contain structurally relatedCa2binding EF-hands, troponin C20
does not bind to or activate nNOS. The study revealed that the "latch domain" of CaM
(helices 2 and 6 of CaM) is essential for activation of nNOS (91).
1.2 Enzymology of NOS
1.2.1 Control of NO-synthesis and electron transfer
The three NOS isoforms differ in the rates of flavin mediated reactions (cytochromec3
and DCIP reduction) as well as in the rates of heme-mediated reactions (NO and
citrulline formation). The rank order for NO-synthesis and cytochrome c3, flavin and
heme reduction is iNOS > nNOS > eNOS (38). The rate of heme reduction (2.3 s'
eNOS, 49 sfor nNOS, and 101s_Ifor iNOS
sI)is much slower than flavin reduction
(107s_IeNOS, 242 s nNOS and 689 s' for iNOS) (92). Investigation of the activities
of several chimeric NOS constructs, in which the reductase domains of eNOS and iNOS
were swapped with the reductase domain of nNOS, suggests the maximal rate of NOS
synthesis is determined by the maximum intrinsic ability of the reductase domain to
deliver electrons to the heme domain (38).
The rate of NADPH oxidation at the reductase domain varies considerably as a
function of the binding of L-arginine and H4B, and the pattern of this variability is
isoform specific. nNOS exhibits the highest degree of uncoupling in the absence of L-
arginine (93). The addition of H4B increases the rate of uncoupling 2-fold, whereas the
addition of L-arginine decreases the activity 4-fold (94).In contrast, eNOS
demonstrates little NADPH oxidase activity in the absence of L-arginine and the21
addition of substrate or H4B stimulates NADPH oxidation. The addition of H4B and L-
arginine to iNOS also increases the level of NADPH oxidation.
Due to the uncoupled NADPH-oxidase activity, nNOS will generate superoxide
at L-arginine Kmand in CaM-dependent manner (7). When L-arginine is present,
binding of the guanidino nitrogen in an ordered position near the heme allowing
oxidation of L-arginine to proceed (47). However, in its absence, electron donation to
the ferric heme leads to the subsequent activation of molecular oxygen. The transfer of
the second electron from the flavins reduces the heme iron again generating superoxide
(95).Under conditions of superoxide formation, the rate of NADPH oxidation
increases, suggesting electron transfer from NADPH to02is faster than the transfer of
electrons to catalyze the formation of NO and citrulline. iNOS and eNOS can also
generate superoxide in the presence of L-arginine (96-98). The inability of NaCN to
significantly inhibit superoxide production in iNOS suggests that the free radical is
generated through electron leakage from the flavin domain (99). NaCN was unable to
block superoxide production from eNOS indicating that, like nNOS, superoxide is
generated by heme-based oxygen activation (97, 100).
The constitutive (nNOS and eNOS) and inducible isoforms employ different
mechanisms for controlling electron transfer to the heme. As discussed above, the
binding of Ca2-CaM to nNOS and eNOS facilitates electron transfer from the flavins to
heme by inducing a conformational change in the enzyme. In contrast, CaM is a tightly
bound to iNOS at basal cellular levels of Ca2; therefore, an alternative mechanism for
controlling electron transfer is required. Investigation of the heme midpoint potentials
of the various isoforms lead to the discovery that iNOS, like P450-cam and P450-BM3,22
controls heme reduction through the binding of substrates and cofactors (101). In the
absence of L-arginine and H4B, the iNOS midpoint potential is -347 mV and electron
transfer from the flavins is not thermodynamically favorable. The binding of either the
substrate or H4B increases the redox potential by 100 mV making electron transfer
thermodynamically feasible. In contrast the nNOS midpoint potential (-239 mY) is 100
mV higher than iNOS and this isoform is able to retain this elevated midpoint potential
in the absence of L-arginine or H4B. This feature of nNOS corresponds to the high
Ca2-CaM-dependent NADPH-consumption rates exhibited in the absence of L-arginine.
NO-production by nNOS is controlled by the breakdown of a ferrous heme-NO
complex. During steady-state turnover, the nNOS heme binds self-generated NO and
the resulting complex is inactive (102). The ferrous heme-NO complex formation is
rapid (-2 sec'; 92, 102) and results from the reduction of the ferric heme-NO-species
that is an intermediate in catalysis (103). Based on the slow dissociation of the NO-
heme complex (k = 0.06 sec'), an estimated 7090 % of the nNOS population is
inactive during steady state catalysis. Normal catalysis is resumed upon the02-
dependent decay of the NO complex (34, 104). The apparentKmfor02increases -10-
fold (38 tM to 350 RM) during steady-state NO synthesis compared to that for
uncoupled NADPH oxidase activity. The ability of the nNOS heme to reversibly bind
NO distinguishes it from the cytochrome P450s, which are irreversibly inactivated
because the ferrous heme-NO complex rapidly break downs to form an inactive
cytochrome P420 (105). NO binding is reversible albeit slow in nNOS, and multiple
rounds of complex formation and decay do not slow enzyme activity (106). The binding
of L-arginine and H4B stabilizes the 6-coordinate-NO ferrous complex and prevents the23
formation of the inactive P420 species (107).Aromatic stacking on the distal and
proximal side of the nNOS heme by two conserved aromatic residues, Phe-584 and Trp-
409 also stabilize the ferrous-NO complex (108). Although NO can recombine with the
ferrous and ferric forms of eNOS (109), the ferrous heme-NO complex does not build-
up to detectable levels during steady-state catalysis (110). The slow NO synthesis of
eNOS is associated with slow heme reduction (92, 110).
1.2.2 Steps of NO-synthesis
NOS produces NO via two mixed-function oxidation reactions.In the first step, L-
arginine is hydroxylated to form the intermediate NHA and H2O in a reaction analogous
to the two-electron substrate hydroxylation performed by cytochrome P450 enzymes.
The subsequent three-electron oxidation of NHA is similar to the last step of the P450
aromatase reaction (111, 112) in which a ferric peroxide species is proposed to further
oxidize NHA. The mechanism describing NO-synthesis has been largely based on P450
chemistry since the two enzymes catalyze similar substrate hydroxylations in addition to
possessing a thiolate axial heme ligand, which serves as a strong internal electron donor
in the process of oxygen bond scission. However, NOS is unique from the cytochrome
P450s because its heme active center catalyzes two mechanistically distinct oxidations
of similar substrates L-arginine and NHA, which are bound in the same conformation in
the active site (113). Furthermore, NOS catalysis requires an additional cofactor, H4B,
for catalysis.
Nevertheless, the mechanism describing cytochrome P450 catalysis will be
framework for the initial description of NO synthesis. Thus, catalysis begins with an24
NADPH-derived electron reducing Fe(III) to Fe(II) (Figure 1.3).This facilitates the
binding of02to the sixth ligand position to give the intermediate [Fe(II)-02]. Based on
the crystal structure of the iNOS oxygenase domain, L-arginine binds with the
guanidinium nitrogen in the protonated form.Its close contact with a glutamic acid
residue and the heme it-electrons make it a likely candidate for proton donation to the
bound dioxygen (47). The thiolate axial heme ligand serves as a strong internal electron
donor and this facilitates 0-0 bond scission, which produces an electrophilic oxo-iron
intermediate (P.-Fe(IV)=0 where P. is a porphyrin or protein radical). This species is
thought to abstract a hydrogen atom from L-arginine and then rapidly recombine with
the resulting free radical to form the hydroxylated product (113).
The second step (Figure 1.4) may occur by a mechanism where one electron
from NADPH reduces the heme iron to the ferrous form.02binds to Fe (II) to form a
superoxo-iron (P-Fe(III)-00) that removes an electron and proton, possibly from the N-
hydroxy-group of NHA forming a proposed peroxo-iron intermediate[P-Fe(III)-00H]2
(10, 114).The [P-Fe(III)-OOH]
2+can participate in nucleophilic attack on the
guanidino carbon of .NHA to produce a putative, tetrahedral intermediate (10, 114,
115). The collapse of the tetrahedral intermediate to the observed products, citrulline
and NO can occur by proton transfer, hydride transfer or single electron chemistry.
Alternatively, once formed the[Fe(III)-OOH]2intermediate can decay by
subsequent heterolytic cleavage to a high valent iron-oxo complex [(Fe(IV)-0)]
which can hydroxylate NHA in a P450-type catalyzed reaction.The iron-oxo
intermediate has the capacity to oxidize the substrate by accepting two electrons but theC- 02
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Figure 1.3 Possible mechanism for the NOS-catalyzed conversion of L-arginine to
NHA. The reaction, based on P450 chemistry, begins with reduction of the heme iron
from the ferric to ferrous form. This enables02to bind and form a ferric super-oxo
complex, which abstracts a proton from guanidinium nitrogen of L-arginine. Oxygen-
oxygen bond scission accompanies this step and a high valent electrophilicoxo-iron
intermediate is formed which hydroxylates the guanidinum nitrogen forming NHA.HO NH
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Figure 1.4 Possible mechanism for NOS-catalyzed oxidation of NHA to L-citrulline and
NO. As with the first-step, the ferric heme is converted to the ferrous form and02binds
forming a ferric super-oxo intermediate. Hydrogen-atom abstraction from NHA generates the
ferric hydroperoxo intermediate and an NHA radical. Nucleophilic addition of peroxide to the
guanidino carbon produces a tetrahedral intermediate which decomposes to L-citrulline, NO and
H2O.27
conversion of NHA to L-citrulline and NO is a three-electron oxidation.Therefore,
there is general agreement that the second step is a peroxide-mediated reaction.
Mechanistic information on NHA oxidation, derived from peroxide shunt reactions, in
whichH2O2is substituted or NADPH and02also supports the peroxide-mediated
reaction (116). The hydrophobic environment of the distal pocket of the NOS heme
favors a peroxide-mediated reaction, and the neutralization of the guanidinium group in
NHA may discriminate between the formation of the oxo- and peroxo-iron species in the
two steps of NO synthesis (47).
1.2.3 Roleoftetrahydrobiopterin
Pteridines are widespread cofactors in mammalian cells that generally function as co-
substrates or allosteric regulator molecules. H4B exerts multiple allosteric effects on
NOS including changing the conformation around the heme substrate binding pocket,
lowering the Kd for the substrate L-arginine (117), and preventing the binding of bulky
ligands such as DTT (118) or nitrosoalkanes(39)to the heme. The addition of H4B also
causes a shift in the spin equilibrium of the heme iron to the high spin state(119-121)
and stabilizes the Fe-S bond in ferrous-CO or NO complexes(122).H4B also increases
the reactivity of theferrous-02complex 70-fold. For nNOS and iNOS, H4B was shown
to stabilize axial ligand geometry of the heme iron, promote dimerization and attenuate
feedback inhibition of NO(123).
In the aromatic amino hydroxylases (AAH), H4B has a redox role during
catalysis, as it reacts with02to form a 4a-hydroperoxy complex. Reaction of thisperoxy intermediate with a non-heme iron atom in tyrosine hydroxylase generates the
Fe(IV)=O species which is responsible for the amino acid hydroxylation. The reaction
generates quinoid H2B (124). Biochemical and structural evidence indicates that H4B
does not have a similar redox role in nNOS. An accessory pterin-4a-carbinloamine
dehydratase was not able to augment the reaction of H4B to quinoid-2B and 5-methyl-
H4B was unable to support NO synthesis while it was able to stimulate phenylalanine
hydroxylase. Evidence also indicates that the NOS heme is the site of02activation.
However, this does not exclude H4B from participating in alternate redox chemistry
since the 5-methyl derivative, although having a different redox potential than H4B, is
still able to mediate the oxidation reduction reaction (125).
Several independent studies suggest that H4B does carry out a specific redox
role. Pterin derivatives, such as dihydrobiopterin and 4-amino analog of H4B, bind to
NOS and induce the above-mentioned allosteric effects, yet they are unable to sustain
NO synthesis. An oxidation-resistant deaza analog of 6-methyltetrahydrobiopterin as
well as the potent dihydrobiopterin reductase inhibitor 4-amino-tetrahydrobiopterin
were able to inhibit NO synthesis indicating that recycling of the cofactor may be
essential for NO synthesis. These results indicate that NOS needs H4B in a particular
oxidative state that has the potential for catalysis. Heme iron reduction can take place
independently of the pterin ring oxidation-state.
Studies have suggested that H4B is a stoichiometric reactant in the first
oxygenation step of NO synthesis, in a role analogous to the role of H4B in amino acid
hydroxylases. Since catalytic amounts of H4B are required for activity, the cofactor may
remain tightly bound and be regenerated throughout the catalytic cycle through a29
dihydrobiopterin reductase like activity intrinsic to the enzyme (126). The neuronal
isoform has this capability as it can reduce quinonoid H2B to H4B (127). N°-nitro-L-
arginine, NNA, an inhibitor that blocks electron transfer to the heme, increases the qH2B
reduction rate, as does the binding ofCa2-CaM. These molecules may increase the
number of reducing equivalents, possibly direct flavin transfer, for qH2B reduction.
Inspection of the x-ray crystal structure does not provide any clues as to a
catalytic role for H4B since the cofactor lies perpendicular and distant from the active
site and has minimal contact with the heme edge (41).In tyrosine hydroxylase the
pyrimidine portion of the pterin ring is involved in a direct oxidation/reduction reaction
but there is no direct protein interaction with the N-3 of the pterin and the cofactor is
weakly associated with the enzyme. In contrast, H4B has three orders greater affinity
towards NOS than tyrosine hydroxylase, primarily through its numerous hydrogen
bonding contacts with the enzyme, therefore, the cofactor may go through redox
recycling on the enzyme rather than be released.
H4B may play a critical role in the first oxygenation step by supplying an
electron for reducing the ferric heme superoxide species[Fe(III)-O2.]2to the ferric
peroxo species [Fe(III)-OOH]2, thereby activating the molecular oxygen for P450-type
mono-oxygenation at the heme active site (128).This is suggested by experiments
showing that low H4B concentrations (100 nM) diminish the formation of superoxide
but not hydrogen peroxide. During catalysis oxygen binds to the ferrous-heme group
forming the ferrous-heme dioxygen complex [Fe(II)-O2]2, the most stable intermediate
of the reaction cycle. This complex is isoelectronic with the ferric superoxide complex
[Fe(III)-O2.]2.In the absence of H4B and L-arginine, the ferric superoxide complex30
may readily dissociate to generate superoxide and the ferric heme[Fe(III)]3. H4B may
enhance the rate of reduction of the[Fe(III)-02.}2complex to generate the peroxyl iron
complex [Fe(III)-OOHj2. The breakdown of this product would lead to the formation
of hydrogen peroxide, which has been detected as the product of uncoupled oxygen
reduction under limited H4B. H4B may mediate this activity by either favoring flavin-
dependent reduction of the[Fe(III)-02.]2species or by direct hydrogen atom donation
or electron transfer to the heme. Therefore, it is likely that H4Bdoes not inhibit the
generation of superoxide by controlling electron transfer through the enzyme. Since
only one electron is required for this transition to the peroxo species if H4B is the
electron donor, the trihydrobiopterin radical (H1B) would be the oxidized pterin product
formed during catalysis. Freeze quench EPR demonstrated that some H4B can convert to
an H1B radical during the reaction of ferrous nNOS oxygenase domain with02(129).
H4B may be regenerated by reduction of H3B radical through electron donation from a
downstream intermediate, possibly the heme-complexed tetrahedral intermediate.
H4B may also participate in the second step of catalysis by donating an electron
to the ferrous dioxy-species. It was originally suggested that NHA was the electron-
donor candidate to the ferrous-dioxy complex; however, experiments have not
demonstrated this (129-132). Electron transfer could be facilitated through the heme
propionate (42, 113).31
1.3 Properties, Cellular Distribution and Expressional Control of NOS Isoforms
1.3.1 Neuronal NOS
NOS activity is found in a wide variety of cells and tissues such as liver, brain, heart,
artery, vein, adrenal, lung and spleen. Cells such as macrophages, endothelial cells,
platelet, astrocytes, hepatocytes, mast cells, adreno-carcinoma cells, neuroblastma,
mesangial, microglial and epithelial cells also contain NOS activity. The neuronal
isoform is concentrated in a variety of neuronal structures in the brain, most notably the
pyramidal cells of the hippocampus (13, 133, 134).The isoform is also in the
epithelium of the respiratory track and skeletal muscle, where it is concentrated in fast
fibers (135-139).
The human gene for nNOS is the largest of the three isoforms, spanning 150kb
(140).The mRNA is encoded over 29 exons and the gene is located on human
chromosome 12. There is a high conservation of protein sequence (93%) between the
nNOS isolated from the rat and human brain. A human variant form of nNOS, nNOSj.t
arises from the splicing of an additional exon between exons 16 and 17 of the human
nNOS gene, which causes an in-frame insertion of 34 amino acids (141, 142). The
alternatively spliced form is expressed in various tissues, including striated muscle.
The neuronal isoform contains an additional 220 amino acids. The PDZ motif,
which is a repeat of GLGF residues that spans 100 amino acids, is located in this
sequence (143).This motif is found in diverse group of cytoskeletal proteins and
enzymes. The PDZ motif facilitates interaction between nNOS andal-syntrophin, a
binding partner of dystrophin (144). This interaction localizes nNOS to the membrane32
in this tissue, since the scarcolemma of skeletal muscle contains a family of intracellular
and transmembrane glycoproteins associated with dystrophin (144). The nNOS PDZ
motif also interacts with similar motif in post-synaptic density-95 protein (PSD-95) and
PSD 93. This interaction concentrates nNOS at synaptic junctions in brain and motor
endplates in skeletal muscle (145). Peptides binding with high affinity to the nNOS
PDZ domain selectively uncouple NOS activity from the N-methly-D-aspartate
(NMDA) receptor stimulation, suggesting that the interaction with post-synaptic
proteins targets nNOS to the NMDA receptors, creating a link between post-synaptic
glutamate binding and NO synthesis.
The two-hybrid screen led to the identification of a 10 KDa protein, which
interacts with nNOS and inhibits activity by destabilizing the NOS dimer (146). The
protein, named PIN for protein inhibitor of nNOS, binds in a 1:2 stoichiometry to a 17
amino acid insert in nNOS, which is absent in eNOS and iNOS (147). The expression
levels of PIN and nNOS are nearly parallel in different brain regions, suggesting that
PIN may function in vivo by regulating nNOS activity. However, results of Hemmens
et al. showed that a 290-fold molar excess of PIN over nNOS was required for nNOS
inhibition, and at this concentration PIN formed higher order aggregates (148).
1.3.2 Inducible NOS
Although iNOS was first isolated from murine macrophages (22, 149), it is also
localized in heart muscle, astroglia, liver and smooth muscle cells (150). Unlike nNOS
or eNOS, iNOS is regulated mainly at the transcriptional level. Thetranscription of the
iNOS gene is induced by the presence of cytokines such as interferon gamma, tumor33
necrosis factor alpha, interleukin and interleukin 2 or lippopolysaccahrides.The
signaling cascades leading to iNOS production is cell-type specific, but appears to
involve the activation of tyrosine kinases and NF-K13 (151, 152).
The overproduction of NO in response to infection can cause symptoms of septic
shock, such as extreme hypotension or cardiovascular disease.To prevent such
occurrences, macrophage cells may institute a negative feedback loop involving p53.
Accumulation of NO increases the cellular concentration of p53, which in turn down
regulates iNOS expression through inhibition of the iNOS promoter (153).iNOS
activity can also be affected by NAPI 10 (NOS-associated protein), which is expressed
in murine macrophages. NAP1 10 inhibits the catalytic activity of the enzyme by directly
interacting with the amino terminus of iNOS and preventing the formation of
homodimers. Inhibition of iNOS is a possible means by which macrophage protect
themselves from cytotoxic levels of NO (154).
1.3.2 Endothelial NOS
The endothelial isoform was first identified in endothelial cells (155), but
immunohistochemical studies have located the enzyme in cytotrophoblasts of human
placenta, kidney tubular epithelial cells, interstitial cells of the colon, and neural cells
(156-159). The NO which regulates blood pressure and platelet function, originates
mainly but not exclusively, from endothelial cells. The disruption of eNOS in mice or
the administration inhibitors specific for eNOS significantly increases the blood
pressure (160).34
This isoform is myristolated and palmitolated at the N-terminus.Acylation
targets eNOS to the plasmalemmal caveolae in endothelial cells and cardiac myocytes
(161). The plasmalemmal caveolae are small invaginations in the plasma membrane
composed of the structural transmembrane protein caveolin (162). They serve as signal
transducing microdomains as they sequester signaling molecules such as receptors, G-
proteins, and protein kinases (163). eNOS interacts with caveolin-1 in endothelial cells,
and in cardiac myocytes eNOS associates with the muscle specific caveolin-3 (164,
165). The association with caveolin-1 or caveolin-3 suppresses eNOS enzyme activity
in a manner that is reversed by Ca2-CaM (166-169).
1.4 Physiology of NO
1.4.1 Chemistry ofNO
The biological effects of NO are determined by its ability to freely diffuse through
plasma membranes and its chemical reactivity. NO is among the more stable of the
biologically relevant free radicals, having a lifetime of several seconds in oxygenated
water and much longer life span in anaerobic conditions (170). NO has to capability to
diffuse unimpeded across cell membranes, because it is a small amphipathic molecule
with relatively long half life (171).
The various fates of NO include the following: (1) NO may be oxidized to nitrite
and nitrate, which are ultimately eliminated from the body as waste products (172) or
(2) NO may diffuse into red blood cells and be consumed by reaction with hemoglobin.
NO, unlike02or CO can bind to Fe(III)porphyrins; the Fe(III)-NO can undergo a35
charge transfer complex reaction to form Fe(II)-NO (173).(3) Non-heme metal
complexes, such as iron sulfur centers are also targets for NO. (4) NO also forms
reversible S-nitrosyl complexes with thiols of cysteine residues of a number of proteins
(e.g. hemoglobin and glutathione) which extends its lifetime, as the free radical cycles
between the free and nitrosothiol states (172, 174).
The reactivity and toxicity of NO is enormously increased by its near diffusion-
limited reaction with superoxide to form the peroxynitrite anion (ONOO). Both NO
and superoxide are paramagnetic species that react by a diffusion-limited reaction (6.7 X
iO M' s'; 175); therefore, NO successfully competes with superoxide dismutase for
superoxide. Peroxynitrite can take part in a number of chemical reactions that involve
the modification of lipids, carbohydrates, nucleic acids, and proteins. For example,
peroxynitrite may directly initiate lipid peroxidation by abstraction of an allylic
hydrogen from polyunsaturated fatty acids (176). The oxidation of liposomes by 0N00
results in the formation of dienes, aldehydes and increased consumption of oxygen,
which contributes to the atherogenic processes. Theof the peroxynitrite oxoanion is
6.87, so that protonation at physiological pH yields peroxynitrous acid, (ONOOH).
This species decomposes to form a hydroxyl radical (OH) and nitrogen dioxide (NO2),
both of which are potent oxidants. The hydroxyl radical is capable of initiating lipid
oxidation, oxidizing cysteine and methionine residues, deaminating nucleic acids and
nitrating aromatic compounds (177, 178).
Several studies indicate that the formation of ONOO has the potential to disrupt
signal transduction events in the cell through modification of cysteine or tyrosine
residues on proteins involved in a signal cascades. The 0N00 anion reacts with36
reduced glutathione (GSH) andCO2leading to GSH oxidation and the formation of
nitrosoperoxycarbonate (0NO2CO2), which is a potent nitrating agent of tyrosine (179).
The reaction between peroxynitrite and SOD forms a powerful nitrating agent,NO2,
which also modifies tyrosine residues to form nitrotyrosine.
The autooxidation of NO forms the nitrosating agent nitrous anhydride(N,O1)
which directly damages DNA by deaminating cytosine and guaninein
deoxynucleosides, forming uracil and xanthine, respectively (180). DNA damage may
be central to neurotoxicity elicited by NO and other free radicals, because such types of
DNA damage activates poly (ADP-ribose) synthase (PARS), a nuclear enzyme which
ADP-ribosylates nuclear proteins such as histones and PARS itself (181). This activity
depletes energy storage through the reduction of NAD and ATP pools, eventually
leading to cell death.
1.4.2 Pathological effects of NO
Pathologies linked to excessive NO production include immune type diabetes,
inflammatory bowel disease, rheumatoid arthritis, carcinogenesis, septic shock, multiple
sclerosis, transplant rejection, and stroke (182).Whereas pathologies linked to
insufficient NO production include hypertension, impotence, arteriosclerosis and
susceptibility to infection (170, 183, 184). A consensus is emerging that the toxic or
trophic properties of NO depend on the steady state concentration and the site of
generation. Typically, NO is present at high concentrations in macrophages where it
participates in host defense against tumor cells and pathogens. In contrast, in neuronal
and endothelial cells NO is present at lower concentrations where it acts as a signaling37
molecule in processes such as vasodilatation and neurotransmission. The uncontrolled
generation of NO in a particular cell type will can lead to a variety of pathological
disorders.For example, the over-production of NO by nNOS and iNOS is directly
linked to the pathogenesis of stroke and shock (185, 186), respectively. The global
inhibition of the NOS would result in complications since the NO generated by eNOS
has been shown to be antiatherogenic and critical for angiogenesis. Therefore isoform-
specific drugs are required to inhibit NO production by nNOS and iNOS under
pathological conditions, without hindering NO generation by eNOS.
Fortunately several NOS inhibitors have proven to have differential effects on
NOS activity. Roman et al. investigated the inhibitory effects on N-amino-, N-methyl,
and N-nitro-L-arginine analogs on the various isoforms of NOS. The rank order
potency for inhibition of iNOS NO biosynthesis was found to be N-aminoN-methyl
>>N-nitro. In contrast the rank order potency was N-nitro>> N-aminoN-methyl for
eNOS and nNOS (187, 188).S-methyl-L-thiocitrulline (Me-TC) and S-ethyl-L-
thiocitrulline (Et-TC) were found to be more potent inhibitors of nNOS compared to
eNOS. (189).
1.4.3 NO as an endothelial relaxation factor
The discovery of NO as important signaling molecule in mammals was achieved
through the quest to identify an endothelium-derived relaxation factor (EDRF). EDRF
was found to be unstable, transient species, which caused smooth muscle relaxation by
raising intracellular cGMP concentrations via activation of guanylyl cyclase.
Hemoglobin, methylene blue, and superoxide were found to inactivate EDRF activity.Furchgott and Ignarro provided evidence, through NO-donating compounds, such as
sodium nitroprusside and nitroglycerin, that NO was the primary endogenous
vasodilator (190, 191). Later it was found that the enzymatic production of NO required
L-arginine as a substrate, and that L-arginine analogs served as potent vasoconstrictors.
The NO, which functions as an EDRF, originates mainly, but not exclusively
from endothelial cells and eNOS. The tonic production of endothelial-derived NO is
crucial for maintenance of normal blood pressure and platelet function; therefore,
regulation of eNOS is relevant to hypertension, atherosclerosis, and heart disease. The
agonists, acetlycholine and bradykinin activate eNOS activity by increasing intracellular
levels of Ca2, which leads to the binding ofCa2-CaM (192). eNOS activity is also
upregulated by hemodynamic shear stress which causes localCa2increase near the
plasma membrane (193)
Vasorelaxation and platelet inhibition occurs by NO binding to the heme of
soluble guanylyl cyclase, which activates the enzymes production of cGMP several
hundred-fold (194, 195). The raise in intracellular level of cGMP leads to vasodilatation
through the cGMP-dependent modification of several intracellular processes including
activation of potassium channels through cGMP-dependent kinases. Nitric oxide also
acts as an EDRF by inhibiting receptor agonist (e.g. ADP)-evokedCa2mobilization
from intracellular stores. These effects are mediated by cGMP-dependent protein kinase
and involve inhibition of phospholipase C, inositol triphosphate receptor and perhaps
intracellularCa2release channels.Evidence also suggests that NO directly activates
Ca2-dependent K channels in rabbit aortic smooth muscle cells, possibly through39
nitrosylation of sulfhydryl groups.Inhibition of platelet aggregation occurs by the
cGMP-dependent extrusion of intracellularCa2from the platelet.
The NO generated in skeletal muscle is involved contraction and relaxation of
muscle cells possibly through the cGMP pathway or through interactions with reactive
oxygen species (ROS) (139).The latter mechanism involves reactive oxidants
modulatingCa2flux at the sarcoplasmic reticulum by redox-sensitive thiol targets on
Ca2release channels and theCa2dependent ATPase. In the actively contracting state,
increased production of ROS will probably divert NO away from metal centers towards
sulfydryl targets through formation of nitrosothiols. The resultant S-nitrosylation and
thiol oxidation reaction would promoteCa2release and force production.
1.4.4 RoleofNO in the immune system
NO constitutes a primary mechanism of defense against tumor cells and intracellular
and extracellular microorganisms.At high concentrations, NO functions as a
bacteriocidal or antitumorgenic agent by inhibiting mitochondrial respiration. The
pioneering work of Hibbs demonstrated that tumor cells exposed to activated
macrophages had impaired mitochondrial respiration due to inhibition of complexes I
and II of the mitochondrial electron transport chain (196). NO was also discovered to
complex with iron-sulfur groups within key enzymes necessary for DNA replication
such as ribonucleotide reductase and mitochondrial energy production, cis-aconitase
(197-199). Along with NO, activated macrophages also produce significant amounts of
superoxide. The macrophage-generated NO andO2can react to form peroxynitrite
(ONOO-), which participates in a number of reactions leading to cell apoptosis.40
1.4.5. NO in the nervous system.
NO was implicated as a key signaling molecule in the CNS when rat cerebral cells
stimulated with N-methyl-D-aspartate (NMDA), a agonist for the glutamate receptor
were found to release the EDRF (200, 201).Histochemical staining lead to the
identification of nNOS in the rat forebrain tissue and established the existence of an L-
arginine-NO pathway in the CNS.In post-synaptic terminals, binding of glutamate to
NMDA-type receptors lead toCa2influx and the activation of nNOS. The increase in
NO stimulates guanylyl cyclase to produce cGMP (202, 203).
Because NO has the ability to diffuse freely from the point of synthesis to
intracellular target sites in neighboring cells, it differs from the more conventional
neurotransmitters in being independent of vesicular release, membrane receptors or lipid
cell boundaries (1). Therefore, it was postulated to function as a retrograde messenger
contributing to the formation of memory and development, e.g. long term potentiation
(LTP; 204, 205). The formation of LTP is proposed to occur by the following sequence
of events: (1) Glutamate, released from the presynaptic cell, activates the NMDA
receptor in the postsynaptic cell. (2) Activation of the receptor causes aCa2influx via
theCa2channel associated with the NMDA receptor or via voltage-gatedCa2channels.
(3) The increase inCa2activates NO synthase. (4) NO then diffuses randomly through
the cytosol and membranes and is absorbed by the heme group of guanyly cyclase in the
presynaptic cells. (5) The production of cGMP then evokes an increase in the release of
transmitter and synaptic transmission.
Several biochemical and mutagenic studies support the involvement of NO in
LTP. Through the use of NO donors and NOS inhibitors, Shibuki and Okado initially41
demonstrated that endogenous NO was important for the development of long term
depression in the cerebellum (206).Histochemical staining showed NOS post-
synaptically vesicles of dendrites and NO-sensitive guanylyl cyclase has been found
pre-synaptically in the hippocampus. NO was also shown to increase the release of
neurotransmitter in the hippocampus and the basal ganglion (207). Postsynaptic but not
presynaptic injection of NOS inhibitors block LTP indicating NO is produced in the
presynaptic neuron (208). Knock-out mice that are doubly mutant in eNOS and nNOS
also have reduced LTP in stratum radiatum of CAl of the hippocampus (209).
The excessive release of excitatory amino acids, such as glutamate is associated
with convulsions and neurotoxicity in addition to contributing to pathogenic
mechanisms in Alzheimer's disease and amyotrophic lateral sclerosis (210). The link
between excitation of the NMDA receptor and the activation of nNOS implicates the
involvement of NO in these disease states. Furthermore, NMDA toxicity acting via NO
may account for neural damage associated with AIDS dementia as well as neural
damage in cerebral infarction. Interestingly, Ca2-dependent neurotoxicity is triggered
most efficiently whenCa2influx occurs through NMDA receptors and can not be
reproduced by loading neurons with equivalent quantities ofCa2through non-NMDA
receptors or voltage sensitive channels (211)
NO has been shown to have neuroprotective role in CNS if the molecule changes
redox state.Sodium nitroprusside (SNP), which has NO character, significantly
protected rat cortical neurons against NMDA-induced neurotoxicity. The nitrosium ion
was able to modify the thiolate anions on the NMDA redox sites (212). This lead to42
down regulation of the receptor such that it would no longer be over stimulated by the
excessive release of excitatory amino acids (174).
In the peripheral nervous system, NO functions as a nonadrenergic-
noncholinergic (NANC) neurotransmitter mediating actions of autonomic motor
neurons on vascular and nonvascular smooth muscle (213). Neurons that are NANC
innervate a variety of smooth muscle tissues such as the gastrointestinal track, corpus
caveronsum and the esophagus. NO is responsible for NANC mediated events such
relaxation and dilation of the stomach (214), development of penile erections in humans
(215), and regulation of bronchial smooth muscle tone (216). These NANC-mediated
events appear to utilize the NO-cGMP pathway.
Due to the large number of protective and destructive effects of NO in a diverse
array of physiological events, a major challenge for the medical and pharmaceutical
communities will be to specifically target one site of NO-production, presumably with
drugs that aim to modifying one of the isoforms. Fortunately, the NOS isoforms exhibit
varying affinities for various L-arginine analogs that have proven useful for inhibiting a
specific isoform. Another target for controlling NO-synthesis is the NOS reductase
domain. The three isoforms display different means for controlling the rate of electron
transfer, (i.e.Ca2concentration, heme-redox potentials) and have varying rates of NO
synthesis which is controlled by the intrinsic rate of the flavin-mediated electron
transfer. By understanding the involvement of structural features present in the NOS
reductase domain, (i.e. autoinhibitory domains, residues close to the flavins and
NADPH, CaM-binding residues) which control electron-transfer it may ultimately be43
possible to not only decrease, but also stimulate the rate of NO-synthesis at a specific
locus.
This thesis aims at gaining an understanding of the stimulatory effects Ca2-CaM
on the mechanism of electron transfer in the reductase domain of nNOS by measuring
the reduction of DCIP and cytochromec3in the presence and absence of the activated
cofactor.These two electron acceptors were chosen since DCIP is reduced by a two-
electron transfer from reduced FAD and is stimulated only 2- to 3-fold by Ca2-CaM. In
contrast, cytochromec3is reduced by donation of one electron from FMN and the
binding of Ca2-CaM causes a 10- to 20-fold increase in activity. Kinetic mechanisms
were proposed for the reduction of these two-substrates based on initial velocity and
product and dead-end inhibition studies in Chapter 2. The pH-dependence of the rate of
electron transfer and binding of substrates was investigated to determine if Ca2-CaM
influences any ionizable groups involved in these steps (Chapter 3). Finally, data from
primary substrate (NADP(D)) and solvent isotope effects of the various kinetic
parameters were used in conjunction with the proposed kinetic mechanism to determine
the location of rate-determining step(s) (Chapter 4).44
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2.1 Summary
Binding of Ca2-activated calmodulin (Ca2-CaM) to neuronal nitric-oxide synthase
(nNOS) increases the rate of 2,6-dichloroindolphenol (DCIP) reduction 2- to 3-fold and
that of cytochrome c10- to 20-fold. Parallel initial velocity patterns indicated that both
substrates were reduced via two-half reactions in a ping-pong mechanism. Product and
dead-end inhibition data with DCIP were consistent with an iso ping-pong bi-bi
mechanism; however, product and dead-end inhibition studies with cytochromec3were
consistent with the (two-site) ping-pong mechanism previously described for the
NADPH-cytochrome P450 reductase-catalyzed reduction of cytochrome c[Sem and
Kasper (1994) Biochemistry 33, 12012-12021]. Dead-end inhibition by 2'-adenosine
monophosphate (2'-AMP) was competitive versus NADPH for both electron acceptors,
although the value of the slope inhibition constant,K1,, was to25 to 30 fold greater for
DCIP as the substrate than for cytochrome c3. The difference in the apparent affinity of
2'-AMP is proposed to result from a rapidly equilibrating isomenzation step that occurs
in both mechanisms prior to the binding of NADPH. Thus, initial velocity, product, and
dead-end inhibition data were consistent with a di-iso ping-pong bi-bi and an iso (two-
site) ping-pong mechanism for the reduction of DCIP and cytochrome c3, respectively.
The presence Ca2-CaM did not alter the proposed kinetic mechanisms. The activated
cofactor had a negligible effect on (k/Km)NADpH, while it increased (k,/Km)DCIp and
(kcajKm)cyt.c4.5- and 23-fold, respectively.46
2.2 Introduction
Nitric oxide (NO) is a ubiquitous molecule involved in a diverse array of physiological
and pathological roles (2, 201, 217-219). NO is synthesized in mammals by the NO-
synthases, a family of three homodimeric enzymes. Each of the isoforms consumes 1.5
equivalents of NADPH and two equivalents of 02 in the five-electron oxidation of L-
arginine to produce NO and L-citrulline (3, 4). The enzymes can be classified into two
distinct groups according to regulation of transcriptional expression and dependence on
intracellularCa2concentrations. The constitutively expressed neuronal (nNOS)' and
endothelial (eNOS) isoforms require an increase inCa2levels to promote the
subsequent binding of Ca2-activated calmodulin (Ca2-CaM) for NO synthesis (133).
The inducible isoform (iNOS) is transcriptionally regulated by the action of cytokines
and its NO synthesis activity is independent ofCa2concentration since CaM is tightly
bound to this isoform even at basal cellular levels of the divalent cation (220).
The CaM-binding domain, located at the center of the NOS polypeptide subunit,
tethers the N-terminal oxygenase domain to the C-terminal reductase domain (19, 30,
220).The reductase domain is structurally similar to NADPH-cytochrome P450
oxidoreductase (CPR) since each polypeptide contains one equivalent each of FAD and
FMN and the binding site for NADPH (15, 149). The oxygenase domain is structurally
unique and contains a P450-type heme, the binding site for the cofactor (6R)-5,6,7,8-
tetrahydro-L-biopterin (H4B), and the substrate L-arginine (11, 14, 47, 221). For the
constitutive isoforms, the binding of Ca2-CaM is essential for NO synthesis, because it47
triggers the electron transfer between the flavins in the reductase domain and the heme
in the oxygenase domain (18, 76).
Evidence from several laboratories indicates that the NOS reductase domain and
CPR share the same mechanism of electron transfer to the heme. The FAD and FMN
redox centers of both enzymes shuttle two electrons from the oxidation of NADPH to a
one-electron heme acceptor (15).In the absence of NADPH, both CPR and NOS
maintain an air-stable one-electron reduced state (FAD-FMNH.; 71, 222), which is
unable to reduce the heme (72, 223).The donation of two electrons through the
oxidation of NADPH reduces either enzyme to the three-electron reduced state. The
flavins then subsequently reduce the P-450 heme in two one-electron transfers returning
the enzyme to the one-electron reduced state (224, 225). Therefore, during turnover it is
proposed that NOS, like CPR, cycles between the one-electron and three-electron
reduced states (74).Furthermore, analysis of the flavin midpoint potentials and the
removal of the FMN cofactor suggests that the path of electron transfer in both enzymes
is from NADPH to FAD to FMN to the heme (73, 79, 81, 222, 226).
NOS and CPR are also able to reduce 2,6-dichioroindoiphenol (DCIP),
ferricyanide (FeCN), and cytochromec3with electrons derived from NADPH oxidation
(31, 75). However, nNOS is unique in that the binding of Ca2tCaM to the enzyme
stimulates a 2- to 3-fold increase in DCIP and FeCN reduction and a 10 to 20-fold
increase in cytochromec3reduction (30, 76). The Ca2-CaM induced stimulation of
these activities is independent of electron transfer from the flavins to the heme since the
same level of stimulation of ferricyanide and cytochromec3reduction occurs with
nNOS devoid of its oxygenase domain (74, 76, 77). Stopped-flow studies have indicatedthat the binding of Ca2-CaM increases the pre-steady state rate of electron transfer from
NADPH to the flavins (76, 78). The binding of Ca2-CaM has a negligible affect on the
flavin redox potentials indicating that the thermodynamic driving force of electron
transfer remains unchanged (73). However, the increase in electron transfer may be
facilitated by the ability of Ca2-CaM to induce a conformational change in the enzyme
(30, 74).
The reductase domain of NOS also has additional amino acid sequences that are
not found in CPR. nNOS and eNOS, which have slower rates of electron transfer to the
heme, DCIP, and cytochrome c3, contain an additional 40-50 amino acid insert located
in the FMN-binding subdomain. This insert is thought to be an autoinhibitory domain
since it was shown to promote the dissociation of CaM from nNOS at low intracellular
Ca2concentrations and to inhibit electron transfer in the absence of Ca2-CaM (79, 80,
82). Both iNOS and the constitutive isoforms possess an additional 2 1-42 amino acid-
tail at the C-terminus, which is not present in CPR. This sequence is proposed to
modulate electron transfer between the flavin moieties or between FMN and cytochrome
c3(83).
Considering the additional structural and dynamic features in NOS that are
absent in CPR, there is interest in how Ca2-CaM imparts control of electron transfer.
Although several pre-steady state kinetic and mutational analyses have been performed
to investigate the effects of Ca2-CaM on interfiavin electrontransfer, the influence of
the cofactor on the kinetic mechanism of electron transfer within the reductase domain
of the enzyme remains to be elucidated. Establishing a mechanism is important for
studying the overall rate of NO production since the control point of electron transfer49
resides within the reductase domain of the enzyme. This is suggested by the different
rates of NO-synthesis exhibited by the three isoforms as determined by the rate of
electron transfer between FAD and FMN or between FMN and the heme (38). The data
presented below describes the steady-state kinetic mechanism of the NOS-catalyzed
electron transfer to cytochromec3and DCIP in the presence and absence of Ca2-CaM.
We chose to investigate these two electron acceptors since DCIP is reduced by a two-
electron transfer from reduced FAD and is stimulated only 2- to 3-fold by Ca2-CaM
(8 1). In contrast, cytochromec3is reduced by donation of one electron from FMN and
the binding of Ca2-CaM causes a 10- to 20-fold increase in activity. Initial velocity and
product inhibition data for the nNOS-catalyzed reduction of DCIP was consistent with
an iso ping-pong bi-bi mechanism, with a steady-state isomerization step between the
release of NADP and the binding of DCIP. In contrast, initial velocity and product
inhibition data for the reduction of cytochromec3were best accommodated by a
nonclassical (two-site) ping-pong mechanism. However, dead-end inhibition studies
revealed a large difference in the K, values of 2'-AMP in competitive inhibition patterns
versus NADPH for DCIP compared to cytochrome c3t To rationalize the difference in
thevalue an additional rapidly equilibrating isomerization step between the enzyme
form found immediately after the release of the last product (E1') and the enzyme form
competent to bind NADPH (E1) was required in both mechanisms (E1' binds to 2'-AMP,
but not NADPH, whileE1does not bind 2'-AMP). The rate equations describing DCIP
and cytochromec3reduction were derived for a di-iso ping-pong bi-bi and an iso (two-
site) ping-pong mechanism, respectively. The presence of Ca2-CaM did not alter the
observed steady-state kinetic mechanisms proposed for the reduction of DCIP and50
cytochrome c3. Ca2-CaM did affect to varying degrees the kinetic parameters for the
substrates NADPH, cytochrome c3, and DCIP.
2.3 Experimental Procedures
2.3.1 Materials
The eDNA for rat neuronal NOS was kindly provided by T.M. Dawson (Johns Hopkins
University; 227), and the pCWori expression vector was a gift of F.W. Dalhquist
(University of Oregon; 228). Tetrahydrobiopterin (H4B) was purchased from Cayman
Chemical (Ann Arbor, MI), the 2', 5' ADP-Sepharose was purchased from Amersham
Pharmacia Biotech (Piscataway, NJ), and the CaM-Sepharose and CaM were generous
gifts of S. Anderson and D. Malencik (Oregon State University).All other reagents
were from Sigma Chemical Co. (St Louis, MO).
2.3.2 Enzyme expression and purification
The enzyme was purified according to the protocol published by Gerber and Ortiz de
Montellano with slight modification (229). nNOS was more than 85% pure as judged by
SDS-polyacrylamide gel electrophoresis with a specific activity of 150 nmol NO mm'
mg' at 25 °C. The rate of NO production was measured by the hemoglobin-NO capture
assay following the procedures of Stuehr et al (26).Protein concentration was
determined with the Lowry Assay using BSA as a standard (230).51
2.3.3 Measurementofreductase activities
Reactions were performed in 5 mL volume at 25 °C using either a 10 cm or 5 cm path
length cuvette. The reaction rate was measured by reduction of cytochromec3 (AE =
21.1 mM' cm') at 550 nm or DCIP = 21mM' cm') at 600 nm (231). Reaction
mixtures contained 50 mM Hepes-NaOH (pH 7.5), variable concentrations of substrates
(NADPH, cytochromec3or DCIP), and where appropriate, 10 tM CaC12, 100 nM CaM,
and variable concentrations of inhibitor (NADP, 2'AMP, or cytochrome c2). Reactions
were initiated in a total volume of 5 mL by the addition of 0.08-0.8 p.g of nNOS.
2.3.4 Preparationofcytochromec2
Cytochromec2was prepared by reducing cytochromec3with sodium dithionite. After
10 mins of incubation at room temperature, the sodium dithionite was removed by
passing 1 mL of the solution over two, 2 mL columns of G-25 resin equilbrated in H20.
The concentration of cytochromec2was determined by measuring the absorbance at
550 nm before and after reduction with sodium dithionite using the extinction
coefficients for reduced (= 29.5mM1cm') and oxidized (e = 8.4 mM'cm1)
cytochrome c (231).
2.3.5 Data analysis
Data were first analyzed graphically using primary plots of reciprocal velocities and
reciprocal substrate concentrations. Slopes and intercepts obtained from the primary
plots were then graphed as secondary plots against inhibitor concentrations. The form of52
the over all rate equation was determined by examination of the results of the graphical
analysis.Although the kinetic results are presented in double reciprocal plots, the
computer analysis was performed by the nonlinear least-squares fit to the specific rate
equation using the computer program Origin v. 4.0 (MicroCal Software Inc., North
Hampton, MA). The data from initial velocity studies were fit to equation 2.1 for a
ping-pong mechanism and to equation 2.2 for a sequential mechanism.
VAB
VI
KBA+KAB+AB
(2.1)
VAB
V.= (2.2)
IK,AKB+KBA+KAB+AB
where v is the initial velocity, A and B are concentrations of NADPH and the electron
acceptor (cytochromec3or DCIP), respectively. Vis the maximal velocity,KAandKB
are corresponding Michaelis constants for A and B, respectively, andKIAis the
dissociation constant for NADPH. Data from inhibition studies were fit to equations for
competitive (eq 2.3), uncompetitive (eq 2.4), and noncompetitive (eq 2.5) inhibition:
VA
v.= (2.3)
K111(l+ I/Kjç) + A
VA (2.4) V. =
K + A(l + I/K,,)
VA (2.5)
Krn(l + I/Kjc) + A(1 + I/K1)53
where v, is the initial velocity, Vis the maximal velocity, A is the varied substrate,Km is
the apparent Michaelis constant, / the inhibitor concentration,K11the intercept inhibition
constant, andK1the slope inhibition constant. For all reactions, the non-varied substrate
was present at a level close to itsKm.
2.4 Results
2.4.1 Initial velocity studies with DCIP as an electron acceptor
Initial velocity experiements demonstrated that substrate inhibition by NADPH for DCIP
reduction occurred at concentrations of NADPH 2-fold above itsKm.Substrate
inhibition by NADPH is also observed for the FAD-containing enzyme, nitrate reductase
(232). Therefore, the concentration of NADPH with DCIP as an electron acceptor was
varied between K1j5 toKmfor the initial velocity experiments. A plot of1/v1versus
l/[DCIP] at varying fixed concentrations of NADPH showed a family of parallel lines in
the absence of Ca2-CaM (Figure 2.IA) and in the presence Ca2-CaM (Figure 2.IB).
Similarly, a plot of I/v versus 1/[NADPH] at varying fixed concentrations of DCIP
showed a family of parallel lines in the absence and presence of Ca2-CaM (Figures 2.1 C
and 2. 1D, respectively). A parallel pattern is typical of ping-pong mechanisms in which
an irreversible step such as release of a product or the addition of substrate at saturating
levels separates the addition of either of the two substrates in the reaction sequence
(233). A nonlinear least-squares fit of the initial velocity data yeilded a lowerx2value
with the equation describing a ping-pong mechanism (eq 2.1) compared to that for a54
Figure 2.1 Initial velocity patterns for the nNOS-catalyzed reaction involving the
reduction of DCIP by NADPH. The symbols represent the experimentally determined
mean of three values, while the lines are best nonlinear global fit to the data.(A)
Varying concentrations of DCIP at NADPH concentrations of U 0.05, 0.08, A 0.12,
and V 0.25 tM.(B)CaC12at 1OtM and CaM at 100 nM present with varying
concentrations of DCIP at NADPH concentrations of 0.059, 0.094 A 0.142 and V
0.2 13 tM. (C) Varying concentrations of NADPH at DCIP concentrations of U 3, 6,
A 12, and V 25 jiM. (D)CaC12at 10 jiM and CaM at 100 nM present with varying
concentrations of NADPH at DCIP concentrations of 6, 10, A 20, and V 35 jiM.1 /v
(nmol/min)
1 /v
(nmol/min)
5-1
5-I
.
A
V
A
0.05 0.10 0.15 0.20 0.25 0.30 0.35
1/ [DCIP] (j.tM)
F1
S
A
V
0.020.040.060.080.100.120.140.160 18
1/ [DCIP] (RM)
Figure 2.11 lvi
(nmollmin)
1 /v
(nmol/min)
56
C
50
40
.
4 6 8 10 12 14 16
1/[NADPHJ (j.tM)
3c
2S
20
B
4 6 8 10 12 14 16 18
1l[NADPHJ (iM')
Figure 2.1 (Continued)57
sequential mechanism (eq 2.2). The latter equation did not reduce the chi-squared value
and gave an undefined value forKIA.
Ping-pong mechanisms are characterized by the enzyme oscillating between two
or more stable forms (234). As illustrated in Scheme 2.1, the air-stable one-electron
reduced state of nNOS,E1,is designated as one of these stable enzyme forms. The
oxidation of one NADPH molecule generates the second stable enzyme form, the three-
electron reduced state of nNOS, E3.Since DCIP reduction is a two-electron process
only one molecule is required to react withE3in the subsequent half-reaction to return
the enzyme toF1.
NADPH NADP DCIPDX DCIPd
E1 (E1 .NADPH - E3.NADP) E3 (E3 Es DCIPred) E1
(Scheme 2.1)
If DCIP reduction were to follow this classical ping-pong mechanism, the substrates and
products would bind to the enzyme in a tetra-uni fashion.
The presence of Ca2-CaM resulted in a 3-fold increase in kcat, a 4.5-fold increase
in (kcat/Km)DCIp, and a 1.5-fold increase in (kcat/Km)NADpH (Table 2.1). The experimentally
determined Michaelis constants for NADPH (22, 235) and DCIP and the turnover
number (kcat) for DCIP reduction with and without Ca2-CaM agree with previously
reported values, which have been reported to be 300mind460mm1(3 1).58
Table 2.1 Values for the steady-state kinetic parameters of nNOS-catalyzed reduction
of DCIP and cytochrome c3 in the absence and presence of Ca2-CaM
ElectronCa2+ KNADPH4C Kacc kcaiCC kcatd
Acceptor -CaM (liM) (1.LM) (s1) KNADpH
(M's' x105) (M's' x105)
DCIP 0.18 ± 0.05(5) 15.9 ± 1.9 (3)5.41 ± 0.35 (5) 300.7 ± 85.7 3.43 ± 0.47
0.35 ± 0.05 (5)10.3 ± 1.7 (3)16.10± 0.52 (5)460.0± 67.3 15.63 ± 1.18
cyt& 0.02±0.01 (6)0.4±0.1 (11)1.64±0.05 (5)725.7±261.743.17±11.3
+0.25 ± 0.09 (5) 0.4 ± 0.1 (4) 37.16 ± 0.91 (5)1486 ± 536 1004 ± 272
aKNADPH is the Michaelis constant for NADPH
bKaccis the Michaelis constant for the designated electron acceptor.
Ckcat is the maximal velocity, V, divided by the nNOS concentration.
dkcatJKNADPH and kca/Kacc are the V/KNADPHand V/Kacc divided by the nNOS concentration,
respectively.
the values are the mean and standard deviation determined from n determinations
where n is enclosed in parenthesis.
cytc is cytochrome c32.4.2 Product inhibition studies with DCIP as an electron acceptor
As indicated in Table 2.2, NADP was noncompetitive with either NADPH or DCIP as
the variable substrate, and the dead-end inhibitor, 2'AMP, was competitive versus
NADPH and uncompetitive versus DCIP. The inhibition patterns are consistent with the
classical ping-pong mechanism illustrated in Scheme 2.1 with one exception. Product
inhibition by NADP is expected to be competitive versus DCIP, because they both bind
to the same enzyme form,E3(234). However, NADP was noncompetitive versus DCIP
indicating that they bind to different forms of E3. The kinetic mechanism was therefore
revised to incorporate a step which allowsE1to isomerize to a distinct three-electron
reduced state, E1', which exclusively binds DCIP (Scheme 2.2). When an isomerization
of a stable form of the enzyme occurs in the reaction sequence it is referred to as an iso-
mechanism (234). To follow previously established nomenclature, the mechanism is
drawn in Scheme 2.2 is referred to as an iso ping-pong bi-bi (234).
NADPH NADP DCIPred
E(E .NADPH E3.NADP)E1 E1' (E1' DCIP0,-E.DCIPred)E
(Scheme 2.2)
Saturating levels of Ca2-CaM in the reaction mixtures did not affect the product and
dead-end inhibition patterns.It did increase the K, for 2'-AMP versus NADPH-2-fold,
but did not affect the K for 2'-AMP with DCIP as the variable substrate (Table 2.2).2.4.3 Initial velocity studies with cytochromec3as an electron acceptor
Cytochromec3shows substrate inhibition at concentrations above 2 p.M (5-10 times its
Km); therefore, this electron acceptor was maintained at sufficiently low concentrations
to minimize this effect. Substrate inhibition by cytochromec3also occurs with CPR at
5-10 times itsKm(236). A plot of 1/v versus l/[cytochrome c3} at varying fixed
concentrations of NADPH gave a family of parallel lines both without Ca2-CaM (Figure
2.2A) and with Ca2-CaM (Figure 2.2B). Likewise, a plot of 1/v versus 1/[NADPH] at
varying fixed concentrations of cytochromec3in the absence and presence of Ca2tCaM
produced a family of parallel lines (Figures 2.2C and 2.2D, respectively). The lack of a
slope effect suggests that both basal and CaM-stimulated cytochromec3reductase
activities are consistent with ping-pong mechanisms.This graphical analysis is
consistent with the computer analysis as the rate equation for a ping-pong mechanism
(eq 2.1) gave a better fit to the initial velocity data compared to the rate equation for a
sequential mechanism (eq. 2.2). The latter equation did not reduce the chi-squared value
and gave an undefined value for KIA.
If the nNOS reduction of cytochromec3were to follow the classical ping-pong
mechanism the binding of substrates and release of products would proceed in a hexa-
uni fashion (Scheme 2.3; 236).After the initial conversion ofE1toE1by NADPH
oxidation, two molecules of cytochrome c3, each of which are reduced by one electron,
are required to react with the enzyme to return it to its initial state,E1(Scheme 2.3).
Thus, the two-electron reduced state, E2, now appears after the reduction of the first
molecule of cytochrome c3t Equation 2.1 is also consistent with a nonclassical (two-61
Table 2.2 Dead-end and product inhibition of nNOS-catalyzed reduction of DCIP
in the absence and presence of Ca2-CaM
VariedCa2-CaM
Substrate
Inhibitor Type of
Inhibition
Inhibition
Constants (jiM)
DCIP NADP noncompetitive K.=8.1±1.8
K..=13.0± 2.0
+ NADP noncompetitive K=18.6±5.2
K..=
II12.2± 5.2
2'-AMP uncompetitive K..=435.4±23.1
+ 2'-AMP uncompetitive K..=435.6±34.0
NADPH NADP noncompetitive K.=14.5±1.5
K.=27.7± 1.8
+ NADP noncompetitive K.=8.1±1.4
=58.9±12.0
2'-AMP competitive
K1=840.9±92.9
+ 2'-AMP competitive
K1=1437.0±280.8Figure 2.2 Initial velocity patterns for the nNOS-catalyzed reaction for the reduction of
cytochromec3by NADPH. The symbols represent the experimentally determined mean
of three values, while the lines are best nonlinear fits to the data.(A) Varying
concentrations of cytochromec3(cytc) at NADPH concentrations of I 0.029, 0.047,
A 0.089, and V 0.534 pM. (B)CaCl2at 10 tM and CaM at 100 nM present with
varying concentrations of cytochromec3at NADPH concentrations of I 0.098,
0.196, A 0.588, and V 1.96 jiM. (C) Varying concentrations of NADPH at cytochrome
c3concentrations of 0.154, 0.246, A 0.619, andY 1.848 jiM. (D)CaC12at lOjiM
and CaM at 100 nM present with varying concentrations of NADPH at cytochromec3
concentrations of I 0.28, 0.51, A0.85, and V 1.99 jiM.1 lvi
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Table 2.3: Dead-end and product inhibition of nNOS-catalyzed reduction of
cytochromec3in the absence and presence of Ca2-CaM
Varied Ca2-CaM Inhibitor Type of Inhibition
Substrate Inhibition Constants (tiM)
cytc3 cytc2 competitive =2.3±0.3
+ cytc2 competitive =4.1±0.4
- NADP uncompetitive K11 =6.2±0.5
+ NADP uncompetitive Ki1=1.6±0.1
2'AMP uncompetitive Ku=95.3±2.7
+ 2'AMP uncompetitive K11 =82.4±2.3
NADPH cytc2 noncompetitive K1=6.1±1.1
=2.3±1.0
2+ + cytc noncompetitive =7.1±1.0
Ku=9.6±0.7
NADP competitive Ku8=1.2±0.1
+ NADP competitive K1=2.1± 0.1
2'AMP competitive =31.5±2.9
+ 2'AMP competitive K15=71.5±3.8NADPH NADP cytc3 cytc2cytc3 cytc2
E1 (E1.NADPH E3.NADP) E3 (E3. cytc- E2. cytc) E2(E2. cytc- E1.cytc2)E1
(Scheme 2.3)
NADPH NADP cytc3 cytc2 cytc3 cytc2
E1 (E1.NADPH-E3.NADP) E3 (E3cytc-E2.cytc) E2 (E2cytc-E1.cytc) E1
Site -1 Site-2
(Scheme 2.4)
site) ping-pong mechanism (236). In this kinetic mechanism, NADPH and cytochrome
c3react at two catalytically independent sites on the enzyme. Scheme 2.4 illustrates the
(two-site) ping-pong mechanism with the active sites for NADPH and cytochromec3
labeled as site-I and site-2, respectively. This mechanism has been previously proposed
forthe CPR-catalyzed reductionof cytochrome c3.Consideringthe
structural/functional similarities of nNOS with CPR it seems reasonable that this
mechanism also applies for the nNOS cytochromec3reductase activity. The classical
(one site) and the non-classical (two-site) mechanisms drawn in Schemes 2.3 and 2.4,
respectively, generate different product and dead-end inhibition patterns (236, 237);67
therefore, there is a means for discerning which mechanism applies for the nNOS
reduction of cytochromec3
The presence of Ca2-CaM did not alter the parallel pattern of the double
reciprocal plots (Figures 3.2B and 3.2D); however, the presence of the activated cofactor
resulted in a 23-fold increase inkcatand(kcat/Km)cytc(Table 3.1). The average value of
(kca/Km)NADPHincreased 2-fold with the addition of Ca2-CaM; however, due to the large
errors associated with the values, the change was not considered significant (Table 3.1).
2.4.4 Product inhibition studies with cytochrome cas an electron acceptor
Although the parallel initial velocity patterns with cytochromec3as the terminal
electron acceptor are consistent with either a classical (one-site) ping-pong mechanism,
(Scheme 2.3) or a non-classical (two-site) ping-pong mechanism (Scheme 2.4), product
and dead-end inhibition patterns are consistent only with the latter of these two kinetic
mechanisms. The results of the inhibition studies, summarized in Table 2.3, show that
product inhibition by NADP was competitive versus NADPH and cytochromec2was
competitive versus cytochrome c3. These patterns are consistent with the (two-site)
ping-pong mechanism (Appendix 2; 236). In the classical (one-site) hexa-uni ping-pong
mechanism drawn in Scheme 2.3, both of these inhibition patterns are expected to be
noncompetitive; therefore, this mechanism is not consistent for the nNOS-reduction of
cytochromec3(Appendix 2). The remaining inhibition patterns listed in Table 2.3 are
consistent with the (two-site) ping-pong mechanism since product inhibition by NADP
was found to be uncompetitive versus cytochromec3and cytochromec2was found to
be a noncompetitive product inhibitor versus NADPH. Finally, the dead-end inhibitionby the NADPH analog, 2'-AMP, was competitive with NADPH as the variable substrate
and uncompetitive with cytochromec3as the variable substrate.
The presence of Ca2-CaM did not effect the product and the dead-end inhibition
patterns. However, a saturating amount of Ca2-CaM in the reaction mixture increased
the value ofK1by 1.5- to 2.5- fold for both NADP and 2'-AMP with NADPH as the
variable substrate. TheK11for 2'-AMP inhibitionversus cytochromec3or DCIP did not
change significantly in the presence of Ca2-CaM.However, theKfor NADP
decreased approximately 4-fold in inhibition studies with varying concentrations of
cytochromec3.
2.4.5 Dead-end inhibition by 2 '-AMP
The
K1for 2'-AMP in inhibition studies with NADPH as the variable substrate
decreased 25- to 30-fold when the electron acceptor was changed from DCIP to
cytochromec3(Tables 2.2 and 2.3). Furthermore, thefor 2'-AMP was 4- to 5-fold
higher when DCIP rather then cytochromec3was the variable substrate. BothK11and
Kvalues for the NADPH analog changed by similar amounts under the same conditions
with Ca2-CaM.In the kinetic mechanisms proposed for DCIP (Scheme 2.2) and
cytochromec3(Scheme 2.4), 2'-AMP is expected to bind to the same enzyme form as
NADPH, E1. This would accommodate both competitive and uncompetitive patterns for
2'-AMP versus NADPH and versus the electron acceptor, respectively. If this were the
case both of the apparent affinity constants for 2'-AMP should be the same regardless of
the electron acceptor, because the dead-end inhibitor is binding to a substrate-free form
of the enzyme,E1,in both mechanisms. To explain the observed differences in apparentaffinity for 2'-AMP, a second form ofE1,labeled as E1'in Figures 2.3 and 2.4, which is
able bind 2'-AMP but not NADPH, is proposed to exist in both kinetic mechanisms. To
satisfy the competitive dead-end inhibition patternsversusNADPH, the isomerization of
E'toE1must be in rapid equilibrium. If this step was at steady-state, 2'-AMP would be
noncompetitiveversusNADPH. The kinetic mechanism for the reduction of DCIP was
modified and renamed to include this second, faster isomerization step and is now
referred to as a di-iso ping-pong bi-bi mechanism.Likewise, the reduction of
cytochromec3is now proposed to follow an iso (two-site) ping-pong mechanism.
2.5 Discussion
The classical method for distinguishing between sequential and ping-pong reaction
mechanisms is by analysis of the initial velocity patterns obtained by varying the
concentration of one substrate at several fixed concentrations of a second substrate.
When the data are plotted in double-reciprocal form, ping-pong mechanisms give
patterns of parallel lines while sequential mechanisms will yield a family of lines which
intersect to the left of the vertical axis (238), The initial velocity experiments with DCIP
and cytochromec3in the presence and absence of Ca2-CaM fit best to equation 2.1 for
a ping-pong mechanism. Abu-Soudet al.have shown that the flavin cofactors of nNOS
can be reduced with the addition of excess NADPH in the absence of any electron-
acceptor (92, 239).This data supports the ping-pong mechanism, because it
demonstrates that a binary complex between nNOS and either electron acceptor is not a
prerequisite for the binding and subsequent oxidation of NADPH.70
Although nNOS maintains one electron on its flavins in the form of a flavin-
semiquinone (FAD-FMNH.), it is unable to transfer this electron to either DCIP or to
cytochromec3(72). This one-electron reduced state of nNOS,E1,is then postulated as
one of the stable enzyme forms in the ping-pong mechanisms for DCIP and cytochrome
c3. Since hydride transfer from NADPH results in the transfer of two electrons to the
flavins, the three-electron reduced state,E1,is thought to be the second stable enzyme
form in the reaction sequences for both electron acceptors.However, the kinetic
mechanisms for DCIP and cytochromec3differ once the number of electrons required
to reduce the electron acceptor is considered. The reduction of DCIP is a two-electron
process; therefore, one molecule combining withE3is enough to return the enzyme to
E1. Scheme 2.1 illustrates the tetra-uni ping-pong mechanism for the reduction of this
substrate.In contrast, cytochromec3is reduced by one electron; therefore, it would
follow hexa-uni ping-pong mechanism, which would include the formation ofE2after
the reduction of the first molecule of cytochromec3(Scheme 2.3).
The kinetic mechanisms for the reduction of DCIP and cytochromec3illustrated
in Schemes 2.1 and 2.3, respectively, are modified to be consistent with the product and
dead-end inhibition studies in Tables 2.2 and 2.3. The kinetic mechanism for DCIP
reduction was revised to incorporate an iso-step, or an isornerization ofE3toE1'
(Scheme 2.2), based on the noncompetitive inhibition by NADPat varying
concentrations of DCIP. According to the classical ping-pong mechanism depicted in
Scheme 2.1, NADP and DCIP combine with the same enzyme form, E1; therefore,
NADP is expected to be competitive versus DCIP. However, if the two molecules bind71
exclusively to different conformations ofE3or to alternate forms ofE3that arise from
differences in the distribution of the three electrons on the flavins (i.e. (FADH.-
FMNH2)versus(FADH2-FMNH.)), and the rate of isomerization between the two
forms is at steady-state, noncompetitive inhibition is expected. Thus, this iso-step is not
included in either rapid equilibrium segment Y or Z of Figure 2.3. If the iso-step were to
occur in rapid equilibrium, NADP would be a competitive inhibitor when DCIP is the
variable substrate.The noncompetitive inhibition of NADP when NADPH is the
variable substrate (Table 2.2) is consistent with the proposed mechanism in Scheme 2.2
since the reduced and oxidized forms of the nucleotide bind toE1and E3, respectively.
Dead-end inhibition patterns with the NADPH analog, 2'-AMP, are also consistent with
the proposed kinetic mechanism. The dead-end inhibitor was found to be competitive
versusNADPH, which is consistent with them both binding to the same enzyme form.
The NADPH-analog was also found to be uncompetitiveversusDCIP (Table 2.2), which
is consistent with binding to different enzyme forms connected by an irreversible step,
the release of NADP
The parallel initial velocity patterns observed with cytochromec3as an electron
acceptor agree with both the classical (one-site) ping-pong mechanism (Scheme 2.2),
and the (two-site) ping-pong mechanism (Scheme 2.4; 233).However, product and
dead-end inhibition studies are consistent only with the latter of these two kinetic
mechanisms. The defining characteristic of the (two-site) ping-pong mechanism is
presence of two separate and functionally distinct catalytic sites on the enzyme that are
linked by a mobile component or by an internal electron carrier. This type of system
was first used to describe enzymes that contain a mobile component,such as a biotinyl72
prosthetic group (237, 240) or lipoic acid cofactor (241), which links the non-
overlapping catalytic sites on the enzyme. It has also been shown to be applicable for
enzymes with redox cofactors that serve as internal electron carriers, such as xanthine
dehydrogenase (242), glutamate synthetase (243), nitrate reductase (232), two
hydrogenases (244, 245) and dihydroorate dehydrogenase (246). The two-site ping-
pong mechanism is also proposed for the CPR-catalyzed reduction of cytochromec3in
which the FAD/FMN prosthetic groups act as internal electron carriers between the
NADPH and the cytochromec3active sites. Considering the functional and structural
similarity between CPR and nNOS reductase domain, it seems reasonable that the
product and dead-end inhibition studies for the nNOS-catalyzed reduction of cytochrome
are also consistent with a (two-site) ping-pong mechanism. In this mechanism, the
product (NADP or cytochrome c2) can be released before or after the addition of the
substrate (NADPH or cytochrome c3) and the reaction is not restricted to either
exclusive formation of binary complexes or to compulsory formation of a central ternary
complex.
This is in contrast to the classical (one-site) hexa-uni ping-pong mechanism
shown in Scheme 2.3 where the formation of the ternary complex is precluded. With
this mechanism, product inhibition by NADP is expected to be noncompetitiveversus
NADPH and competitiveversuscytochromec3(Appendix 2).Furthermore, product
inhibition by cytochromec2is expected to be noncompetitiveversusNADPH and
noncompetitiveversuscytochromec3(Appendix 2). Instead, NADP was found to be a
competitive inhibitor when NADPH was the variable substrate and an uncompetitive
inhibitorversuscytochrome c3. Cytochromec2was noncompetitiveversusNADPH73
and competitive when cytochromec3was the variable substrate (Table 2.3).These
patterns are identical with those reported for the CPR-catalyzed reduction of cytochrome
c3(236) and are consistent with the unique product inhibition patterns that are
commonly observed with the enzymes listed above which follow a (two-site) ping-pong
mechanism. The first product (P) is always competitive with the first substrate (A).
Similarly, inhibition by the second product (Q) is competitive with the second substrate
(B; 232). Therefore, we propose that the nNOS-catalyzed reduction of cytochromec3
also follows a (two-site) ping-pong mechanism in which the enzyme binds NADPH at
site-i in a uni-uni fashion and follows a tetra-uni ping-pong reaction for two molecules
of cytochromec3at site-2 (Scheme 2.4). This kinetic mechanism is only applicable for
CPR at high-ionic strength of 850 mM (236). At lower ionic strength (300 mM) the
CPR cytochromec3reductase activity is still consistent with a (two-site) ping-pong
mechanism, but the binding of cytochromec3follows a bi-bi random sequential
mechanism at site-2 (247). This was deduced from the nonlinear initial velocity patterns
observed when cytochromec3was the variable substrate for CPR at low ionic strength.
However, nNOS does not show any curvature in the initial velocity patterns for
reduction of cytochromec3at low ionic strength (Figures 2.2A and 2.2B).
Inhibition by NADP versus cytochromec3at non-saturating concentrations of
NADPH should be noncompetitive for a two-site ping-pong mechanism, but CPR and
nNOS both exhibited uncompetitive inhibition patterns (Table 2.3). To explain this
observation it was assumed that the reverse rate of hydride transfer, k4, catalyzed by
CPR was much slower than the rate of cytochromec3reduction,k9(Figure 2.4; 236).
The lack of any pronounced curvature in inhibition patterns with cytochromec2further74
indicated that hydride transfer, k1, was much slower than electron transfer from the
flavins to cytochromec3, k9(236). Since nNOS exhibits the same inhibition patterns as
CPR and it does not display any curvature in the inhibition patterns with cytochrome
c2(data not shown) this assumption(k9 >>k4) was also used in the derivation of the
(two-site) ping-pong mechanism for nNOS-catalyzed reduction of cytochromec3
(Appendix 2).
In the one-site ping-pong mechanism for DCIP, only binary enzyme-substrate
complexes form and the release of the first product, NADP, occurs before the addition
of DCIP.However, since NADPH and cytochromec3are proposed to act at
catalytically independent sites on the enzyme the formation of a ternary complex
between the two substrates and nNOS is possible. The difference may be do to the
flavin cofactor that reduces the electron acceptor. Since nNOS depleted of its FMN
cofactor is still able to reduce DCIP the reduction of this substrate may occur through
the direct two-electron transfer from the fully reduced FAD, presumably through the
conversion of (FADH2-FMNH.) to (FAD-FMNH.; 81).Once NADPH reducesE1
(FAD-FMNH.) to E1, disproportionation of electrons on the flavins establishes an
equilibrium of (FADH2-FMNH.) and (FADH.-FMNH2). It has been proposed that
NADP shifts the reduction potential of the FAD semiquinone to a more negative value
and stabilizes the FADH.-FMNH2 form of the enzyme (73). Similar effects have been
observed in P450-BM3 (248), and adrenodoxin reductase (249). As such, it is possible
that the oxidized nucleotide is required to dissociate from the nNOS to allow the
disporportionation of electrons on the flavins to favor the reduction of DCIP, thereby75
restricting the kinetic mechanism to the exclusive formation of binary enzyme-substrate
complexes.
According to the two-site ping-ping mechanism NADPH oxidation and
cytochromec3reduction operate independently during nNOS catalytic turnover. This
catalytic independence may be facilitated by topographically separate substrate binding
sites on nNOS and/or by FMN acting as the terminal electron donator.Based on
sequence comparisons, the nNOS reductase domain and CPR belong to a class of dual
flavin containing proteins that have independent NADPH/FAD and FMN binding
domains (70). Mutational analysis and sequence comparison with CPR suggests that
cytochromec3interacts with a cluster of acidic residues in the FMN domain, while
NADPH binds in close proximity to FAD (81).Therefore, if the substrates bind to
different domains, which are separated by an internal electron carrier, that stores
reducing equivalents, independent reactions with either substrate could occur.
Comparison of the inhibition constants for 2'AMP determined with DCIP or
cytochromec3as electron acceptors lead to the second modification of the mechanisms
proposed for DCIP and cytochromec3reduction.In both the iso ping-pong and the
(two-site) ping-pong, the NADPH analog binds to the same enzyme form as NADPH,
E1. This is consistent with 2'AMP dead-end inhibition patterns listed in Tables 2.2 and
2.3; however, if 2'AMP bound toE1in both mechanisms then the values of the
inhibition constants for 2'AMP should be the same regardless of the electron acceptor.
Nevertheless, a large increase in the apparent affinity for 2'AMP in the presence of
DCIP compared to cytochromec3was observed.To interpret these results, an
additional free enzyme form, E1', was proposed to occur in both mechanisms. TheI -, r
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Figure 2.3 Kinetic scheme for a di-iso ping-pong bi-bi mechanism for the nNOS-
catalyzed reduction of DCIP. A, B, P, Q, and I represent NADPH, DCIPDX,NADP,
DCIPred, and 2'-AMP respectively, and thevalues refer to their respective dissociation
constants.E1and E1' are the one-electron (FAD/FMNH.) forms of nNOS that
exclusively bind NADPH and 2'-AMP, respectively.E1and E1' are the three-electron
(FADH./FMNH2) or (FADH2/FMNH.) forms of nNOS that exclusively bind NADP
and DCIPDX,respectively. K is the equilibrium constant for the conversion of the two
enzyme forms,E1and E1'. The dotted boxes labeled X, Y, and Z indicate the proposed
rapid equilibrium segments for the reaction mechanism, whereX = E1 + E' + E'I +
E1'IQ+E1'Q +E1A;Y =E 1P+E1; Z = E1'+77
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Figure 2.4 The kinetic scheme illustrating the iso (two-site) ping-pong mechanism for
the nNOS-catalyzed reduction of cytochrome c3. A, B, P, Q, and I represent NADPH,
cytochrome c3, NADP, cytochrome c2, and 2'-AMP, respectively.E1,E1,' andE3are
the same as in Figure 2.3, and E2represents the two (FADIFMNH2) electron reduced
form
of nNOS.FA
differences in the inhibition constants for 2'AMP would arise if the following conditions
were met: (I) the NADPH analog could only form dead-end complexes with E1' and not
E1,E3, or in the case of cytochromec3, E2;(2) NADPH and NADP could not bind to
E";and (3)E1is in rapid equilibrium with E1'. The last assumption still results in a
competitive inhibition pattern for 2'AMP versus NADPH. The kinetic mechanisms
proposed for DCIP and cytochromec3were revised to include the isomerization step for
the free enzyme governed by the equilibrium constant, K (Figures 2.3 and 2.4). The two
mechanisms also include different dead-end complexes between E1' and 2'-AMP which
could account for the differences in the apparent affinity of 2'-AMP observed in dead-
end inhibition studies.
Based on sequence similarity, the putative NADP and FAD binding motifs of
nNOS belong to the family flavoenzymes of which ferridoxin-NADP reductase (FNR)
is the prototype. The early crystal structure of FNR failed to reveal the geometry
between FAD and the nicotinamide ring. The only relevant structural information was
obtained with the 2'AMP portion of the NADP molecule complexed with the enzyme
(250). This occurred because positioning of the nicotinamide ring in close proximity to
the re-face of the FAD cofactor required the energetically unfavorable displacement of a
tyrosine residue (251). The two alternate forms of nNOS,E1and E1', may likewise
result from the positioning of a similar residue in nNOS.
Rate equations were derived for the proposed di-iso ping-pong bi-bi mechanism
for DCIP and the iso (two-site) ping-pong mechanism for cytochromec3under initial
velocity conditions and for product and dead-end inhibition studies (Appendix 2). The
derivation of nNOS-catalyzed reduction of cytochromec3is similar to the derivation for79
the CPR-catalyzed reduction which assumes that the binding and release of ligands
occurs in rapid equilibrium and the conversion of enzyme forms (i.e. E to E1) occurs at
steady-state. This assumption was also used for the derivation of the nNOS-catalyzed
reduction of DCIP. All of the experimental initial velocity and inhibition patterns were
consistent with the patterns predicted for the rate equations derived under the appropriate
conditions. The turnover rate (kcat), Michaelis constant (Km), and the values for kca/Km
for each substrate are also defined in terms of rate and equilibrium constants in the
Appendix, (i.e. (kcat 1Km)NADPH= k1/KIA(1+1/K) (Figures 2.3 and 2.4) and (kcat 1Km)ip =
k7kIl/KIB(k7+k8) (Figure 2.3), (kca, 1Km)=k9kIs/KIB(k9k5) (Figure 2.4). The ratio of
rate and equilibrium constants to define(kca/Km)NADpHwas the same for both
mechanisms.
Although Ca2-CaM increased the rate of DCIP and cytochrome c3 reduction, it
did not change the proposed kinetic mechanism for the reduction of either electron
acceptor.Identical types of initial velocity, product and dead-end inhibition patterns
were observed in the presence or absence of Ca2-CaM. The presence of the activated
cofactor did have variable effects on the kinetic parameters for the various substrates
listed in Table 2.1 and on the inhibition constants listed in Table 2.2 and 2.3. The
influence of Ca2tCaM on these various parameters will be discussed in the context of
the mechanisms presented in Figures 2.3 and 2.4 in an effort to describe how individual
rate constants are affected.
NADP is a competitive inhibitor of NADPH in the presence of non-saturating
concentrations of cytochrome c3; therefore, the reported K1, is a direct measure of the
dissociation constant for NADP. The presence of Ca2-CaM in the inhibition studycaused a 2-fold increase in the inhibition constant for NADP suggesting that it may
slightly reduce the affinity of the enzyme for NADP. The activated cofactor also
caused an increase in the K,, of 2'-AMPversusNADPH with either DCIP or cytochrome
as the electron acceptor. Although the dead-end inhibitor is also competitiveversus
NADPH, theK,,value is not a direct measure of the dissociation constant because it is
also a function of the equilibrium constantK,equal to E1 /E1', (eqs A2.19, A2.20, and
A2.39 in Appendix 2).Assuming that Ca2-CaM has a negligible effect on the
equilibrium between E1 and E1', the increase in the K1,value for 2'-AMP may be
interpreted as the ability of the cofactor to slightly reduce the affinity of nNOS for 2'-
AMP. The activated cofactor also caused a 1.5-fold increase in (kca/Km)NADPH with DCIP
as an electron acceptor (Table 2.1).While the average value of (kcat/Km)NADPH with
cytochrome c3increased about 2-fold in the presence of Ca2-CaM, the large error
associated with the value, which originates with the difficulty in determining the low Km
for NADPH under these conditions, did not make the change significant (Table 2.1).
Assuming that the 1.5 to 2-fold increase (kca/Km)NADPH is valid for both acceptors, it
would be do an increase in the value of the expression:k3/KIA(l+1/K)(Appendix 2).
Thus, the presence of Ca2-CaM could either affect the rate of hydride transfer, k1, the
dissociation constant for NADPH, KIA, or both.
Ca2-CaM caused a 4.5-fold increase (kCa/Km)DCIP and a 23-fold increase in
(kcat/Km)cytc (Table 2.1). Both of these kinetic parameters are defined by ratio of forward
rate constants for the reduction of the electron acceptor in the second half reaction (k7
and k11 for DCIP and k9 and k15 for cytochrome c3) as well as their associated binding
constants shown in equations 2.6 and 2.7.(kCf/KflI)DCIP
k7k11 (2.6)
K,E(k7+k8)
(kcat 1Km)cytc
k9k15
KIB(k9+5)
(2.7)
KB is the dissociation constant for DCIP or cytochrome c3in equations 2.6 and 2.7,
respectively. The rate constants, k7, k8, and k11 in equation 2.6 are the same as those in
Figure 2.3, and the rate constants, k9 and k15 in equation 2.7 are the same as those in
Figure 2.4. The data suggests that the binding of Ca2-CaM may stimulate the rate of
electron transfer to the electron acceptors by increasing the forward rate constants for
these steps andlor decreasing the dissociation constant for the electron acceptor.
The presence of Ca2-CaM also caused an approximate 2-fold increase in
Michaelis constant for NADPH,KNADPH,with DCIP as an electron acceptor and a 10-fold
increase with cytochrome c3as an electron acceptor.Equations 2.8 and 2.9 define
KNADPHin terms of rate and equilibrium constants according to the derivation of the
mechanisms proposed for the reduction of DCIP and cytochrome c3, respectively.
KA (1 1/K)
(2.8) KNADPH
(1+ +k1/k11)
KIA(l+1/K)
KNADPH
(1 +k3/k9+k1/k15)
(2.9)The rate constants,k1,k7, and k11 in equation 2.8 are the same as those in Figure 2.3, and
the rate constants,k1,k9 and k15 in equation 2.7 are the same as those in Figure 2.4. The
reason why Ca2-CaM exerts more of a change in KNADPH with cytochromec3 may be the
difference in the ratios of rate and equilibrium constants defined for KNADPH. Assuming
that Ca2-CaM had no effect onK,then the increase in KNADPH may be do to the decrease
in k3/k9 and/or k3/k15 ratios.In other words, Ca2-CaM accelerates electron transfer to
cytochrome c3 by increasing k9 and/or k15 to a greater extent then its stimulation of
hydride transfer given by k1. The Ca2-CaM-induced increase in k9 andlor k13 also agrees
well with the large increase (23-fold) in(kca/Km)cytc(eq. 2.7).Similarly, the 2-fold
change in KNADPH with DCIP may be caused by changes in k3/k7 andJork3/k11ratios.
The presence of Ca2-CaM does not significantly change the K11 for 2'-AMP with
either DCIP or cytochromec3as the variable substrate. For DCIP, this observation is
consistent with the reaction occurring in two-half reactions and for cytochrome c3, the
observation is also consistent with the two-half reactions occurring at two separate
catalytic sites on the enzyme.
In summary, we have shown that the nNOS-catalyzed reduction of DCIP and the
nNOS-catalyzed reduction of cytochromec3are accommodated by the di-iso ping-pong
bi-bi mechanism and by the iso (two-site) ping-pong mechanism, respectively.
Although the presence of Ca2-CaM accelerates the rate of electron transfer, its presence
does not alter either of these mechanisms.2.6 Acknowledgements
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Chapter 3
The Effects of Ca2-Activated Calmodulin on Neuronal Nitric-Oxide Synthase
Reductase Activity and Binding of Substrates Characterized by pH
Kirsten R. Woithers and Michael I. Schimerlik3.1 Summary
The pH-dependence of the basal and calmodulin (CaM)-stimulated neuronal nitric-oxide
synthase reduction of 2,6-dichiorophenolindoiphenol (DCIP) and cytochrome cwas
investigated. The wave-shaped log V profile revealed optimal DCIP reduction occurred
when a group with aPKaof 7.1-7.3 was ionized. The(V/K)NADPHand(V/K)DcIppH
profiles increased with the protonation of a group with apKof 6.5 or 5.9 and the
ionization of 2 groups with the same pK of either 7.5 or 7.0, respectively.(V/K)1also
decreased with the ionization of a group with aPKaof 9.0. Similar log V,(V/K)NADPH,
and(V/K)DcIppH profiles for the reduction of DCIP were obtained with and without
CaM, indicating it does not influence ionizable groups involved in catalysis or substrate
binding. In contrast, CaM affected the pH-dependence of cytochromec3reduction.
The wave-shaped log V profile for basal cytochromec3reduction revealed that
ionization of a group,PKaof 8.6, increased catalysis. V for CaM-stimulated cytochrome
c3reduction displayed a bell-shaped pH-dependence with the protonation of a group
with aPKaof 6.4, and the ionization of a group with a pK of 9.25, resulting in a loss of
activity. The pH profiles for with and without Ca2-CaM were bell-shaped with
the ionization of group atPKaof 7.1 and 7.6 (Ca2-CaM) andPKaOf 9.38 and 9.62(Ca2-
CaM), increasing and decreasing (V/K), respectively. These results suggest thatCa2-
CaM may change the nature of the rate-limiting catalytic steps or the ionizable groups
involved in cytochromec3reduction.3.2 Introduction
The nitric-oxide synthases (NOS) are a family of three mammalian isozymes which
produce the physiologically important free radical nitric oxide, NO, (for reviews see 2,
201, 217, 219, 252). Each of the isozymes functions as a homodimer to produce NO and
L-citrulline via the 5-electron oxidation of L-arginine (3, 4). The polypeptide subunit
for each of the three isoforms is divided into two distinct domains. The oxygenase
domain contains a P450-type heme, and the binding sites for the cofactor (6R)-5,6,7,8-
tetrahydro-L-biopterin (H4B) and the substrate L-arginine (11, 14, 47, 221).The
reductase domain contains one mol each of FAD and FMN and the binding site for
NADPH (15, 149). The calmodulin (CaM)-binding motif, located at the center of the
NOS polypeptide subunit, tethers the oxygenase domain to the reductase domain (19, 30,
220). A rise in intracellularCa2concentrations promotes the binding of CaM to
neuronal (nNOS) and endothelial (eNOS) which triggers interdomain electron transfer,
an essential step for NO-synthesis (18, 76, 133). In contrast, CaM is tightly bound to the
inducible (iNOS) isoform at basal intracellular levels ofCa2;its activity is modulated at
the transcriptional level through the action of cytokines (220).
The dual flavin-containing domain of NOS is structurally and functionally
similar to NADPH-cytochrome P450-reductase (CPR) (15, 149). During catalysis, the
enzyme-bound flavins on nNOS and CPR cycle between the one- and three-electron
reduced states as they shuttle reducing equivalents from NADPH to FAD then FMN and
finally to the P450-heme (15, 73, 81, 222, 226). CPR and nNOS are both able to reduce
the non-physiological flavinelectronacceptors, ferricyanide (FeCN), 2,6-dichlorophenolindophenol (DCIP), and cytochromec3(31, 75). The binding ofCa2-
CaM to nNOS alleviates the inhibition of flavin-mediated electron transfer. This allows
nNOS to achieve of the same level of FeCN and DCIP reduction (2- to 3-fold increase)
and cytochromec3reduction (10- to 20-fold increase), exhibited by CPR (30, 76). The
same level of Ca2-CaM induced stimulation of these activities is achieved with the
nNOS reductase domain; thus, this behavior is not attributed to the cofactor triggering
electron transfer to the heme (76, 77, 253). Ca2-CaM also has a negligible effect on the
flavin midpoint potentials; thus, the cofactor does not change the thermodynamic
driving force behind electron transfer in the reductase domain (73). However, Ca2tCaM
has been shown to increase the pre-steady state rate of electron rate transfer from
NADPH to the flavins (76) and induce conformational changes in the diflavin domain
(30, 74, 81).
The binding of Ca2-CaM may remove the suppression of electron transfer by
acting on structural components which are absent in CPR. All three NOS isoforms
possess 2 1-40 additional amino acids at the C-terminal tail, and the constitutive isoforms
(nNOS and eNOS) contain a 45-50 amino acid insert located in the FMN-binding
domain. In the absence of Ca2-CaM, eNOS and nNOS lacking their C-terminal tail
exhibit faster rates of flavin and cytochromec3reduction compared to wild-type (78).
The CaM-stimulated cytochromec3reductase activity was similar for the wild-type and
the truncated forms, suggesting that the C-terminal tail acts to suppress electron transfer,
which can then be alleviated with the binding of Ca2-CaM (78). Removal of the 45-50
amino acid sequence in the FMN-domain demonstrated that thisis a putativeautoinhibitory element as it promotes the dissociation of CaM at low intracellularCa2
concentrations and inhibits electron transfer in the absence of Ca2-CaM (79, 80, 82).
The NOS isoforms exhibit varying rates of NO-synthesis, which is correlated to
the rate of interfiavin electron transfer and/or transfer between the FMN and the heme
(38). Because the efficiency or behavior of the reductase domain controls the rate of NO
production, there is great interest in the role of Ca2-CaM in mediating electron transfer.
The steady-state kinetic mechanisms for DCIP and cytochromec3reduction were the
same in the presence and absence of the activated cofactor. Both the reduction of DCIP
and cytochromec3occur in two-half reactions by a di-iso one-site ping-pong and a non-
classical iso (two-site) ping-pong mechanism, respectively. (254). The role Ca2-CaM is
further investigated in this manuscript by determining its influence on ionizable groups
associated with catalysis or binding of substrates. The pH profile for V yields values
for groups involved in rate limiting step(s) of the mechanism. In contrast, the values
in the V/K pH profiles represent groups in the steady-state mechanism that participate in
events from binding of the substrate up to the first irreversible step, which could be a
catalytic step or product release. If theto appears in both the V and V/K profiles, it
represents the particular ionization state of a group on the enzyme or substrate that is
limiting for catalysis rather than one involved solely in substrate binding (255). The
proposed steady-state kinetic mechanisms for the reduction of these two substrates also
provided a framework for the interpretation of the dependence of V and V/K for
substrates on pH.3.3 Experimental Procedures
3.3.1 Materials
NADPH, NADP, DCIP, and horse heart cytochromec3were purchased form Sigma
Chemical Co. (St Louis, MO).Hepes was purchased from Research Organics
(Cleveland, OH). Tetrahydrobiopterin was purchased from Cayman Chemical (Ann
Arbor, MI), the 2', 5'-ADP-Sepharose was purchased from Amersham Pharmacia
Biotech (Piscataway, NJ), and the calmodulin-Sepharose and calmodulin were generous
gifts of Dr. S. Anderson (Oregon State University). All other reagents were from Sigma
Chemical Co. (St Louis, MO).
3.3.2 Protein expression and purification
Recombinant rat nNOS was purified from E.coli strain BL21(DE3) after over
expression of the eDNA with the pCWori vector. The enzyme was purified according to
the protocol published by Gerber and Ortiz de Montellano with slight modification
(229). The rate of NO production was measured by the hemoglobin-NO capture assay at
25 °C following the procedures of Stuehr et at (22). nNOS was more than 85% pure as
judged by densometric scan of an SDS-polyacrylamide gel with a specific activity of
150 nmol NO min
1mgat 25° C.Protein concentration was determined with the
Lowry Assay using bovine berum albumin as a standard (230).3.3.3 Substrate titrations
3P-NMR spectra for NADPH titration curves were obtained with a Bruker DRX 600
spectrometer operating at 242.9 MHz using a 900 observation pulse. Chemical shifts
were referenced to H20. Experiments were performed at 25°C using a 5 mm Nuclear
Magentic Resonance (NMR) tube. The spectra were collected unlocked with constant
compensation for field drift.Titration samples contained 1 mM NADPH in the buffer
used for the pH kinetic studies. The spectrophotometric titration of DCIP at 600 nm was
performed at 25 °C. The samples contained 20 jiM DCIP in the buffer used for the pH
kinetic studies.
3.3.4 Measurement of reductase activities
A three-component buffer system consisting of 15 mM MES (p Ka 6.15), 15 mM Hepes
(PKa 7.55) and 15 mM CHES (PKa 9.5) was used for the pH-dependence studies. The
buffer was titrated to the desired pH with NaOH. Reactions were performed in a 5.0 mL
volume at 25 °C using either a 1 cm or 5 cm path length cuvette. The rate of cytochrome
c3was measured by following absorbance changes at 550 nm (A= 21.1 mM' cm')
(231). The rate of DCIP reduction was measured by following absorbance changes at
600 nm using an extinction coefficient for DCIP that was calculated at each pH
(described below). Reaction mixtures contained variable concentrations of substrates
(NADPH, cytochromec3or DCIP), and where appropriate 10 jiMCaCl2and 100 nM
CaM. Reactions were initiated by the addition of 0.54 jig of nNOS to a 5 mL reaction
volume. The pH profiles were extended as far as possible into the pH extremes until91
enzyme or substrate instability prevented the measurement of initial rates. At pH values
below 7 the level of uncatalyzed NADPH oxidation in the absence of nNOS were
subtracted from initial rates obtained in the presence of the enzyme.
3.3.5 Data analysis
Values for the various parameters were derived by non-linear least-squares fitting
(Levenberg-Marquardt algorithm) of a given equation to the data using the computer
programs Origin v. 4.0 (MicroCal Software Inc., North Hampton, MA) or MicroMath
Scientist (MicroMath Scientific Software, Salt Lake City, UT.). V and (V/K)values
for the basal and CaM-stimulated reduction of cytochrome c3' were obtained by
measuring the rate of cytochromec3reduction at fixed saturating concentration of
NADPH (10 jiM). The initial rates were fit to the Michaelis-Menton equation (eq 3.1).
VAV,KA (3.1)
where v represents the initial rate, V is the maximal velocity,Ais variable substrate
concentration, andKmthe Michaelis constant for the variable substrate.Similarly,
(V/K)NADPHvalues for the basal and CaM-stimulated reduction of DCIP were obtained
from a fit to eq 3.1 with DCIP present at a constant sub-saturating concentration of20
p.M.Concentrations of NADPH >2KFIinhibits DCIP reduction at DCIP
concentrations<KDCIP; thus,(V/K)1in the presence and absence of Ca2-CaM was
determined by fitting the initial rate at various DCIP concentrations with fixed non-92
saturating levels NADPH (0.3 jiM) and fitting the data to eq 3.1. This method is valid
since the basal and CaM-stimulated reduction of DCIP follows a ping-pong mechanism
(254); therefore, the concentration of the nonvariable substrate can be maintained at
nonsaturating levels without effecting the value of (V/K) for the variable substrate. The
log V profile for basal and CaM-stimulated reduction of DCIP was determined by
measuring the initial rate at saturating amounts of NADPH (20 tM) and DCIP (100 jtM)
in the reaction mixture.
Titration curves for NADPH and DCIP (Figure 3.1A and 3.1B, respectively)
were fit to the following equation:
[YH +YL(H/K)]
(H/K+1)
(3.2)
where Y is the 31P-NMR chemical shift (NADPH profile) or the extinction coefficient
(DCIP profile),His the proton concentration,Kis the acid dissociation constant, andL
andHare the low- and high-pH plateau values, respectively, for Y.All plots of the
kinetic data contain error bars for each the average of four data points corresponding to
one standard deviation. The following equation was used to fit a wave with ionization of
one group leading to an increase in the rate of catalysis.
(3.3) logY
log[YH +YL(H/K2)1
(1+H/K2)
]
where Y denotes the maximal velocity, H is the proton concentration, K2is the acid
dissociation constant, andHand Lare the values for Y at the high- and low- pH93
plateaus, respectively. The log V pH profile for the reduction of DCIP in the absence
and presence of Ca2-CaM (Figure 3.2) and nNOS-catalyzed basal reduction of
cytochrome c3 (Figure 3.5A) were fit to eq 3.3. The (V/K)NADPH pH profiles (Figure 3.3)
with DCIP as the second substrate in the presence and absence of Ca2-CaM in which the
ionization of a group with a low PKa decreases (V/K)NADPH and the ionization of two
groups with the same PKa leads to an increase in (V/K)NADPH were fit to the equation 3.4.
YH+YL(H/KI)(H/K2)l loY=lo[y] (3.4)
where Y is (V/K)NADPH,His the proton concentration,K1is the acid dissociation of the
group which ionizes at a lower pH, K2 is the acid dissociation constants for the two
groups that ionize at a high pH, andHandL arethe values of (V/K)NADPH at the high-
and low-pH plateaus, respectively. The (V/K)DcIp pH profiles (Figure 3.4), in which the
ionization of group with a low PKa, the protonation of two groups with the same mid-
range PKa. and the ionization of a group with a high pKa all lead to a decrease in (V/K1
were fit to the following equation.
"H+YL(H/K)(H/K2)2
1 logY1o[(
+H/K)(l + H/K2)2 (1 + H/K1)]
(3.5)
where Y is (V/K, K1,K2, K3are the dissociation constants for the groups that ionize at
low, neutral and high pH, respectively. HandL arethe high- and low-pH plateau
values for Y, respectively.The pH profiles that were bell-shaped, where catalysis94
requires the ionization of a group at a low pH and the protonation of a group at a higher
pH, were fit to the following equation
(1+H/K2+K1/H)
I logYlog[
(3.6)
where Y is V or (V/K),K1and K2 are the dissociation constants for the groups that
ionize at low and high pH, respectively, andHis the value for V or (V/K) when both
groups are in their preferred ionization states. The log V versus pH profile for CaM-
stimulated cytochrome c3, reduction (Figure 3.5B) and the (V/K)versus pH profiles
with and without Ca2-CaM (Figure 3.6) where fit to eq 3.6.
3.4 Results
3.4.1 pH-characterization of substrates
TheP'afor ionizable groups on NADPH and DCIP were determined to aid in the
interpretation kinetic pH profiles. The pH variation in the chemical shift of the 31P by
NMR has been the method previously employed to determine thePKaof the NADPH
2'phosphate.ThePKavalues were reported to be 6.1 for NADPH in 100% D20
containing 500 mM KCI at 11°C (256) and 6.52 in 10 % D20 and 10% (w/v) glycerol at
25°C (257). At an ionic strength of 800 mM and in the absence of D20, Sem and Kasper
reported aPKaof 5.91 for the 2'-phosphate of NADPH (258). From the variation in the
above reported values, it is apparent that both ionic strength and the presence of D20
will affect thePKaof the NADPH 2'-phosphate.Therefore, it was necessary to
determine thePKaunder the conditions of our pH studies. To avoid the use of D20 in5.(
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Figure 3.1 (A) pH variation of the 31P-NMR chemical shift of the 2'-phosphate of
NADPH in the buffer used for pH studies. (B) pH variation of the extinction coefficient
for DCIP at 600 nm in the buffer used for the pH studies A fit of the data to eq 3.2 gave
a of6.46forpanalA andapK
aof5.87forpanalB.Table 3.1 pH-dependence of kinetic parameters for DCIP reduction
Kinetic
Parameter CaM
pK1 pK2 pK3
V - 7.65±0.06
V + 7.77±0.04
(V/K)NADPH - 6.47±0.37 7.51±0.07
(V/K)ApH + 6.47±0.02 7.56±0.05
(V/K)DcIp 5.86a 6.97±0.07 9.00±0.22
(V/K)1 + 5.86a 7.08±0.07 9.01±0.21
a valuewas fixed97
± 0.02. (B) pH variation of the extinction coefficient for DCIP at 600 nm in the buffer
the buffer the spectra were collected unlocked with constant compensation for the field
drift. At 25°C thePKaof the NADPH 2'-phosphate is 6.47 ± 0.02 (Figure 3.lA).
A hydroxyl group on DCIP is known to ionize in the pH range studied and change the
extinction coefficient for the substrate.ThePKaof this group under the buffering
conditions used for the nNOS pH studies was determined by measuring the absorbance
of used for the pH studies. A nonlinear least squares fit of eq 3.2 yielded aPKafor the
hydroxyl group of 5.87 ± 0.02 (Figure 3. 1B) which is identical within error to the value
obtained by Sem and Kasper (258). The extinction coefficients used for calculating
initial rates of DCIP reduction in the pH-dependence studies were calculated at each pH
with eq 3.2, which assumes an extinction coefficient of 21.0 mM' cm' at pH 7.0 (259).
3.4.2 pH-dependence of kinetic parameters for DCIP reduction
The kinetic parameters for the nNOS-catalyzed reduction of DCIP were measured over
the pH range of 5.59.0. ThePKavalues for V, (V/K)NADPH, and(V/K1are listed in
Table 3.1. The pH-dependence of V for the basal and CaM-stimulated reduction of
DCIP were wave-shaped with the ionization of a group,PKaof 7.65 ± 0.06 and 7.77 ±
0.04 (Ca2-CaM) leading to an increase the rate of DCIP reduction (Figure 3.2).
The(V/K)NADPHversus pH profiles for basal and CaM-stimulated DCIP reductase
activity are shown Figure 3.3.(V/K)NADPHincreased in the low-pH extreme as a group a3.8
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Figure 3.2 pH-dependence of V for the nNOS-catalyzed reduction of DCIP in the (A)
absence and (B) presence of 10 .tMCaCl2and 100 nM CaM. The reaction mixtures also
contained 100 p.M DCIP and 20 p.M NADPH and 1.5 p.g of nNOS. The data points in A
and B were fit to equation 3.3 and the values are listed in Table 3.1.3.80
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Figure 3.3 pH dependence of(V/K)NADPHfor the nNOS-catalyzed reduction for DCIP in
the (A) absence and in the (B) presence of 10 p.MCaCl2and 100 nM CaM. The reaction
mixtures also contained varying concentrations of NADPH, 20 p.M DCIP and 0.5 p.g of
nNOS. The data points in A and B were fit to equation 3.4 and the values are listed
in Table 3.1.100
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Figure 3.4 pH dependence of(V/K)1for the nNOS-catalyzed reduction for DCIP in
the (A) absence and in the (B) presence of 10 j.tMCaC12and 100 nM CaM. The reaction
mixtures also contained varying concentrations of DCIP, 0.25 j.tM NADPH and 0.5 jig
of nNOS. The data points in A arid B were fit to equation 3.5 and the values are
listed in Table 3.1.101
with aPKaiof 6.47 ± 0.37 (basal) and 6.47 ± 0.20 (+Ca2-CaM) was protonated. The
PKa1may reflect the ionization of the 2'phosphate of NADPH, since it equals thePKa
determined in the titration of 31P for NADPH (Figure 3.1A), and it does not appear in the
log V profile (Figure 3.2). The increase in(V/K)NADPHat a low pH suggests that the
protonated or monoanionic form of the 2'-phosphate is the preferred state for binding of
the nucleotide to nNOS.(V/K)NADPHincreases with the ionization of two groups each
withP'a2of 7.51 ± 0.07 (basal) and 7.56 ± 0.05 (Ca2-CaM). One of the groups in each
profile reflects a group involved in catalysis since a similarPKais observed in the log V
pH profile (Figure 3.2).
A plot of log(V/K)1versus pH also increases at low pH (Figure 3.4). ThePKa
for this group is shifted to the left compared to the pH profile for(V/K)NADPH(Figure
3.3). As such, the number of data points was insufficient to obtain an accurate
determination ofPKa1when eq 3.4 or eq 3.5 was to fit the data. The pH profile could not
be extended to lower pH values due to the increase in uncatalyzed NADPH oxidation.
However, if we assume that this group originates from the ionization of the hydroxyl
group on DCIP and fixPKaiat 5.87 during the fitting routine, a reasonable fit of the data
is obtained with eq 3.5. The ionization of two groups which lead to an increase in
(V/K)Dclp had equalPKavalues of 6.97 ± 0.07 (basal) and 7.08 ± 0.07 (Ca2-CaM). On
the basic pH limb,(V/K1decreased with a ionization of a group,PKa3of 9.00 ± 0.22
(basal) and 9.01 ± 0.21 (Ca2-CaM). A more accurate determination ofPKa3could not be
obtained because nNOS quickly lost stability at pH > 9.0. The value ofPKa2is102
Table 3.2 pH-dependence of kinetic parameters for cytochromec3reduction
Kinetic Ca2- pK1 pK2
Parameter CaM
V - 8.60±0.04
V + 6.40 ± 0.06 9.25 ± 0.09
(VIK), - 7.10±0.12 9.38±0.23
(VfK), + 6.47 ± 0.02 9.62 ± 0.375.0
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Figure 3.5 pH-dependence of V for the nNOS-catalyzed reduction of cytochromec3in
the (A) absence and (B) presence of 10 RMCaC12and 100 nM CaM. The reaction
mixtures contained varying concentration of cytochromec3and 20 .tM NADPH, 0.5 j.tg
of nNOS. The data points in A were fit to eq 3.3 and the data points in B were fit to eq
3.6. The pK values are listed in Table 3.2.104
comparable to thePKa2in the log V pH profile for basal and CaM-stimulated reduction
of DCIP (Figure 3.2); therefore it likely reflects an ionizable group involved in catalysis
and not the binding of group,PKaof 6.40 ± 0.06, which is must be unprotonated for
activity and a slope of 1 for DCIP. However, the second PKa2 and PKa3, represent
ionizable groups on nNOS that affect the binding of DCIP as they only appear in the log
(V/K)1versus pH profile.
3.4.3 pH-dependenceofthe kinetic parameters for cytochromec3reduction
The PKa values associated with pH-dependence of the steady-state kinetic parameters for
cytochromec3reduction are summarized in Table 3.2. The pH profile for V for the
basal reduction of cytochromec3forms a wave, where the ionization of a group with a
PKaof 8.60 ± 0.04 leads to optimal cytochromec3reductase activity (Figure 3.5A). In
contrast, the log V pH profile for the CaM-stimulated reduction of cytochromec3forms
a bell-shaped curve (Figure 3.5B). The log V pH profile has a slope of 1 from a group,
PKaof 9.25 ± 0.09 that must be protonated for activity.Comparison of the pH-
dependence on V for basal and CaM-stimulated cytochromec3reduction indicates that
Ca2-CaM incorporates either 2 different ionizable groups or shifts the lowerPKaover 2
pH units and incorporates an additional group that ionizes at a higher pH.
The pH variation for (V/K)for the basal and CaM-stimulated reduction of
cytochromec3are shown in Figure 3.6. Both profiles show a bell-shaped curve, with
the ionization of a group with apKaiof 7.10 ± 0.12 and 7.58 ± 0.12 (Ca2-CaM)3.50
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Figure 3.6 pH-dependence of (VIK)for the nNOS-catalyzed reduction of cytochrome
c3in the (A) absence and (B) presence of IOp.MCaCl2and 100 nM CaM. The reaction
mixtures contained varying concentration of cytochromec3and 20 tM NADPH, 0.5 p.g
of nNOS. The data points in A and B were fit to equation 3.2. ThePKavalues are listed
in Table 3.2.106
increasing(V/K1and the ionization of a group with apKa2of 9.38 ± 0.23 and 9.62 ±
0.37 (Ca2-CaM) resulting in a decrease in (V/K)(Table 3.2).For the basal
cytochromec3reductase activity, thePKaishifts from 8.6 in the log V pH profile to 7.1
in the log (V/K) pH profile. SincePKa1appears in both profiles, it reflects an ionizable
group involved in a catalytic step during the basal and CaM-stimulated reduction of
cytochrome c3. The .1.5 pH unit perturbation forPKaifor the basal cytochromec3
reductase activity to the left in the log (V/K)profile could reflect differences in the
microenvironment of the cytochrome-free enzyme compared to the nNOS complexed
with the electron acceptor. The log (V/K)pH profile also shows an additionalpKa2for
a basic group, which is not in the corresponding log V p11 profile. Thus, the ionization
of this group is responsible for the decrease in binding of cytochrome c3.The
calculatedPKavalues appear in both bell-shaped log V and log (V/K1versus pH
profiles for CaM-stimulated cytochromec3reduction; thus, they represent groups
involved in catalysis. ThePKa1value shifts outward from the log V pH profile by 1.2 pH
units, possibly reflecting a slow substrate release step or solvent exclusion from the
active site.
3.5 Discussion
3.5.1 InterpretationofpH profilesfor the reductionofDCIP
The interpretation of the pH profiles for the catalysis and binding of substrates for basal
and CaM-stimulated nNOS catalyzed reduction of DCIP and cytochromec3will be107
-.H
k3 : k7
E1A '-E1P '
E1, E1' 'k ' "k8
AH
I Kth
K Kjq 1k12
E1 "E1''E1'Q E3'B
Figure 3.7 Kinetic scheme for a di-iso ping-pong bi-bi mechanism for the nNOS-
catalyzed reduction of DCIP. A, B, P, and Q represent NADPH, DCIPDX,NADP, and
DCIPred, and thevalues refer to their respective dissociation constants.E1and E1' are
the one-electron (FAD/FMNH.) forms of nNOS that exclusively bind NADPH and
2'AMP, respectively.E3and E1' are the three-electron (FADH.IFMNH2) or
(FADH2IFMNH.) forms of nNOS that exclusively bind NADP and DCIPDX,
respectively.Kis the equilibrium constant for the conversion of the two enzyme forms,
E1andE1'done in the context of their proposed steady-state kinetic mechanism (254).Initial
velocity, product, and dead-end inhibition studies were consistent with DCIP reduction
following a di-iso ping-pong bi-bi mechanism drawn in Figure 3.7 in the presence and
absence of CaM. The features of the proposed mechanism include the following: (1)
NADPH, binds to the one-electron reduced state,E1.(2) The oxidation of NADPH
reduces nNOS to the three-electron reduced state,E1.(3) A steady-state isomerization of
E1occurs after the release of NADP, and prior to the binding of DCIP, (i.e.E3to E3')
(4) After the reduction and release of reduced DCIP, there is a rapidly equilibrating
isomerization of the free enzyme form prior to the binding of NADPH, (i.e E1' to E1).
E,',is able to bind the NADPH analog, 2'-AMP, but not the substrate NADPH. To
simplify the derivation of the di-iso ping pong mechanism the binding of
substrates/inhibitors and the release of products is assumed to occur in rapid equilibrium.
The derivation of the rate equation for the mechanism drawn in Figure 3.7 allowed V and
the Michaelis constants for NADPH and DCIP to be defined in terms of the following
rate constants.
V k1k7k11
(3.7)
E (k1k7 +k1k11 +k7k11)
KIA (k7k11)(1 + 1/K)
(3.8) KA
(k1k7 +kk +k7k)
KIB(klk7 +k1k8)
K8
(k1k7 + k1k1 + k7k1)
(3.9)
where V is the maximal velocity, E is the nNOS concentration,KAandKBare the
Michaelis constants for NADPH and DCIP, respectively andKIAandKIBare their109
corresponding dissociation constants. The rate constants are the same as those in Figure
3.7, and K(equal toE1! E1') is the equilibrium constant for the conversion of the two free
enzyme forms.
The log V pH profile for the basal and CaM-stimulated reduction of DCIP forms
a wave where the ionization of a group with a PKa of 7.5 to 7.6 leads to an increase in
catalysis (Figure 3.2).The rate of catalysis reaches a plateau at high and low pH;
therefore, it follows the simplified mechanism shown in Scheme 3.1; where the proton
can associate with either the substrate free or substrate-enzyme binary complex, and
both the ionized and protonated forms of nNOS are catalytically active.
SE+W SE+H EPW
_LK2__
S+EH 'SEH EH+P (Scheme 3.1)
While (V/K) profiles generally show a loss of activity when groups are
incorrectly protonated, V profiles may show changes to a new plateau level when
ionization of a group increases the rate of the step that is normally rate-limiting (233).
Thus according to eq 3.7, the ionization of a group that leads to an increase in a rate-
limiting step may affect hydride transfer, k1, the steady-state isomerization of E1 to E1',
k7 andlor the rate of electron transfer to DCIP, k11.110
To discern which of these rate constants may be affected by pH, the log
(V/K)NADPHand the log(V/K)1profiles were investigated.(V/K)NADPHand(V/K)1are
defined by the following rate and equilibrium constants.
(v/E,, k3
K )NADPH KIA (i+ 1/K)
(3.10)
V/E, k7k11
KJDCIPKiB(k7+k8)
(3.11)
The log(V/K)NADPHpH profiles with and without Ca2-CaM were a similar in shape
(Figure 3.3). On the acidic limb,(V/K)NADPHincreased due to the protonation of a group
with aP'aof 6.47. As the pH increased,(V/K)NADPHincreased as two groups both with a
PKaof 7.5-7.6 ionized. The ionization of one of these groups is responsible for an
increase rate of catalysis, since the samePKavalue also appears in the log V profile. As
shown in eq. 3.10 the only catalytic rate constant which appears in(V/K)NADPHis k3, the
rate of hydride transfer.Thus the ionization of this group, with aPKaof 7.5-7.6
increases the rate of k3.Ifk3is slow, or rate limiting compared tok7and k11, then V is
largely dependent on k1. Thus thePKaof 7.5-7.6 which appears in the log V pH profile
may represent a group whose ionization status affects the rate of hydride transfer to from
the nictotinamde ring to FAD.
The second group with aPKaof 7.5-7.6 and the group with aPKa1of 6.47, effect
the binding of the nucleotide since they only appear in the log(V/K)NADPHprofile and not
the log V profile. The value of 6.47 forPKaiwas observed in the titration of NADPH 2'-
phosphate (Figure 3.IA) suggesting that thisoriginates from the nucleotide. If this
were the case, then the monoanionic form of 2'-phospahate of NADPH preferentially111
binds nNOS. This is in contrast to a number of other nicotinamide-binding enzymes
including CPR (258), iso-citrate dehydrogenase (257), dihydrofolate reductase (260),
and glyceraldehyde-3-phosphate dehydrogenase (261) in which the dianionic form of
NADPH preferentially binds.Interestingly, NADPH complexed with these enzymes
typically exhibits a lower thePKavalue (5-5.5) for the 2'-phosphate, suggesting that it
interacts one or more positively charged groups in the active site or there is distortion of
the O-P-O angles (261). The dianionic form of NADPH may also binds to nNOS,
provided that thePKaof the 2'-phosphate is shifted to a lower pH value, as with the
above nucleotide-binding enzymes, to prevent it from being observed in the(V/K)NADPH
pH profiles. This situation would place the group with aPKa1of 6.47 on nNOS. The
second acidic group with aPKa2equal to 7.5 likely originates on nNOS since NADPH
does not have an ionizable group with thisPKavalue.
Amino acid sequence of the NOS NADPHIFAD binding motif in the reductase
domain is homologous to a class of flavoproteins, the transhydrogenases, which include
ferridoxin-NADP reductase (FNR), CPR, NADH-nitrate reductase, NADH-cytochrome
b5 reductase and phthalate dioxygenase reductase (66). The three-dimensional structure
of FNR.2'phosphate-AMP complex shows interaction between the 2'-phosphate and
residues Ser234, Arg235, Tyr236 and possibly Lys224 (250). These conserved residues
have been also been implicated in the binding 2'-phosphate of NADPH with other
members of the transhydrogenase family.The corresponding residues in nNOS,
Ser1327, Arg1328, Lys1334 and Tyr1336 may also play a role in stabilizing the 2'-
phosphate. Site directed mutagenesis combined with pH studies identified Arg597 on
CPR with aPKaof 9.5 as a residue involved in ionic interactions with the 2'-phosphate112
of NADPH (262). The log(V/K)NADPHprofile for nNOS could not be extended beyond
9.0 due to enzyme instability, preventing a similarPKavalue on the basic limb of the
profile from being observed. Assignment of these residues in stabilizing NADPH in
nNOS awaits the three-dimensional crystal structure of the enzyme and/or site directed
mutagenesis of these residues.
The pH profiles for(V/K)DcIpand(V/K)NADPUare similar in that(V/K)1
increases at the low pH limit. A fit of the data to eq 3.4 or eq 3.5 does not generate a
defined value for this PKa, because of an inability to obtain data at the lower pH value.
If we assume that thisPKaoriginates from the ionization of the DCIP hydroxyl, and fix
this parameter at 5.87 (Figure 3.1B), then the remaining parameters can be defined
through a nonlinear least squares fit of eq 3.5 to the data.
pH-dependence studies on CPR-catalyzed reduction of DCIP revealed that
(V/KDcJp decreases at low pH as a group with aPKaof 5.9 is protonated (258), which
was suggested to originate from the ionization of the DCIP hydroxyl. In contrast, an
increase in(V/K)DcIpin both the basal and CaM-stimulated activities indicates that
protonated form of DCIP has a higher affinity for nNOS. If thisPKacorresponds to the
DCIP hydroxyl group, the change in the direction of the nNOS and CPR(V/K)1pH
profiles at acidic pH may be attributed to the two enzymes having different binding sites
for DCIP. Alternate binding sites may explain why nNOS depleted of the FMN can
reduce DCIP (81), while CPR cannot (226).Alternatively, the lowerPKamay originate
from a group on nNOS that facilitates DCIP binding.
A fit of equation 3.5 to the data in Figure 3.4 generatedPKa7values for the ionization of
two groups ranging between 6.9-7.1 and aPKaof 8.8-9.2 for the ionization113
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Figure 3.8 The kinetic scheme illustrating the iso (two-site) ping-pong mechanism for
the nNOS-catalyzed reduction of cytochrome c3t A, B, P, Q, and I represent NADPH,
cytochrome c3, NADP, and cytochrome c2, and 2'-AMP, respectively.E1and E1' are
the one-electron (FADIFMNH.) forms of nNOS that exclusively bind NADPH and 2'-
AMP, respectively.E2andE3represent two (FAD/FMNH2) and three-electron
(FADH./FMNH2) reduced form of nNOS. K is the equilibrium constant for the
conversion of the two enzyme forms,E1andE1'.114
of a third group. The presence of Ca2-CaM did not significantly influence the values of
these groups. According to eq 3.12, thesePKavalues may be a function of rate constants
defining the following (1) steady-state isomerization ofE1toE3', k7andk8,(2)
dissociation of DCIP, KIBor (3) the rate of electron transfer from the flavins to nNOS,
k1
3.5.2 Interpretation of pH profiles for cytochromec3reductase activity
Initial velocity, product, and dead-end inhibition studies for basal and CaM-stimulated
reduction of cytochromec3are consistent with an iso two-site ping-pong mechanism
shown in Figure 3.8 (254). Although the reaction consists of two-half reactions, the two
active sites operate independently; therefore, unlike the classical one-site ping-pong
mechanism, formation of a ternary complex is possible. NADPH binds in a uni-uni
fashion at site 1 and converts the enzyme fromE1to E1. Cytochrome c3, binds in a tert-
uni ping-pong fashion at site 2. Similar to the mechanism described for DCIP, after the
release second molecule of cytochrome c2, there is a rapidly equilibrating isomerization
of the free enzyme form prior to the binding of NADPH, (i.e E1' to E1). E1', is able to
bind the NADPH analog, 2'-AMP, but not the substrate NADPH. According to the
derivation of the rate equation for the iso two-site ping-pong mechanism shown in
Figure 3.8, the maximum rate of catalysis, V and the Michaelis constants for substrates
NADPH and cytochromec3are defined in terms of the following rate constants.115
V k3k9k15
(3.12)
(k1k9+k3k15+k9k5)
(KIA )(k9k15)(1 + 1/K)
(3.13) KA
(kk +k3k15+k9k,5) 39
K
(K,B)(klkl5k3k9)
(3.14)
B(k3k9+k3k15 +k9k5)
where KA and KB are the Michaelis constants for NADPH and cytochrome c3 and KA
and KIB are their corresponding dissociation constants. The rate constants are the same
as those in Figure 3.8, and K (equal to E1/ E1') is the equilibrium constant for the
conversion of the two free enzyme forms.
The log V versus pH profile for the basal cytochrome c3 reductase activity forms
a wave where the ionization of a group with a PKa of 8.6 optimizes catalysis (Figure
3.5A). The V profile may exhibit high and low plateaus at varying pH if ionization of
this group increases the rate of the step that is normally rate-limiting (233). According
to eq 3.12, the rate-limiting catalytic step is either hydride transfer, k3 or electron transfer
from FMN to cytochromec3,k9, k15.
The pH-dependence on cytochromec3reduction is dramatically altered in the
presence of Ca2-CaM as the log V profile is bell-shaped with catalysis dependent on the
deprotonation of an acidic group with a PKa of 6.4 and protonation of basic group with a
PKa of 9.2.The binding of Ca2-CaM may change the rate-limiting step(s).For
example, if the rate of hydride transfer is slower than electron transfer from the flavins to116
cytochromec3 (k3 <k9,k15), then the PKaobserved in the log V profile for the basal
cytochromec3reductase activity will reflect the pH-dependence of the former step. The
increased rate ofk1with respect tok9andk15,induced by the binding of Ca2-CaM could
potentially shift the from 8.6 to 6.4.Alternatively, the conformational changes
associated with the binding of Ca2-CaM may change which ionizable groups on nNOS
participate in hydride transfer or electron transfer from FMN to cytochrome c3t
Several candidates for ionizable residues on nNOS that could participate in
hydride transfer include Cys1348, Sen 177, and Asp1407. The three dimensional crystal
structures of FNR and CPR reveal that these conserved residues are close to the FAD
isoalloxazine ring. Substitution of the corresponding cysteine in CPR (Cys630) to an
alanine shifted the of a ionizable group necessary for catalysis from 6.9 to 7.8,
indicating that it may be a proton donor/acceptor to FAD the prosthetic group. The
corresponding residue in nNOS (Cys 1348) is in the putative NADPH-adenine binding
motif, adjacent in primary sequence to the C-terminal, which has been shown to inhibit
electron transfer to FAD in the absence of CaM (78). The C-terminal tail may affect the
location of the Cys 1348, Sen 177 andlor Asp1407 by distancing these residues from the
FAD causing them to be ineffective in hydride transfer. This may explain the different
PKavalues observed in the log V versus pH profile for cytochromec3in the presence
and absence of Ca2-CaM. Alternatively thePKaexhibited in these profiles may also
originate from the flavins themselves which exhibitPKavalues in the range studied, and
are known to be perturbed dramatically with changes in flavin redox state or when the
flavins are protein bound (263, 264).117
The pH-dependence of (V/K)was also investigated for basal and CaM-
stimulated reduction of cytochrome c1. Both profiles showed that (V/K)increased
with the ionization of an acidic group with aPKaof 7.l(basal) and 7.6 (Ca2tCaM) and
decreased when a group with aPKaof 9.49.6 ionized. According to equation 3.15,
which is the expression for (V/K)thePKavalues observed in these pH profiles may
reflect groups on nNOS , whose ionization status effect the rates of electron transfer
from FMN to cytochromec3, k9andk15or the binding of cytochromec3.
(v/E k9k15
KBJ(Kfl )k5 + k9)
(3.15)
The two groups in the (V/K)also appear in the log V versus pH profile for the CaM-
stimulated reduction of cytochromec3,indicating that they do not originate from
residues on nNOS or cytochromec3that effect binding of the substrate. Thus they
represent groups involved in electron transfer from the flavins to cytochromec3, k9and
k5.The outward displacement of the acidic pKa by 1.2 pH units from the log (V/K)
profile(PKa= 7.6) to the log V profile(PKa= 6.4) for CaM-stimulated cytochromec3'
may indicate thatk3is partially rate limiting such that it effects the observedPKavalue in
the log V profile. Alternatively, the shift inPKamay be attributed to differences in the
microenvironment of cytochrome c3-free nNOS compared to the cytochrome c3-nNOS
complex (i.e. solvent exclusion; 233).Sem and Kasper also noted aI pH unit
perturbation (7.23 to 6.21) in the log (V/K)to log V pH profiles for CPR reduction of
cytochromec3(258). Interestingly, the two enzymes exhibit the same pH profiles when
they elicit similar kinetic mechanisms (two-site ping-pong) and turnover rates. The
former occurs when the steady-state kinetic analysis of CPR-cytochromec3reductase is118
performed in high ionic strength (850 mM) and the latter occurs when nNOS
cytochromec3reductase activity is stimulated by Ca2-CaM.
ThePKaof 9.38, appearing in the (V/K)versus pH profile, is not present in the
pH profile for V for basal cytochromec3reduction, indicating that this residue is
involved in the binding of cytochrome c3. The ionizable group may originate from
cytochrome c3, which is known to have several lysine residues involved in binding
interaction with other electron transfer pairs including CPR (258). The corresponding
PKamay not occur in the (V/K)for CaM-stimulated cytochromec3reduction because
the group ionizes at high pH, and it is difficult to resolve two versus onePKain this
region.Alternatively, Ca2-CaM may induce a conformational change such that this
ionizable group no longer participates in the binding interaction between cytochromec3
and nNOS.
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Chapter 4
Neuronal Nitric-oxide Synthase: Substrate and Solvent Kinetic Isotope Effects on the
Steady State Kinetic Parameters for the Reduction of 2,6-Dichioroindoiphenol and
Cytochromec3
Kirsten R. Woithers and Michael I. Schimerlik120
4.1 Summary
The neuronal nitric-oxide synthase basal and calmodulin-stimulated reduction of2,6-
dichloroindophenol and cytochrome c3 follow ping-pong mechanisms [Wolthers and
Schimerlik(2001) Biochemistry 40; 472 1-4737].Primary deuterium (NADPH(D)) and
solvent deuterium isotope effects on the kinetic parameters were studied to determine
rate-limiting step(s) in the kinetic mechanisms for the two substrates. nNOS was found
to abstract the pro-R (A-side) hydrogen from NADPH. Values forDV and D(v/K)NADPH
were similar for the basal(1.3-1.6)and CaM-stimulated(1.5-2.1)reduction of DCIP,
while Dy (2.1-2.8) was higher than D(y/NADpH(1.1-1.5)for cytochrome c3 reduction
with and without CaM. The data suggests the overall reaction rate may be limited by the
rate of the reductive half-reaction (NADPH oxidation) versus the oxidative half reaction
(reduction of the DCIP or cytochrome c3). A value for D(v/NADpH close to I indicates
the intrinsic isotope effect on hydride transfer is suppressed by a slower step in the
reductive half reaction. The oxidative half reaction is insensitive to the NADPD isotopic
effects as both D(v/K)Dclp andD(y/Jç)equal one within experimental error.Large
solvent kinetic isotope effects (SKIE) observed for (V/K). for basal (-8) and CaM-
stimulated(-31)reduction of cytochrome c3suggests that proton uptake from the
solvent limits the rate of the oxidative half reaction. This step does not severely limit the
overall reaction rate as D2OV equaled 2 and D2O(v/NADpH was between0.87and 1 .3 for
basal and CaM-stimulated cytochrome c3 reduction. Proton inventory analysis indicates
that multiple transition-state protons contribute to the observed SKIE.121
4.2 Introduction
Mammalian nitric-oxide synthase (NOS)' produces the physiologically ubiquitous
molecule nitric oxide (NO; 265-267). One reaction cycle consumes 1.5 NADPH and
two02in the two-step conversion of L-arginine to NO and L-citrulline (3, 268). In the
first step, NADPH-derived electrons and02are used to hydroxylate L-arginine to form
the intermediate N-hydroxy-L-arginine and H20 (114). The second step utilizes 0.5
mol of NADPH and one02to oxidize N°-hydroxy-L-arginine to produce L-citrulline,
NO, and H20 (6, 130). All three known isoforms of NOS, neuronal (nNOS), endothelial
(eNOS) and inducible (iNOS) function as homodimers (4, 114, 268). Each polypeptide
subunit is divided into an oxygenase domain, which contains a P450-type heme and the
binding sites for (6R)-5,6,7,8-tetrahydrobiopterin (H4B) and L-arginine (11, 12, 14) and
a reductase domain, which contains FAD, FMN, and the binding site for NADPH (15,
62, 149).During catalysis the flavins transfer NADPH-derived electrons to the
oxygenase domain to enable heme-based oxygen-activation and subsequent oxidation of
L-arginine (114).The binding of Ca2-activated calmodulin (Ca2-CaM) to the
calmodulin-binding motif located between the two domains facilitates electron transfer
between the flavins and heme (1 8). A rise in intracellularCa2concentration triggers the
binding of CaM to eNOS and nNOS (24); however, CaM remains tightly bound to iNOS
at basal levels ofCa2(220).
The NOS reductase domain is structurally and functionally homologous to
cytochrome P450 reductase (CPR). Amino acid alignment of the last 641 residues on122
nNOS revealed 36% sequence identity and 58% sequence similarity with CPR (15).
nNOS and CPR are both composed of an NADPH-FAD module, homologous to
ferridoxin-NADP reductase (FNR) and an FMN module that is homologous to bacterial
flavodoxin (15, 66, 250). The mode of electron transfer in NOS and CPR is proposed to
proceed from NADPH to FAD to FMN and then finally to a P-450 heme (73, 81, 222,
226). The flavins on NOS and CPR are thought to cycle between the one and three-
electron reduced states during catalysis (74, 224, 225). Finally, both NOS and CPR are
able reduce non-physiological electron acceptors such as DCIP, ferricyanide (FeCN),
and cytochromec3(31, 75). The binding of Ca2-CaM to nNOS and eNOS alleviates
partial inhibition of electron transfer to these substrates (30, 74, 76, 269), as DCIP and
FeCN reduction increases 2- to 3- fold and cytochromec3reduction increases 10 to 20-
fold (30, 76). The CaM-stimulated reduction of these non-physiological acceptors is not
linked to electron transfer to the heme, production of superoxide (74, 76, 269), or a
change in the redox potentials of the flavins (73). Ca2-CaM does increase pre-steady-
state flavin reduction (76, 78) and induces conformational changes in the diflavin
domain (30, 74, 270). The structural rearrangement may remove the autoinhibitory
effects of a 40-50 amino acid insert located in middle of the FMN-binding domain of
eNOS and nNOS (82).This insert, which is not found in other structurally related
flavoproteins or iNOS, was shown to promote the dissociation of CaM at low
intracellularCa2concentrations and inhibit electron transfer in the absence ofCa2(79,
80).Additionally, Ca2-CaM may realign a 20-amino acid C-terminal tail to promote
interfiavin electron transfer. The C-terminal tail, unique to the NOS isoforms, was also123
shown to block electron transfer to non-physiological electron acceptors in the absence
of Ca2-CaM (78, 83).
In lieu of a three-dimensional crystal structure of NOS depicting the specific
structural role of CaM, an understanding of how the activated cofactor imparts control of
electron transfer relies on the above mentioned and future biochemical and mutagenic
studies as well as comparative analysis with structurally related enzymes. Recently,
steadystate kinetic data for the basal and CaM-stimulated reduction of cytochromec3
catalyzed by nNOS was shown to be consistent with a nonclassical iso two-site ping-
pong mechanism, which is similar to the mechanism previously described for the CPR
cytochrome c3-reductase activity (254). Ternary complexes are permissible for this
kinetic mechanism as the substrate active sites and the catalytic activities do not overlap.
In contrast, the kinetic mechanism for basal and CaM-stimulated reduction of DCIP is
limited to the formation of binary complexes as initial velocity and inhibition data with
this substrate is consistent with a di-iso ping-pong bi bi mechanism. In this manuscript,
primary deuterium isotope effects using NADPD and solvent isotope effects were
employed to identify possible rate limiting step(s) in these kinetic mechanisms. nNOS
was found to be an A-side dehydrogenase as the enzyme abstracts the pro-R hydrogen
from NADPH. Primary deuterium (NADPH(D)) isotope effects on V and (V/K) for
basal and CaM-stimulated DCIP and cytochromec3reduction revealed that of the two
half reactions, the reductive half-reaction involving NADPH oxidation limits the overall
reaction rate but hydride transfer to FAD is not the slow step. Large solvent kinetic
isotope effects (SKIE) observed for (V/K). suggests that proton uptake is the rate-
limiting step in the oxidative half reaction. However, proton uptake does not limit the124
overall reaction rate as small SKIE on V and(V/K)NADPHwere observed. The proton
inventory technique was used to assess the number of transition state protons that
contribute to the observed SKIE.
4.3 Experimental Procedures
4.3.1 Materials
The eDNA for rat neuronal NOS was kindly provided by T.M. Dawson (Johns Hopkins
University, Baltimore, MD; 271), and the pCWori(+) expression vector was a gift form
F.W. Dalhquist (University of Oregon, Eugene, OR; 228). Tetrahydrobiopterin (H4B)
was purchased from Cayman Chemical (Ann Arbor, MI), 2', 5 'ADP-Sepharose was
from Amersham Pharmacia Biotech (Piscataway, NJ), and the TSK-GEL
TOYOPEARLTM DEAE-650M (65 micron resin) was bought from Supelco (Bellefont,
PA). Hepes was purchased from Research Organics (Cleveland, OH). Ammonium
acetate, from EM Scientific, (Gibbstown, NJ) was prepared from reagent grade crystals
and the pH was adjusted to 7.5 with NH4OH. NADPH, NADP, DCIP, cytochromec3,
dihydrofolate, yeast glucose 6-phosphate dehydrogenase (G6PDH) (260 UI/mg),
Aspergillus niger glycerol dehydrogenase (0.227 U/mg), and yeast hexokinase (270
UI/mg) were also purchased from Sigma (St. Louis, MO). The D-[1-3H(N)}-glucose
(specific activity of 11.3 Ci/mmol) was obtained from New England Nuclear (Boston,
MA). D2O (D, 99.9%) and deuterated glycerol (1, 1, 2, 3, 3-D5, 99 %) were from
Cambridge Isotope Laboratories (Andover, MA). T4 bacteriophage dihydrofolate
reductase (DHFR) was a gift from Dr. Christopher Mathew's laboratory (Oregon State125
University), and calmodulin and calmodulin-Sepharose were donated by Drs. Sonia
Anderson and Dean Malencik (Oregon State University).
4.3.2 Preparation of [4(S)-3H]NADPH
The procedure for the synthesis of [4(R)-3H}NADPH and [4(S)-3H]NADPH was adapted
from Moran et al (272). A 0.1 mL sample containing 1 j.tCi (8.7 nmol) of [3H]-glucose
dissolved in 95 % ethanol was dried with a gentle stream of argon. The [l-3H]-glucose
was then dissolved in 100 pL of 50 mM Tris-HC1 (pH 7.8) containing I j.tmol of MgC12,
0.1 p.mol of ATP and phosphorylated to give [1-3H1-glucose-6-phosphate with the
addition of 0.5 U of hexokinase (273). After incubation at room temperature for 10
minutes, the reaction volume was brought to 0.2 mL with H20. Ten nmol of NADP and
0.5 U of G6PDH were added to generate [4(S)-3H]NADPH. The reaction was incubated
at room temperature for 30 minutes then brought to a volume of 1 mL with H2O and
applied to an 8 mL (1.2 cm2 x 7 cm) TSK-GEL TOYOPEARLTM DEAE-650M (65
micron resin) column equilibrated with 10 mM ammonium acetate (NH4OAc) at 4 °C.
An 80 mL linear gradient from 10 mM to 0.75 M NH4OAc was applied to the column at
a flow rate of 0.5 mL/min and 0.8 mL fractions were collected.The amount of
radioactivity in a 10 jiL sample was determined by liquid scintillation counting.
Fractions with an absorbance ratio A760/A12.4 and a high specific activity (-8.5
Ci/mmol) were pooled.126
4.3.3 Preparation of [4(R)-3H]NADPH
To synthesize [4(R)-3H]NADPH, the purified [4(S)-3H]NADPH was converted to [4-
3H]NADP by dihydrofolate reductase which stereospecifically removes the unlabeled 4
pro-R hydrogen (274). The reaction mixture containing the pooled fraction of [4(S)-
3H]NADPH, 42 mM 13-mercaptoethanol, 0.133 mM dihydrofolate, and 0.5 U of T4
bacteriophage DHFR was incubated at room temperature for 10 minutes and then diluted
to 60 mL with H20 and applied to an 8 mL (1.2 cm2 x 7 cm) TSK-GEL
TOYOPEARLTM DEAE-650M (65 micron resin) column equilibrated with 10 mM
NH4OAc at 4 °C. An 80 mL linear gradient from 10 mM to 750 mM NH4OAc was
applied to the column at a flow rate of 1 mL/min. Fractions were collected (1 mL) and
fractions with a specific activity of -3 Ci/mmol and an A2absorbance without an A3
absorbance were pooled. B-face reduction of the nicotinamide ring was accomplished
using G6PDH by adding the following to approximately 6 mL -.0.5 tM of [4-
3H]NADP: 19.8 mM glucose-6-phosphate, 60 mM MgCl2 and 0.5 U of G6PDH. The
reaction was incubated at room temperature for 10 minutes before dilution with 50 mL
of H20 and purification on TSK-GEL TOYOPEARLTM DEAE-650 as described above.
Fractions with an absorbance ratio A26Q/A12.4 and a high specific activity (-2.5
Ci/mmol) were combined.127
4.3.4 Preparationof[4(R)-2H]NADPH
[4(R)-2H]NADPH was synthesized with the addition of 0.1 U of glycerol
dehyrdrogenase from Aspergillus niger to a 1 mL mixture containing 2 mM NADP and
10 mM deuterated (1, 1, 2, 3, 3-D5)-glycerol in 50 mM glycine/NaOH (pH 9.0). The
reaction was incubated at room temperature for 45 minutes, and the production of
NADPH was followed by an increase in absorbance at 340 nm. The enzyme was then
heat inactivated by immersing the reaction for 2 minutes in a water bath at 41 °C. The
reaction was applied to a 20 mL (1.2cm2x 14 cm) TSK-GEL TOYOPEARLTM DEAE-
650M column pre-equilibrated with 10 mM NH4OAc pH 7.5. A 100 mL linear gradient
from 0.01 M to I M NH4OAc was applied to the column at a flow rate of 0.75 mL/min
and 1 mL fractions were collected. Fraction with an A26/A3 absorbance ratio2.4
were pooled and used in the substrate kinetic isotope studies. The concentration of
NADP(H/D) was determined spectrophotometrically using e= 6.22 mM' cm' (275).
4.3.5 Enzyme expression and purfi cation
Recombinant rat nNOS was purified from E. coli strain BL21(DE3) after over
expression of the cDNAwith the pCWori (+) vector. The enzyme was purified according
to the protocol published by Gerber and Ortiz de Montellano, with slight modification
(229).nNOS was more than 85% pure as judged by SDS-polyacrylamide gel
electrophoresis with a specific activity of 150 nmol NOmintmg' at 25 °C. The rate of
NO production was measured by the hemoglobin-NO capture assay following the128
procedures of Stuehr et al. (22). Protein concentration was determined with the Lowry
Assay using bovine serum albumin as a standard (230).
4.3.6 Determining the stereospecificty of nNOS-catalyzed NADPH hydride transfer
The procedure for determining the stereospecificity of hydride transfer was adapted
from Vanoni and Matthews (276). The oxyhemoglobin assay was used to determine
which hydrogen was transferred under conditions of NO synthesis. A 1 mL reaction
mixture containing0.3-0.7 p.M [4(R)-3HINADPH or [4(S)-3H]NADPH and 4 jiM of
oxygenated hemoglobin, 5 jiM FAD, 100 p.M L-arginine, 10 j.tM CaCl2, 100 nM CaM,
and 8 p.M H4B was incubated with I jig of nNOS at 25 C° for 30 mins. Duplicate
reaction mixtures, lacking nNOS, were also incubated under the oxyhemoglobin assay
conditions to determine the extent of nonenzymatic tritium release into the solvent. The
stereospecificity of hydride transfer under uncoupled NADPH oxidation conditions was
determined by adding 10 p.M CaC12, 100 nM CaM to the reaction containing 0.3-0.7 p.M
[4(R)-3H]NADPH or [4(S)-3HINADPH. Finally, to examine if Ca2-CaM influences the
stereospecificity of hydride transfer, 0.3-0.7 p.M [4(R)-3H]NADPH] or [4(S)-3HINADPH
was incubated along with 50 p.M DCIP and I jig of nNOS at25 C° for 30 mins. At the
completion of the reaction,I mL aliquots were withdrawn and the 3H-radioactivity
released from the solvent was separated from radioactive NADPH and/or NADP by
condensation of the solvent on a cold finger. Solvent fractions from reactions with and
without nNOS were collected from the cold finger (- I mL) and solute fractions from129
the enzymatic and the nonenzymatic reactions were collected and redissolved in I mL of
H20. The amount of 3H-radioactivity in each sample was then analyzed by liquid
scintillation fluorometry.
4.3.7 DeterminationofD(v/K) and D(V) associated with the oxidationof[4(R)-
2H]NADPH
The [4(R)-2H]NADPH eluted from the column at 0.5 M NH4OAc. Fractions containing
[4(R)-2H]NADPH were pooled and the concentration was determined at 340 nm using
= 6.22 mM' cm1. A stock of the sameconcentration was then made of [4(R)-
'HJNADPH from Sigma in 0.5 M NH4OAc. Primary kinetic substrate isotope effects
were measured by direct comparison of the initial rates measured byreduction of
cytochrome c3(A= 21.1mM' cmt) at 550 nm or DCIP (A e = 21 mM' cm') at 600
nm (231) with [4(R)-2H]NADPH or[4(R)-'H}NADPH. Reactions were performed in 3.5
mL at 25 °C using a 5 cm path length cuvette. Reaction mixtures contained 50 mM
Hepes-NaOH (pH 7.5), variable concentrations of substrates [4(R)-2H]NADPH or [4(R)-
'HIINADPH, cytochromec3or DCIP, and where appropriate, 10 l.LMCaC12and 100 nM
CaM. Reactions were initiated with the addition of 0.5-2 tg of nNOS. nNOS catalyzed
reductions of DCIP and cytochromec3follow ping-pong mechanisms; thus,Dyand
D(v/K)NADPHwere obtain by directly fitting initial velocities at varying[4(R)-2H]NADPH
or [4(R)-'H]NADPH concentrations withvarying DCIP or cytochromec3
concentrations to the following equation with Origin v 4.0 software (MicroCal Software
Inc., North Hampton, MA).VI =
VAB
(KAB+KBA+AB)
130
(4.1)
where v is the initial velocity,Ais the concentration of [4(R)-2H]NADPH or [4(R)-
'H]NADPH andBis the concentration of DCIP or cytochrome c, andKAandKBare
their corresponding Michaelis constants.Reciprocal initial velocities were plotted
against the reciprocal substrate concentrations and, in all cases, the plots were linear. A
control experiment showed that [4(R)-'H]NADPH prepared in the same manner as
[4(R)-2HJNADPH exhibited the same kinetic parameters as [4(R)-'H]NADPH purchased
from Sigma.
4.3.8 Solvent kinetic isotope effects
A 50 mM Hepes-NaOH solution in D20 was prepared by two lyophilizations of a 50
mM Hepes-NaOH solution in H20, each time re-dissolving the dry residue in D20. pD
values were determined by adding 0.4 to the pH meter reading (pD = pH + 0.4; 277).
For the reactions performed in D20, nNOS and CaM were diluted in D20 and stock
solutions of NADPH, cytochrome c3, DCIP, andCaCl2were prepared by dissolving
their lyophilzed powders into D20.The SKIE on (V/K)Dclp was determined by
measuring the initial rate of DCIP reduction at varying DCIP concentrations with a fixed
sub-saturating concentration of NADPH (0.25 tM). Since both the basal and CaM-
stimulated reductions of DCIP follow a ping-pong mechanism, the concentration of
NADPH will not influence the value of(V/K)DcIp(254).The data was fit to the
Michaelis-Menton equation (eq. 4.2) by non-linear least squares analysis with Origin v
4.0 software.131
VA
Vj=KA (4.2)
where v, is the initial velocity, V is the maximal velocity, A is the variable substrate
concentration, and Km is the Michaelis constant for A. The SKIE on V and (V/K)was
determined by comparing the initial rate of cytochromec3reduction at increasing
concentrations of cytochromec3and saturating concentrations of NADPH (10 p.M) in
50 mM Hepes (pH/D 7.5) prepared in H20 and D20. A non-linear least squares fit of the
data to eq 2 gave values for V and Since concentrations of cytochromec3 >
5Kminhibit the reduction of the electron acceptor, the SKIE effects on(V/K)NADPHwas
determined by measuring cytochromec3reduction with varying NADPH concentrations
at a fixed sub-saturating concentration of cytochromec3(0.4 tM). The data was fit to
the Michaelis-Menton equation (eq. 2.2) by non-linear least squares analysis.
4.3.9 Proton inventories
The proton inventory method was used to obtain the number of proton(s) being
transferred in the transition-state. The initial rate of DCIP or cytochromec3reduction
was measured at a fixed concentration of NADPH (10 pM) and fixed concentrations of
DCIP (100 .tM) or cytochromec3(10 RM) at different fractional concentrations of D20
in the reaction mixture. Data where fit to various forms of the Gross-Butler equation
(eq. 4.3; 278, 279) by non-linear least squares analysis.132
fl(1_n+nØ,T)
k k0 (4.3)
fl(i_n+n)
In equation4.3,
41Gand
1Tare the ground and transition state fractionation factor at the
ith exchangeable site, v is the number of protons involved in the reaction,kis the
observed rate measured atn,wherenis the fractional concentration of D20, andk0is the
observed rate measured at 0% D20.Although proteins consist of numerous
exchangeable hydrogenic sites, the magnitude of the SKIE is often limited to difference
between4Gand
41Tat a few sites.Thus, proton inventory analysis begins with
simplified forms of equation4.3,which assumes one (eq.4.4)or two protons (eq.4.5)in
the transition state contribute to the observed SKIE and
1G= 1 (true for most protein
hydrogenic sites, with the exception of sulfhydryl groups where4° = 0.65; 280).
k =ko(l_n+nØTi)
k =k0(ln+nØTI)(1n+nçbT2)
(4.4)
(4.5)
To determine if equation4.4or4.5provides a better fit to the proton inventory data,
equation4.5was expanded to the following, where
41Tequals :
k = k0 +2k0(01Tl)n + Ck0(01T - 1)2n2 (4.6)
For assessing the lack of fit a third parameter, C, was added to the expanded equation
which is now an unconstrained quadratic inn.If a nonlinear least squares fit of the data133
to this equation gives a value of CO, the data is consistent with one protonin the
transition state contributing to the observed SKIE, as eq 4.6 reduces to eq 4.5. If C I,
then the data describes a model in which two or more protons in the transition-state
contribute to the observed SKIE. The data were also fit to equation 4.7, which assumes
two protons, which have equal values for their fractionation factors (i.e.
02T)are
transfened in the transition-state.
k =k0(ln+nTi)2 (4.7)
4.4 Results
4.4.1 Stereospecificity nNOS-catalyzed NADPH oxidation
The stereospecificity of NADPH oxidation was determined under conditions for NO-
synthesis, uncoupled NADPH oxidation, and NADPH oxidation with DCIP as an
electron acceptor.Table 4.1 shows that under each of these conditions, the pro-R
hydrogen is abstracted. Approximately 85% of the tritium was released into the solvent
in the presence of nNOS with [4(R)-3H]NADPH as the substrate; whereas, the majority
of the tritium remained with the particulate fraction in the absence of nNOS. The
percentage of tritium released into the solvent was approximately the same in the
absence and presence of the enzyme with [4(S)-3H}NADPH as the substrate. On the
basis of these results, nNOS catalyzes the stereospecific removal of the pro-R hydrogen
at the 4-position of NADPH and the subsequentexchange of this hydrogen with the
solvent occurs, possibly on the enzyme bound flavin.134
Table 4.1: Stereospecificity of the oxidation of NADP(H/T) catalyzed by nNOS
dpm released into solvent dprn retained in residue
Substrate +enzyme -enzyme +enzyme -enzyme
[4(R)-3H]NADPH
HbO2 217,223 (74%) 22,218 (10%) 57,336(26%) 211,839 (90%)
664,264 (84%) 74,046(13%) 109,134 (16%) 570,954(87%)
753,876 (89%) 92,192 (14%) 88,408 (11%) 640,829 (86%)
uncoupled" 641,646(81%) 123,281 (19%)
DCIP 814,592 (87%) 110,381 (13%)
[4(S)-'H]NADPH
l-1b02 99,201 (3 %) 154, 542 (5 %) 2,933,589 (97 %) 3,345,873 (96%)
78,604(3 %) 140,567(4%) 2,993,746 (97 %) 3,133,32(97%)
228,073(9%) 55,513(2%) 2,465,362 (91 %) 3,138,312(98%)
uncoupled 100,706(3%) 3,213,992(97%)
DCIP 487,964 (17 %) 2,869,820 (83%)
aNADPH oxidation was performed under conditions of theHb02assay described in the
Experimental Procedures
bNADPH oxidation was performed in the absence of L-arginine
DCIP was used as the terminal electron acceptor for NADPH oxidation.135
4.4.2 Substrate isotope effects with [4(R)-3H]NADPH.
[4(R)-'H}NADPH was prepared in the same manner as [4(R)-2H]NADPH to ensure that
the synthesized NADPH had the same properties as NADPH purchased from Sigma.
The synthesized [4(R)-'H]NADPH exhibited the same V andKmfor NADPH compared
to [4(R)-1H}NADPH purchased from Sigma (data not shown).The primary deuterium
isotope effects on the basal and CaM-stimulated reduction of NADPH are summarized
in Table 4.2.. The values forD(yin the presence and absence of Ca2-CaM with DCIP
as the terminal electron acceptor were 1.56 ±0.10 and1.91 ± 0.33, respectively.
D(V/K) for basal activity was 1.42 ± 0.13 while CaM-stimulated activity produced a
value of 1.60 ± 0.17. The primary isotope effect ofD(V/K)DcIp with and without Ca2-
CaM was 1.01 ± 0.10 and 1.02 ± 0.10, respectively, indicating that the oxidative half
reaction in isotopically insensitive to hydride transfer.
D(V)for basal reduction of cytochromec3was 2. .72 ± 0.07. In the presence of
Ca2-CaM,D(yequaled 2.24 ± 0.16 The value forD(v/NADpHwas 1.31 ± 0.16 and 1.19
± 0.10 in the presence and absence of Ca2-CaM, respectively. (V/K)did not exhibit
an NADPH(D) primary isotope effect in eitherthe presence (0.97 ± 0.04) or absence
(0.98 ± 0.07) of Ca2-CaM, since the values were one, within experimental error. The
lack of an observed NADPD isotope effect on the oxidative half reaction with DCIP and
cytochromec3is consistent with the reactions following ping-pong mechanisms and136
Table 4.2 Measurement ofDyandD(y/K)for nNOS-catalyzed NADPH
oxidationa
Substrate Ca2-CaM Dy D(y/ D(V/K)
ace
DCIP 1.56±0.10 1.42±0.13 1.01±0.10
DCIP + 1.91 ±0.33 1.60±0.17 1.02±0.10
cytochromec3 2.72±0.07 1.19±0.10 0.98±0.07
cytochromec3 + 2.24±0.16 1.31±0.16 0.97±0.04
aReaction conditions are described under Experimental Procedures. Values are from a
global fit of 3 experiments to eq. 4.1 to the data ± standard errors.137
further suggests that the label exchanges with the solvent prior to reduction of these two
substrates.
4.4.3 Solvent kinetic isotope effects on kinetic parameters
Kinetic solvent isotope studies involve comparing the values of V and (V/K) for various
substrates (NADPH, DCIP and cytochromec3)in buffer prepared in H20 versus D20.
The deuterium in D20 exchanges with all the hydrogenic sites on nNOS and the
substrates, therefore D20 has the potential to affect V and (V/K) by altering substrate
binding, and/or altered stability or conformation of the enzyme (281).
To determine if the latter contributed to the observed SKIE, nNOS and the
substrates (NADPH, DCIP, and cytochrome c3) were equilibrated in D20 and the
catalytic rates of DCIP and cytochromec3reduction were compared to nNOS and the
three substrates diluted in H20 under identical conditions. No differences in catalytic
rates were observed; therefore, the observed solvent isotope effects is not attributed an
irreversible change in the structure of the enzyme itself. The solvent isotope effects on
the kinetic parameters for the reduction of DCIP and cytochromec3are summarized in
Table 4.3. An inverse solvent isotope effect, 0.72 ± 0.07, was observed for(V/K)1for
the basal reduction of this electron acceptor. However, in the presence of Ca2-CaM the
value forD2O(v/K)1was equal to 3.97 ± 0.32. A large SKIE was observed for the basal
reduction of cytochromec3with 8.38 ± 0.69.This value increased
approximately 4-fold in the presence of Ca2-CaM to 31.00 ± 2.99. The values forD2OV138
Table 4.3 Kinetic solvent isotope effect on kinetic parameters for NADPH
oxidationa
Substrate Ca2-CaM DV D(v/K)
NADPH - 0.87±0.08b
NADPH + 1.17 ±O.07b
DCIP ndc 0.72±0.07
DCIP + nd 3.97±0.32
cytochromec3 - 1.99±0.06 8.38±0.69
cytochromec3 + 2.07±0.09 31.00±2.99
aReaction conditions are described under Experimental Procedures. Values are
generated from a fit of equation 4.2 ± standard errors.
bDetermined with cytochromec3as the second substrate.
CNot determined139
for the basal and CaM-stimulated reduction of cytochrome were equal within error, 1.99
± 0.06 (basal) and 2.07 ± 0.09 (Ca2-CaM). The large SKIE associated with (V/K)
indicates that proton uptake from the solvent is the rate-determining step in the half
reaction involving the reduction of this substrate. However, since the value for
D20ç1/)is
-2 for the basal and CaM-stimulated reduction of cytochromec3,proton uptake does
not completely limit the rate of the overall reaction. A value forD2O(v/NADpHof 0.87 ±
0.08 and 1.17 ± 0.07 for the basal and CaM-stimulated reduction of cytochromec3,
respectively, indicates proton transfer is not a rate limiting-step in the reductive half-
reaction.
4.4.4 Proton inventory studies
The proton inventory method was used to determine the number of protons which
contribute to the SKIE (282). The technique involves measuring the reaction rate in
various binary mixtures of H20 and D20 and plotting the observed rate, "k, versus the
fraction of deuterium in the solvent, n. As shown in Figure 4.1, plots of basal DCIP (A)
and cytochromec3(B) reduction rates, k against the atom fraction of D20 in the
solvent, n, bulge downwards.The characteristic bowl-shaped curvatures of the
experimental data points suggest that multiple protons are transferred or "in flight" in the
conversion from the initial (reactant) state to the transition-state. A nonlinear least-
squares fit eq 4.6 to the data in Figure 4.1 A and 4. lB gave values of C equal to1.13 ±140
Figure 4.1: Proton inventory for the basal nNOS-catalyzed reduction of (A) DCIP and
(B) cytochrome c3. The fraction of deuterium (n) is plotted against the rate of steady-
state activity measured in the H20/ D20 mixture (ku). A non-linear least squares fit of
the experimental data in A to eq 4.6, represented by solid lines, gave values for C = 1.13
± 0.06, ØT=O.19 ± 0.06, andk0(rate of DCIP reduction in 0% D20) = 329.2 ± 10.9 min'.
A fit of eq 4.7 to the data yielded a value ofk0= 321.65mindand= 0.28 ± 0.05. A
non-linear least squares fit of the experimental data in B to eq 4.6 gave values for C =
1.22 ± 0.10, T=0.33 ± 0.06, andk0(rate of cytochrome c3reduction in 0% D20) = 118.7
±10.9 mint. A fit of eq 4.7 to the data yielded a value ofk0= 107.6 ± 3.0min1and9 =
0.30 ± 0.03.k (min1)
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Figure 4.1142
0.06 and 1.22 ± 0.10, respectively, indicating that the isotope effect originates from two
or more protons in flight. A fit of eq 4.5, which describes two protons in flight, to the
data gave undefined values for
1Tand42TA fit of eq 4.7, which is a function of two
protons in flight with equal fractionation factors generated defined values for the
fractionation factor (Panel A 0.29 ± 0.05 and Panel B
4T0.30 ± 0.03).
4.5 Discussion
4.51 .StereospectflcityofoxidationofNADPH catalyzed by nNOS
The separate NADPHJFAD and FMN binding modules of nNOS and other related dual
flavoproteins such as CPR (66), sulfite reductase (67), and methionine synthase
reductase (68) are homologous to FNR and flavodoxin, respectively. FNR is the
prototypic member of the transhydrogenases family of proteins which also includes
NADH-nitrate reductase and NADH-cytochrome b5 reductase (65, 250). Enzymes in
this family catalyze the transfer of electrons between nicotinamide nucleotides (obligate
two-electron or hydride donors/acceptors) and obligate one-electron donors (65). The
stereospecifity of hydride transfer appears to be a conserved feature for this enzyme
family as members including FNR (283), CPR (284), NADPH-cytochrome b5 reductase
(285) and NADH-nitrate reductase (286) were shown to abstract the pro-R hydrogen. A
second class of flavin containing enzymes, the carbon-sulfur transhydrogenase family,
are stereospecific for the pro-S hydrogen (65).Enzymes of this family, including
glutathione reductase (273), thioredoxin reductase (287), and lipoamide dehydrogenase143
(288) catalyze two-electron transfers between nicotinamide nucleotides and disulfide-
dithiol pairs.
As shown in Table 4.1, the pro-R hydrogen is abstracted during nNOS-catalyzed
NADPH oxidation. Therefore, nNOS maintains the relationship between the class of
transhydrogenases and stereospecifity of hydride transfer.
4.5.2 Substrate isotope effects.
Establishing that the A-side hydrogen is stereospecifically removed permitted further
investigation of the primary isotope effects on DCIP and cytochromec3reduction. The
basal and CaM-stimulated reduction of these two substrates is proposed to occur in two-
half reactions, whereby the reduction of enzyme bound flavin by NADPH and release of
the oxidized nucleotide is followed by binding of the oxidant, DCIP or cytochromec3,
and reoxidation of the reduced flavin. The steady-state initial velocity and inhibition
studies were consistent with DCIP following a di-iso ping-pong mechanism (Figure 4.2;
254). There are two isomerization steps.After the release of NADP, the three electron
reduced state of nNOS,E1is proposed to isomerize at steady-state toE3'prior to the
binding of DCIP. A rapidly equilibrating isomerzation of the one-electron reduced state
is also proposed to occur between the free enzyme form, which appears after the release
of reduced DCIP, E1', and the enzyme form which binds NADPH,E1.
Like the reduction of DCIP, the basal and CaM-stimulated reduction of
cytochrome c3' also occurs in two-half reactions.However the initial velocity and
inhibition patterns are consistent with the iso (two-site) ping-pong mechanism illustrated
in Figure 4.3 (254). The salient feature of this mechanism is the ability of NADPH and144
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Figure 4.2 Kinetic scheme for a di-iso ping-pong bi-bi mechanism for the nNOS-
catalyzed reduction of DCIP with a step representing the formation of the charge transfer
complex (E1A to E1A). A,B, P,Q and I represent NADPH, DCIPDX,NADP, DCIPred, 2'-
AMP and thevalues refer to their respective dissociation constants.E1and E1' are the
one-electron (FAD/FMNH.) forms of nNOS that exclusively bind NADPH and 2'-
AMP, respectively.E1and E3'are the three-electron (FADH.IFMNH2) or
(FADH2IFMNH.) forms of nNOS that exclusively bind NADP and DCIPDX,
respectively. K is the equilibrium constant for the conversion of the two enzyme forms,
E1and E1'. The dotted boxes labeled X, Y, and Z indicate the proposed rapid equilibrium
segments for the reaction mechanism, where X= E1 + E1' +E1'I + E1'IQ + E1'Q + E1A,
E1A;Y=E3P+E3;Z=E' +E1'B.145
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Figure 4.3 The kinetic scheme illustrating the iso (two-site) ping-pong mechanism for
the nNOS-catalyzed reduction of cytochrome c3with a step representing the formation
of the charge transfer complex (E1A to E1A).A, B, P, Q and I represent NADPH,
cytochrome c3, NADP, and cytochrome c2, and 2'AMP, respectively.E1and E1' are
the one-electron (FADIFMNH.) forms of nNOS that exclusively bind NADPH and 2'-
AMP, respectively.E2 andE3represent two (FAD/FMNH2) and three-electron
(FADH.IFMNH2) reduced form of nNOS. K is the equilibrium constant for the
conversion of the two enzyme forms,E1andE".146
cytochrome c3 to act at catalytically independent sites on nNOS. Figure 4.3 depicts
NADPH binding to site 1 in a uni-uni fashion and two molecules of cytochrome c3
binding to site 2 in a tetra-uni fashion. Unlike the single site ping-pong mechanism,
ternary complex formation is not precluded by the two-site kinetic mechanism. The
name of the kinetic mechanism is prefixed with iso to acknowledge the rapidly
equilibrating isomerization of E1 toE1'.
With the assumption that the substrates bind in rapid equilibrium, the derivation
of the kinetic mechanisms for DCIP and cytochrome c3 produced identical expressions
for (V/K)NADPH (eq. 4.8; (254).
(v/E, k3
KA)KA(1+1/K)
(4.8)
where V is the maximal velocity, E is the concentration of nNOS, KA is the Michaelis
constant for NADPH, KIA is the NADPH dissociation constant, K is the equilibrium
constant for the conversion of E1 to E1' and k1 is the rate of hydride transfer.
In the kinetic mechanisms illustrated in Figures 4.2 and 4.3, only the rate
constant representing hydride transfer, k3, is sensitive to isotopic substitution; thus, the
expression for substrate isotope effect on (V/K)NADPH is as follows:
(Y)
Dk
KNADPH
(4.9)
where Dk3 or the intrinsic isotope effect, equals k3H/klD with kiH defining the rate of
NADPH hydride transfer, and kD the rate of NADPD deuteride transfer. Equation 4.9147
shows thatD(v/K)NADPHis a function only of the intrinsic isotope effect.Typically,Dk3
ranges between 5-8, which corresponds to the differences between thezero-point energy
vibrational energies of C-H and C-D bonds in the ground and transition-state; however,
values are observed outside this range due to the nature of the transition-state or
tunneling (289).
The intrinsic isotope effect was not estimated by method of Northrop (290)
where the tritium isotope effects on(V/K)NADPHare compared withD(V/K)NADPHwith the
assumption that the tritium intrinsic isotope effect,1k1is 1.44 the power of the deuterium
isotope effects,Dk3(291), because the over all tritium isotope effect is measured by the
release of tritium from the reduced flavin into the water, which constitutes the first
irreversible step. In contrast, the first irreversible step for NADPD oxidation is transfer
of the deuteride to FAD. Hence,D(v/K)and T(V/K) are comprise different rate constants;
therefore, there values can not be used to determine the intrinsic isotope effect (see ref
(292) for further details).
As shown in Table 4.2, the value forD(v/K)NADPHwas much lower than the
intrinsic isotope effect for either the basal or CaM-stimulated reduction of DCIP or
cytochromec3indicating that the full value of'k3in the expression forD(V/K)NADPHis
suppressed by a more rate-limiting isotopically insensitive step(s) (293).Thus,
(V/K)NADPHis probably defined by other microscopic rate constants, such as NADPH
binding, NADPH dissociation, or conformational changes associated with the formation
of a charge-transfer complex (E1-NADPH).
To simplify the original derivation of the kinetic mechanism for DCIP and
cytochromec3reduction it was assumed that substrate binding occurs in rapid148
equilibrium, (i.e. the rate of NADPH dissociation is greater than the rate of nNOS and
NADPH complex formation).This assumption was validated by the competitive
inhibition exhibited by the NADPH-analog, 2'AMP against varying concentrations of
NADPH observed for both electron acceptors. If NADPH binding and release were at
steady-state, then the 2'AMP would be a non-competitive inhibitor of NADPH since
they bind to different forms of the one-electron reduced state of nNOS (254). Thus, the
binding and release of NADPH are not the rate-limiting steps in the reductive-half
reaction.
However, comparative analysis with the structurally and functionally related
enzymes, FNR and CPR suggest that putative structural rearrangements in nNOS prior
to hydride transfer may be rate-limiting steps in the reductive-half reaction.
Biochemical and structural studies of FNR and CPR indicate that both enzymes undergo
a structural rearrangement to form a charge-transfer complex between the binding of the
nucleotide and hydride transfer. The crystal structures of rat CPR (70) and pea FNR
(250, 251) revealed that the aromatic ring of a tryptophan residue in the former and a
tyrosine residue in the latter shield the isoalloxazine ring of the FAD from the
nicotinamide cofactor.It is clear that both aromatic side chains need to reposition
themselves for the nicotinamide ring to be at an appropriate distance from the N5 of
FAD for hydride transfer. Stopped-flow fluorescence studies have demonstrated that the
conserved tryptophan residue in human CPR is mobile (i.e. "flips away" from the
isoalloxazine ring) during the formation of the charge-transfer complex (294).
Movement of the homologous residue in nNOS, Phe 1395, in the formation and/or decay149
of the charge-transfer complex, may be the origin of the isotopically insensitive rate-
limiting step.
The kinetic mechanisms for the reduction of DCIP and cytochromec3were
modified to incorporate the formation of the charge-transfer complex (bold portions of
Figures 4.2 and 4.3, respectively). In both kinetic mechanisms,k1andk2represent the
formation and decay rate of charge-transfer complex, respectively. The derivations of
the kinetic mechanisms with this additional step are consistent with the steady-state
initial velocity and inhibition data obtained previously (254), and(V/K)NADPHis now
described by the following equation:
(v/E k1k3
KAJKia(1+1/K)(k2+k3)
(4.10)
The expression forD(v/NADpHassuming thatk3is the only isotopically sensitive step
would then be defined in the following equation.
D(V/K\ Dk+k/k
' "INADPH 1+k311/k2
(4.11)
Equation 4.11 illustrates thatD(v/K)NADPHwould also be a function of k2, or the
dissociation of the change transfer-complex, assuming that this step also occurs in
nNOS. Ifk2 <k3then full expression ofDk1would be reduced inD(v/NADpHFor
example, ifDk3obeys the classical limit for the intrinsic isotope effect and has a value
7, then forD(v/NADpHto range between 1.2 and 1.6, thenklHmust be 10- to 30-fold
greater than k2.Alternatively, ifDk3approaches only 3, observed if there is a small
change in the C-H and C-D vibrational energy difference between the ground state and150
the transition state, thenk3Hneed only be 2.5- to 10-fold greater thank2There is
precedent for consideringk2<klHsince several research groups have characterized
NADPH as a "sticky" substrate (255, 276, 295). A substrate is considered "sticky" if
partitioning of the enzyme-substrate complex towards catalysis is favored compared to
release from the enzyme (i.ek2 < k3;(255).Vanoni and Mathews proposed that
dehydrogenases which exhibit suppression of the isotope effect of hydride transfer in
D(v/K)NADPHare optimized for catalytic efficiency of their reductive half-reaction (276,
296). Thus, nNOS would be exhibiting high forward commitment to catalysis since the
E1-NADPH charge-transfer complex, once formed, preferably would undergo
oxidoreduction to form the E3-NADP complex rather than dissociate to formEand
NADPH.
Although the expressions forD(v/K)NADPHfor DCIP and cytochromec3reduction
are defined by the same rate constants and hence exhibit similar values for°(v/K) the
expressions forDVare not a function of the same rate constants; therefore, the two
substrates will not necessarily exhibit similarDVvalues. As shown in Table 2, the
experimentally observed values forDvfor the basal and CaM-stimulated for DCIP (1.5-
2) reduction were significantly smaller compared to cytochromec1(2.4-2.7).
According to the mechanism illustrated in Figure 4.2, V for DCIP reduction is defined in
the following equation
V k1k3k7k11
E,k1k3k7+k11(k3+k7)+k71(k2+k3)
(4.12)151
where the rate constants are the same as those in Figure 2. Following the mechanism
illustrated in Figure 4.3, V for the basal and CaM-stimulated reduction of cytochrome c3
is a function of the following rate constants.
V kk3k9kj5
k9k5(k k2+k3)+Ik3(k9+k15)
(4.13)
where k1, k2, k3, k9, and k15 are the same as those in Figure 4.3. With k3 defined as the
isotopically sensitive step, DV equals eq. 4.14 and eq. 4.15 for DCIP and cytochromec3
reduction, respectively.
kIl++
Dkij k3H(lJ
(4.14) DV_
k k2
k2 k2 k7 /c
Dk[1 + ++
DV
k2 k2 k9 k15
(4.15)
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+
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The ratio of k1, rate of formation of the charge-transfer complex, over the rate constants
defining the forward rate constants in the oxidative half-reaction differentiate eqs 4.14
and 4.15.If the ratio of k1 over k7 (steady-state isomerization of E3 to E1') andlor k11,
(electron transfer from the flavins to DCIP) is less then k1 over k9 and/or k15 (electron
transfer from the flavins to cytochromec3)then the DV value for DCIP reduction would152
be less compared to cytochrome c3 reduction, because there would be more attenuation
of the ratio klH/k2, which was assumed to be lO based on a value ofD(v/K)NADPHnear
unity and the intrinsic isotope effect equals the classical limit.
Comparison ofDVandD(V/K)values provides information concerning the
relative rates of the two half reactions in ping-pong mechanism (297). For example, a
value forDVsimilar toD(V/K)as observed for the reduction of DCIP, or slightly larger
then "(V/K), as seen for cytochromec3reduction with and without Ca2-CaM, suggests
that the reductive-half reaction limits the overall reaction rate (297). If the oxidative half
reaction is more rate-limiting k1, and/or k3 <k7 or k11, for DCIP reduction and k1, and/or
k1 is <k9 or k15 for cytochrome c3 reduction. Due to the complexity of the ping-pong
mechanisms, i.e the addition of isomerization steps and rate constants in the expressions
forDVit can not be determined if k1 and or k1 is less then or greater then Ic7 or k11 (DCIP
reduction) or k9 or k15 (cytochrome c3 reduction).
Stopped-flow experiments with CPR revealed that there was rapid formation of
the charge transfer complex as the apparent rate constant was >500 s' followed an
isomerization of a second transfer complex (-200 sj, while the rate of hydride transfer
much slower was -3 s(69). If nNOS were to exhibit the same relative rates in the k1
and k7, then it follows that the ratio of k3H/k2< k1/k2 since k3H> k2 and k1> k7. When
equations 4.14 and 4.15 are rewritten to equations 4.16 and 4.17, respectively, one can
see the relative importance of k3H/k2 and k1/k2 inthe value ofDVfor reduction of the two
electron acceptors.153
Dk (1+kI/k2)+klH/k2(1+kl/k7+kI/klI)
(4.16) DV=
I + k1/k2 + k311/k2(I + k1/k7 + k1/k)
Dk (l+kjk2)+k3H/k2(l+kI/k9+kI/k15)
(4.17) DV
i+/k2+k3H/k2(1+kI/k9+/klS)
Ifk1/k>> k3H/k2andk1> k7andk11(eq4.16)ork9,andk15(eq4.17)thenDVwould be
equal for reduction of the oxidants and the value of the intrinsic isotope effectDk3
However, this is clearly not the case, thus the value ofDVmust be suppressed by
different amounts in equation4.16and4.17by the second term in the numerator, i.e. the
value ofklH/k2multiplied the combination of rate constants enclosed in parenthesis. If
the opposite is true, such thatk1/k2<< k3H/k2and k1<k7andk11(eq4.16)ork9, andk15(eq
4.17)thenDVequalsD(v/K)NADPH forthe reduction of either DCIP or cytochromec3.
Since this is clearly not the case for cytochromec3reduction, whereDV>D(v/NADpH
the valuek1/k2must contribute substantially to the value ofDvcausing it to be greater
thanD(V/
The values forD(v/Jc)andD(V/Jwere equal to one within experimental
error. This is consistent with the proposed ping-pong mechanism for these substrates
(254)sinceD(V/Jç)andD(V/Jç)and functions of k3. The data is also suggests that
the label exchanges with the solvent prior to reduction of the DCIP or cytochromec3.
This conclusion is supported by the NADPH stereospecifity study described above as the
pro-R 3H appeared in the solvent fraction, presumably through solvent exchange while
bound to the flavin.154
4.5.3 Solvent kinetic isotope effects
Unlike substrate isotope effects, which investigate changes in the catalytic rate
associated with one isotopic substitution, solvent isotope effects relate the changes
associated with the complete replacement of exchangeable solvent protons with
deuterons on the enzyme and substrate. Due to the global nature of solvent isotope
studies, one must exercise caution in the interpretation of results since deuterium oxide
could change the reaction rate by effecting several steps in a multi-step mechanism,
substrate binding, and/or the stability or conformation of the enzyme (281).
The magnitude of the observed SKIE provides information regarding its origin.
Large SKIE are thought to arise in a partially rate determining step(s) in which there is
direct proton or hydride transfer in the transition-state (281). The isotope effect would
likely be primary, where water is the reactant or functional group(s) on the enzyme or
substrate become labeled by exchange with the solvent. In contrast, secondary isotope
effects, defined by those involving conformational changes in the enzyme caused by the
properties of hydrogen bonds, hydrophobic bonds and other factors typically yield small
(-2) SKIE.
A large SKIE value of 8 for D2O(v/K)was observed for the basal reduction of
cytochrome c3, suggesting that proton uptake directly from the solvent or from an
exchangeable site(s) on nNOS or cytochromec3is the rate-limiting step in the oxidative
half-reaction. The substrate cytochromec3has numerous exchangeable hydrogenic
sites; therefore, one can not exclude that the magnitude of SKIE in part arises from the
effects D20 on protein conformation and thus on substrate binding. The 4-fold increase
in the SKIE on the observed (V/K)may be attributed to a combination of events155
including further rate limitation of proton transfer, an increase in the number of protons
transferred, or the solvent effects on cytochromec3binding becoming more
pronounced. The level of Ca2-CaM stimulated cytochromec3reductase activity was
approximately 20% greater in D20 compared to H20, indicating that deuterium oxide
does not impair the affinity or behavior of the activated cofactor.
The solvent isotope effect on V was approximately 2 for the basal and CaM-
stimulated reduction of cytochrome c3. A significantly smaller value forD2OVcompared
to suggests that while proton transfer is rate-limiting step in the oxidative half
reaction, it does not completely limit the over all reaction rate. These results agree with
the primary NADPH(D) substrate isotope effects showing that the reductive half
reaction is more rate-limiting.Alternatively, structural differences in cytochromec3
induced by D20 affecting its affinity for nNOS and the value forD(V, would not be
observed in 'V as it is not a function of substrate binding.
Small SKIE were observed forD(V, for the basal and CaM-stimulated
reduction of cytochromec3indicating that proton transfer is not a rate-limiting step.
The expression for(V/K)NADPHencompasses all the rate constants from the binding of
NADPH up to the first irreversible step.If hydride transfer from C-4 of the
nicotinamide ring to the N-5 of the flavin constitutes the first irreversible step, then one
would not observe SKIE on subsequent proton transfer steps, such as protonation of the
N-i of the FAD isoalloxazine ring. Alternatively, hydride transfer could be a reversible
step and SKIE on(V/K)NADPHcould be suppressed by slower steps in the reaction.156
4.5.4 Proton inventory analysis
The existence of an isotope effect does imply that some protonic restructuring does
occur in the reaction. To obtain informationconcerning the number of protons and their
individual contributions to the SKIE, a proton inventory experiment performed in which
rate measurements were made in binary mixtures of H20 and D20. The shape of aplot
which compares the catalytic rate, k, against the fraction of deuterium in the solvent, n,
shows if the SKIE arises from the transfer of one of more protons in the transition state.
If a single transition state-proton contributes to SKIE the plot will generate a straight line
since '1k will be a linear function of n (eq. 4.4).However, if two or more protons
contribute to SKIE, the plots will be bowl-shaped since k becomes a polynomial
function of n (eq. 4.5). The characteristic bowl-shaped curvature of the experimental
data points in Figure 4.1 suggests the involvement of multiple protons in the conversion
from the reactant-state to the transition-state in the basal reduction of DCIP and
cytochrome c3t To verify whether the one- or multi-proton model better represents the
proton inventory data in Figure 4.1, the data was fit to equation 4.6. For both data sets, a
fit generated a value for C (1.13 and 1.22 for Figure 4.1, Panels A and B, respectively)
that did not equal zero, indicating that the data does not accommodate a linear (one-
proton) model. A fit of the data to eq 4.5, which assumes 2 protons are in flight, gave
equal values for
Tand
02T;however, values
1Tand
02Twere undefined do to large
standard errors. A fit of equation 4.7, where the number of parameters are reduced by
assuming
01T021; to the data in Figure 4.1 did generate defined values for the
fractionation factor (Panel A,
T=0.29 ± 0.05 and Panel B,Ø10.30 ± 0.03). Although,157
it was possible to statistically demonstrate that more then one proton is in flight, it was
not possible to specify the exact number of protons in flight or the magnitude of their
fractionation factors.
In summary, both primary substrate isotope effects and solvent isotope effects
suggest that the reductive half-reaction is more rate determining then the subsequent
oxidative half reaction in the ping-pong mechanisms for DCIP and cytochromec3
reduction and the presence of Ca2-CaM does not alter this behavior. The slow step in
the reductive half reaction is not hydride transfer, but may be formation of the
energetically unfavorable charge-transfer complex (E1-NADPH), known to form in CPR
and FNR. The slow step in the cytochromec3oxidative half reaction appears to be
multiple proton transfer from the solvent or an exchangeable site on nNOS or the
substrate.
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Chapter 5
Conclusion
The flavoprotein domain nNOS shares considerable structural and functional
similarity with CPR. During catalysis both enzymes shuttle NADPH-derived reducing
equivalents from FAD to FMN and then finally to a P450-heme to enable heme-based
oxygen activation. However, nNOS is unique in that the binding ofCa2-CaM enables
electron transfer from FMN to the heme and alleviates inhibition of electron transfer
within the flavoprotein domain. The latter of these roles for Ca2-CaM is correlated with
the cofactor's ability to stimulate the reduction of flavin electron acceptors, DCIP and
cytochrome c3. The uniqueness of nNOS in terms of Ca2-CaM stimulating electron
transfer have encouraged evaluation of the steady-state kinetic mechanism for electron
transfer to DCIP and cytochromec1in the presence and absence of the cofactor.In
addition the effect of Ca2tCaM on the rate limiting steps in the reaction cycle and the
ionizable groups involved in catalysis or the binding of substrates was also investigated.
Kinetic mechanisms in the presence and absence of Ca2-CaM for the reduction of DCIP
and cytochromec3were proposed based on steady-state initial velocity and inhibition
studies.The pH-dependence on basal and CaM-stimulated reduction of DCIP and
cytochromec3was investigated to determined if the activated cofactor influences
ionizable groups involved in the binding of substrates or catalysis.Finally, primary
deuterium isotope effects (NADP(D)) and solvent isotope kinetic effects (SKIE) were to
employed to probe for Ca2-CaM affects on rate-limiting steps in either mechanism.159
A family of parallel lines on double reciprocal plots of initial velocity studies
indicates that both DCIP and cytochromec3are reduced via two-half reactions in a
ping-pong mechanism.In the reductive half reaction NADPH reduces the nNOS
flavins from the one-electron (E1) to the three-electron reduced state (E3). DCIP is
reduced via two-electron donation; however, one electron is required to reduce
cytochrome c3; therefore, the oxidative half reaction is different for the two substrates.
Abstraction of two-electrons by DCIP returns nNOS to E1, where reduction of two
molecules of cytochromec3is required to return the enzyme back to E1. Product and
dead-end inhibition data with DCIP were consistent with a ping-pong bi-bi mechanism;
however, a steady-state isomerization step ofE1was proposed based on the
noncompetitive inhibition of NADP at varying concentrations of DCIP. Hence the
name of the mechanism was prefixed with iso (i.e. iso ping-pong bi bi).In contrast,
product and dead-end inhibition studies with cytochromec3were consistent with the
nonclassical (two-site) ping-pong mechanism previously described for the NADPH-
cytochrome P450 reductase-catalyzed reduction of cytochrome c3t In the former
mechanism only binary complexes form; however, for the latter, ternary complexes are
permissible. The differences in the kinetics mechanism may be related to the ability of
DCIP to be reduced by nNOS with the FMN cofactor removed, where as the FMN
cofactor is essential for cytochromec3reduction.In other words, cytochrome c
requirement of the low potential flavin may effectively separate the catalytic sites for
NADPH and cytochromec3allowing a ternary complex to form and the reaction
sequence to follow a two-site ping pong mechanism.160
To accommodate competitive dead-end inhibition by 2'-AMP versus NADPH for
both electron acceptors, the NADPH-analog was proposed to bind toE3in both kinetic
mechanisms. However, 2'-AMP exhibited different binding affinities in the presence
of cytochromec3versus DCIP.Both kinetic mechanisms incorporated a rapid
equilibrating isomerization step after the release of the electron acceptor and prior to
the binding of NADPH to account for the difference in the apparent affinity of 2'-
AMP. Thus, the kinetic mechanisms for reduction of DCIP and cytochromec3were
renamed di-iso ping-pong bi-bi and iso (two-site) ping-pong mechanism, respectively.
The presence Ca2-CaM did not alter the proposed kinetic mechanisms; however, it
did effect to varying degrees, the (kca/Km)NADpH, for the various substrates and inhibition
constants.The presence of Ca2-CaM caused a -2-fold increase in the inhibition
constant for 2'-AMP and NADP versus NADPH suggesting that the activated cofactor
may slightly reduce the affinity of the enzyme for these two inhibitors. Ca2-CaM
caused a 1 .5- to 2-fold increase in (kca/Km)NADPH, a 4.5-fold increase (kca/Km)DCIP, and a
23-fold increase in (kcat/Km)cytc.. Based on the ratio of rate constants defining(kca!Km)
for the various substrates, Ca2-CaM may stimulate the rate of electron transfer to the
electron acceptors by increasing the forward rate constants for the catalysis of these
substrate and/or decreasing the dissociation constant for the electron acceptor.
The pH-dependence the kinetic parameters associated with the basal and CaM-
stimulated rate of electron transfer to DCIP and cytochromec3were investigated to
determine the effects of the cofactor on ionizable groups involved in catalysis or the
binding of substrates. The interpretation of the pH-dependence of V and (V/K) for the
various substrates was done in the context of the proposed kinetic mechanisms. The161
log V pH profile for the basal and CaM-stimulated reduction of DCIP forms a wave
where the ionization of a group with aPKaof 7.5 to 7.6 lead to an increase of a step
that is normally rate-limiting.This step may be hydride transfer, the steady-state
isomerization of the three-electron reduced state of nNOS, and/or the rate of electron
transfer from the flavins to DCIP. The pH-dependencies of(V/K)NADPHand(V/K)1,
indicate that of these rate constants, hydride transfer is more-rate limiting compared to
the other two. The pH profiles(V/K)NADPHexhibited additionalPKavalues associated
with ionizable groups involved in the binding of the nucleotide. One of these groups
may represent the 2'-phoshate of NADPH, as suggest by the titration profile of this
substrate.If this were the case, then NADPH preferentially binds to nNOS in its
monoanionic form. The(V/K)DclppH profile also exhibits additionalPKagroups that
affect the binding of this substrate. The above mentioned pH profiles for the reduction
are the same in the presence and absence ofCa2-CaM indicating that the cofactor does
not influence ionizable groups associated with catalytic steps in DCIP reduction or the
binding of NADPH or DCIP.
This is in contrast to the pH-dependencies observed for the basal and CaM-
stimulated reduction of cytochrome c3. The log V versus pH profile for the basal
cytochromec3reductase activity is wave-shaped where the ionization of a group with
aPKaof 8.6 optimizes of catalysis. The rate-limiting catalytic step that is affected by
pH is either hydride transfer or electron transfer from FMN to cytochrome c3t The pH-
dependence on cytochromec3reduction is dramatically altered in the presence ofCa2t
CaM as the log V profile is bell-shaped with catalysis dependent on the deprotonation
of an acidic group with aPKaof 6.4 and protonation of group with aPKaof 9.2. If the162
binding of Ca2-CaM affects the relative rates of k9 and k15 with respect to k3, such that
k3 is no as longer rate limiting, then this could potentially shift the acidic PKa from 8.6
to 6.4 and incorporate an additional PKa at a higher pH. Alternatively,Ca2-CaM may
affect which ionizable groups (through conformational change) on nNOS that
participate in hydride transfer or electron transfer from FMN to cytochrome c3t The
pH-profiles for (V/K)for basal and CaM-stimulated reduction of cytochrome c3
were bell-shaped as(V/K)increased with the ionization of an acidic group with a PKa
of 7.1(basal) and 7.6 (Ca2tCaM) and decreased when a group with a PKa of 9.49.6
ionized.
nNOS was found to abstract the pro-R (A-side) hydrogen from NADPH, consistent
with it belonging to the electron/transferase family of dehydrogenases. Determination of
the stereospecificity of hydride transfer permitted investigation of the primary deuterium
isotope effects with (NADPH(D)) on V and(V/K)for the various substrates in the basal
and CaM-stimulated reduction of DCIP and cytochrome c3.Interpretation of the
primary isotope effects was done in the context of the ping-pong mechanism described
for DCIP and cytochrome c3. The value for D(v/K)NADPH was 1.2-1.7 in the presence of
either electron acceptor; however, D(v/K)NADPH for the reduction the substrates is defined
by the same rate constant,Dk3 which is the intrinsic isotope effect on hydride transfer,
and this value typically ranges between 5-8. Thus, it was concluded thatD(V/K)
incorporates an additional rate-limiting step that suppresses the full expression of the
intrinsic isotope effect in D(v/K)NADPHIt was assumed that (V/K)NADPH is probably a
function of other microscopic rate constants that define a conformational change
associated with the formation of a charge-transfer complex (E-NADPH), which is163
known to form in the related enzymes, CPR and FNR. The derivations of the kinetic
mechanisms with this additional step are consistent with the steady-state initial velocity
and inhibition data obtained previously, and the expression for D(v/NADpH becomes a
function of k2, or the dissociation of the change transfer-complex. If k2 <k3H then the full
value of Dk1 would be suppressed in D(v,K)NADpHNADPH would be considered a
"sticky" substrate where partitioning of the enzyme-substrate complex towards catalysis
is favored compared to release from the enzyme.
The value of DV was slightly lower for DCIP reduction compared to cytochrome
c3 reduction. The expressions DV for the two substrates are distinguished by the ratio of
the formation rate for the charge-transfer complex over the forward rate constants for the
oxidative half reaction.If the ratio were smaller for DCIP reduction compared to
cytochrome c3 reduction then the DV value would be smaller for the former oxidant.
Values for D(V/ and D(V/J<close to unity were consistent with the oxidative half
reaction being isotopically insensitive in their respective ping-pong mechanisms.
Similar DV and D(v/Jc) values were obtained for the basal and CaM-stimulated
reduction of DCIP, while the value for DV was slightly greater than value for
D(v/1)NADpH for the basal and CaM-stimulated reduction of cytochrome c3, indicating
that of the two half reactions, the reductive half reaction is more rate-limiting. This
conclusion is supported by the SKIE, where a valueD20(V/K)of 8 for the basal and
3 1 for CaM-stimulated reduction of cytochrome c3 was reported, while small SKIE
where associated both with V and (V/K)NADPH. The large SKIE value forD2O(v,
indicates that proton uptake directly from the solvent or from an exchangeable site on
nNOS or cytochrome c3is the rate-limiting step in the oxidative half-reaction. The 4-164
fold increase in the SKIE on the observed (V/K)may be attributed to further rate
limitation of proton transfer, an increase in the number of protons transferred, or the
solvent effects on cytochromec3binding becoming more pronounced.Proton
inventory analysis suggests that multiple protons are involved the conversion from the
initial (reactant) state to the transition-state for both the basal reduction of DCIP and
cytochromec3.165
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Appendices194
Appendix 1
Neuronal Nitric-oxide Synthase: Cloning, Expression, Purification, and Activity
Al. I Cloning of Rat Neuronal NOS cDNA into the pCWori (+) vector.
The cDNA for rat neuronal nitric oxide synthase nNOS was cloned into a pCWori(+)
expression vector for expression in E co/i.pCWori(+), a derivative of the plasmid
pHSe5, contains a pBR322 origin of replication, the lac J' gene, the J3-lactamase gene
conferring ampicillan resistance, and a bacteriophage origin of replication. The
transcription/translation region contains the following: a IacUV5 promoter and two
copies of a tac promoter cassette followed by a translation initiation region derived from
the phage T4 lysozyme gene. This DNA sequence contains a seven-base pair Shine-
Delgarno element located three nucleotides 5' of the initiation codon, which is contained
in an Nde I restriction site. pCWori(+) has proven to be a successful expression vector
for yielding soluble and sufficient quantities of cytochrome P450 and NOS (229);
therefore, this plasmid was used to generate a expression construct for nNOS. The key
element for successful expression of these enzymes is a weak tac-tac promoter; efforts to
use strong promoters (including T7) led either to no expression or, in few cases, to the
appearance of inclusion bodies.
The pCWori(+) was cut with Nde I and Hind III and the complete digest was
separated by electrophoreses on a 1.5% agarose gel using Tris acetate buffer. The gel
slice containing large 5 kb fragment was removed and the DNA was isolated using the195
glass milk procedure (298). A pET3a vector containing the nNOS cDNA (pET3anNOS)
was digested with Nde I and the digest was electrophoresed on a 1 .5 % agarose gel and
the linear DNA was isolated using the glass milk procedure (298). A Hind III restriction
site was inserted in the 3' untranslated region of nNOS by PCR amplifying the last 350
bp of nNOS with the 3' primer containing and Hind III restriction site in the linker
region. The PCR reactions contained the following: 0.1 tg of pET3anNOS, 100 pmol of
the NOS2O oligonucleotide (5' GGA ATT CCA GGA ATT GGA ATT CCC GGG AAC
CGG ACA GGC C' containing the Nde I and Sma I restriction sites), 100 pmol of
oligonucleotide NOS 21(5' CCC AAG CTT GGG ATT AGG AGC TGA AAA CCT
CAT CTG CG 3' containing the Hind III restriction sites), 50 iM dNTPs, 1.5 mM
MgC12, Promega reaction buffer, and 5 U Taq DNA Polymerase from Promega). The
total volume of the reaction was 100 pL. The melting temperature was set at 94°C for 30
sec; the primers were annealed at 55°C for 30 sec and the extension time was set at 72°C
for 30 sec. The cycle was repeated 30 times. The reaction mixture was electrophoresed
on a 1 .5 % agarose gel and the 300 base pair amplified PCR fragment was gel purified
using the glass milk/Nal procedure (298). The PCR fragment was digested with Hind III
and Nde I in NEB 2 buffer (New England Biolabs) at 37°C. The reaction mixture was
electrophoresed on a 1.5 % agarose gel and the 300 bp fragment was gel isolated again
using the glass milk/NaT procedure. The isolated 300 bp DNA fragment was ligated with
the Hind III and Nde I digested pCWori(+) vector with T4 DNA ligase buffer from New
England Biolabs and 20 U of T4 DNA ligase plus 1 mM ATP. The ligation reaction
mixtures where incubated overnight at 16°C. The ligation mixture was transformed into196
E.coli strain C38 using the method of Chung (299) and cells were plated on ampicillin
(Amp; 100 jig/mL) LB plates.Several colonies were grown up in LB broth and the
plasmid DNA was isolated using alkaline lysis protocol (303). Mini preps were screened
using restriction digests for the newly ligated plasmid, referred to as pCWORI 3'NOS.
One pCWORI 3'NOS clone was grown inE.coli in a large volume (lL) and the plasmid
was isolated by CsCl gradient method (303). The 300 base pair segment of the clone that
was amplified by PCR was sequenced by the Center for Gene Research and
Biotechnology central services laboratory at Oregon State University to determine that
the sequence was free of mutations. The pCWORI 3'NOS and pET3aNOS were then cut
with Nde I and Sma I and the reaction mixture was loaded on a 1.5 % agarose gel. The
5.4 kb fragment from the pCWORI3'NOS digest and the 4 kb fragment from the
pET3anNOS digest were excised from the gel and the DNA was isolated using the glass
milk/NaT procedure. The two fragments were then ligated together overnight at 16 °C
using T4 DNA ligase. The ligation mixture was transformed intoEcoli strain C38 using
the method of Chung (299) and the cells were plated selecting for Amp resistance.
Colonies were chosen to grow in LB broth overnight and plasmid DNA was isolated
using alkaline lysis protocol. Mini preps were screened using restriction digests with Nde
I and Sma I and Nde I and Hind III.
A digest with correct restriction pattern was transformed into theE.coli BL2I
(DE3) strain (Novagen). Twenty-five mLs of L-broth containing 0.35 tg/ml of Cm was
inoculated with 0.1 to 0.2 mL of fresh overnight culture ofE.coli BL2 1 (DE3). The cells
were grown to anOD6çjnmof 0.4 to 0.6 and then centrifuged for 5 mmat 8,000 rpm with
the SS-34 Sorvall Rotor at 4°C. The pellet was resuspend in 5 mL of sterile RbC1 bufferiI1
(100 mM RbC1, 45 mM MnC12, 10 mMCaC12and 35 mM KCH3CO2, IS % sucrose pH
6.0). The cells were divided into 5 sterile 1 .5 mL microfuge tubes and stored on ice for 5
mins. The cells were centrifuged for 1 mill at 14,000 rpm and the pellet was resuspended
in 0.2 mL of ice cold RbC1 buffer. Ten ng of plasmid DNA was incubated with the cells
and held on ice for 1 hour. The cells were then incubated in a 42 °C water bath for 2
mm. One mL of L-broth was added to the cells and they were grown at 37 °C
Transformed cells were grown on plates containing 100 jig/mL of Amp and 35 j.ig/mL of
chloremphenicol (Cm).
Al .2 Expression and Purification of nNOS from E. coli BL2 1(DE3) Cells
The media formation that has been found to be most useful for nNOS expression is
Terrific Broth (300).This phosphate buffered media maintains the culture pH near
neutrality, even at high cell densities, and contains a readily utilizable carbon source,
glycerol. nNOS expression began with the inoculation of 4 mL of LB containing 100
tg/mL of Amp and 35 p.g/mL of Cm with BL2I(DE3) pCWNOS from a fresh plate
containing the same concentrations of Amp and Cm. The cells were grown at 37°C
overnight and 4-1 L Fernbach flasks containing 35 ig/mL of Cm and 100 pg/mL of Amp
were then each inoculated with I mL of overnight culture. Thecells were grown in
Terrific Broth media at 37°C to an OD600 = 1.2 at which time the flasks were cooled to
room temperature by running under cold water, swirling the flaskconstantly. Then 0.1
mM of IPTG and 4 ig/mL of hemin chloride were added. The hemin chloride stock wasprepared by dissolving 16 mg of hemin chloride, which is stored at 4 °C, in 1 mL of 0.1
N NaOH. The cells were then grown for an additional 16-20 hr at 23°C at 250 rpm
before harvesting. The cells were pelleted at 5,000 for 10 mmin a J-6 Beckman
centrifuge. Cells were then washed in a solution of 50 mM Tris-HCI (pH 7.8), 10 %
(w/v) sucrose, and 150 mM NaC1 then pelleted by centrification and frozen at -70° C.
The enzyme was purified according to the protocol published by Gerber et al. with slight
modification (229). Cells were thawed and re-suspended in Buffer A which contained
the following: 50 mM Hepes-NaOH (pH 7.5), 10% glycerol (w/v), 100 mM DTT, 10 iM
H4B, and the protease inhibitors (1 mM EDTA, 1tg/mL of trypsin inhibitor, I pg/mL
pepstatin A, 17 tg/mL of PMSF, 1 pg/rnL benzamidine, 10 tg/rnL bacitracin, 2.5 pg/mL
leupeptin, 2.5 tg /mL aprotinin and 1.0 jig /mL E-64). The cells (-150 mL) were
transferred to a glass beaker and stored on ice. Lysozyme (20 mg) was added to the cells
and incubated on ice for 15 mm before sonicated (4 x 30 sec pulses at 80% power with a
one mmrest in between pulses). The lysate was transferred to 35 mL round bottom
centrifuge tubes and the cell debris was then pelleted at 18,000 rpm for 45 mmat 4°C
with the J21 Beckman rotor.The lysate was applied to a 10 mL ADP-Sepharose
(Amersham Pharmacia) column equilibrated with Buffer A. The column was washed
with 100 mL of Buffer A at -1 mL/min followed by 50 mL of Buffer A containing 0.5 M
NaCI. The protein was eluted with 50 mL of Buffer A plus 0.5 M NaCI and a 20 mM
mixture of 2'-and 3'- AMP. 2'AMP will not elute nNOS from the resin alone, but theLane 1 2 3 4
205,000
130,000
77,000
43,300
FIGURE Al.! Analysis of purification of nNOS determined by 8% SDS-polyacrylamide
gel electrophoresis. The gel was stained with Coomaisse Blue. Lane I represents the
molecular weight markers from BioRad (205,000, Myosin; 130,000, J-galactosidase,
77,000 bovine serum albumin, 43,300 carbonic anhydrase). Lane 2 is the IPTG induced
E. co/i strain BL2 1 (DE3) with the pCWori vector containing the nNOS eDNA lysate,
Lane 3 is the ADP-Sepharose eluate, and Lane 4 is the CaM affinity column eluate.200
presence of 0.5 M NaC1 along with 20mM 2'-AMP elicits the sharp elution of nNOS.
Two millimolar of MgCl2 and 1 mM CaC12 were added to the ADP-eluate, which was
then applied an 8 mL (1.2cm2x 6 cm) CaM-Sepharose column equilibrated with Buffer
A plus 2 mM MgC12 and 1 mM CaCl2. The column was washed with 50 mL of Buffer
A plus 2 mM MgC12, 1 mM CaC12 and 0.3 M NaC1. Finally the protein was eluted with
Buffer A plus 0.3 M NaCl and 3 mM EDTA. Protein concentration was determined with
the Lowery Assay using BSA as a standard (230). The recombinant purified protein was
more than 85% pure as judged a densometric scan of the by SDS-polyacrylamide gel and
determining the dots per inch (dpi) for each band (Figure Al . I) with a specific activity of
150 nmol NO mind mgat 25°C.
In the absence of added pterin, purified NOS that is frozen or left at 4°C loses
activity rapidly. Thus during the purification procedure 8 tM of H4B must be freshly
added to all the purification buffers and purified nNOS must be stored with this
concentration of H4B. H4B is readily oxidized in air; therefore, it is prepared as an
anaerobic solution under argon or nitrogen or prepared in buffer containing DTT. An 8
mM H4B solution is prepared in 100 mM Hepes (pH 7.5) and 100 mM DTT and can be
frozen at 80C for over three months without any observable oxidation.The
concentration of H4B can be determined spectrally using297= 8710 mM' cm' at pH 8.0.201
Al .3. Determining nNOS Activity by the Oxyhemoglobin (Hb02) Assay.
The hemoglobin assay is a simple, continuous assay based on the reaction of NO and
Hb07.The reaction betweenHb02and NO is stoichiometric and occurs at a rate that is
faster than molecular02and NO; therefore, the formation of NO can be measured under
initial rate conditions. Although the affinity of hemoglobin for NO is 3 xiohigher than
that for02,NO does not react withHb02by displacing bound dioxygen, but rather by
attacking the oxygen molecule directly, forming metHb. The soret peak forHb02at 415
nm shifts towards 406 nm for metHb. Thewavelength where there is a maximal change
in absorbance is at 401 nm (increasing) in the conversion ofHbO2to metHb, and
catalytic activity is measured by following the absorbance change at this wavelength.
TheHbO2stock was prepared by dissolving 5 mg of pig lyophilized hemoglobin
in 5 mL of 100 mM potassium phosphate buffer pH 7.4. The solution was divided
between 4 Eppendorf microfuge tubes. The large particulates were pelleted for 1 mmat
14,000 rpm in a microfuge and the supernatent was put in a 25 mL Erlenmeyer Flask.
Dithionite (2-3 fold molar excess) was added and the color of the solution changed
immediately from brownish red to a dark red (deoxyhemoglobin). The flask was swirled
to oxygenate (5-7 mm) the hemoglobin; the solution turnedbright red. The oxyHb
solution was purified and desalted by passing 1 mL of the solution over a 2 mL (3.2 cm x
0.785 cm2) Sephadex G-25 column. The concentration of the desaltedHbO2stock was
determined spectrophotometrically. The absorbance maximum should be at 415 nm. If
the maximum occurs at lower wavelengths, then metHb is a contaminant in theHb02.
MetHb does not interfere with the use of theHb02in the NO assay as long as enough202
Hb02is present such that it is not depleted at the end of the experiment. TheHb02was
prepared fresh each day since it is subject to autooxidation and microbial contamination
when stored. The following formula was used to determined the concentration ofHb02:
[oxy Hb ]mM = (l.013A576O.3269A630O.7353A560)X iO (301).
A significant problem with the assay is an irreproducible extinction coefficient for
the absorbance change at 401 nm. If quantitative measurements of NOS activity are to
be done with the assay, the extinction coefficient should be made for a particular solution
ofHb02prior to such experiments.The extinction coefficient was determined by
measuring the 401 nm absorbance of11b02solutions at varying concentrations (1-5 tM)
in 100 mM phosphate buffer pH 7.4. The NO releaser, sodium nitroprusside was added to
each solution to oxidize theHb02to metHb.At the completion of the reaction, the
absorbance change for each concentration at 401 nm was recorded. The molar extinction
coefficient was determined from the slope of the calibration curve (plot of absorbance
change versus theHb02concentration). An extinction coefficient of - 60 mM'cm1at
401 nm was calculated using this protocol; therefore, this value was used to determine
the activity of nNOS. The reaction mixtures (lmL) contained 20 iM L-arginine, 10 tM
CaC12, 100 nM CaM, 10 iM NADPH, 8 tM H4B and the reaction was initiated with the
addition of nNOS.203
Al .4 Analysis of Heme Incorporation
The amount of heme incorporation into nNOS was determined by measuring the
difference CO-heme spectra. Carbon monoxide was gently bubbled through 2 mL of the
enzyme solution (- 0.1 to 0.5 tiM) on ice for 2 mm to allow the CO to bind to the ferric
iron of the heme. The spectrum is recorded, and then the iron was reduced to its ferrous
state with the addition of sodium dithoinate. The difference spectrum was then recorded,
and the ferrous-CO complex gave a difference spectrum with a peak at 444 nm. The
heme content was calculated with z= 75 mIvI' cm' at 444 nm.
Al .5 Determining of nNOS Activity with the L-Citrulline Assay
The citrulline assay is a sensitive, discontinuous assay, which employs the use of small
Dowex 50 cation-exchange column to separate radiolabeled L-citrulline from L-arginine.
L-[2, 3, 4, 5-3H] arginine was purchased from New England Nuclear with a specific
activity 40 mCi/mmol. A working solution 3 jiCi/umol was prepared by diluting the
stock with unlabeled L-arginine. Dowex resin (50 x 8-499) in the sodium form is a
strong acidic cation exchanger and was used for the separation of L-citrulline, which at
pH 5.5 is of neutral charge, from L-arginine which is cationic. nNOS was incubated
with 10 jiM of L-arginine, 10 jiM NADPH, 100 nM CaM, 10 jiMCaCl2and 8 jiM H4B
and 4 mL of stop buffer (50 mM Hepes-NOH, (pH 5.5), 5 mM EDTA) was added to the204
reaction test tube after an incubation period. This mixture was applied to a 0.5 mL (0.64
cm x 0.785 cm2) column of Dowex resin (50X8-499)equilibrated with stop buffer. The
column was washed with 2 mL of H20 and the flow trough was collected in 20 mL
scintillation vials.The amount of citrulline that eluted was quantitated using liquid
scintillation counting based on the specific activity of the L-arginine used. The activity
of nNOS measured with this assay was plotted at varying concentrations of L-arginine
and the data was fit to the Michaelis-Menton equation to determine the Km for the
substrate. The specific assay of nNOS was determined to be 227 nmol/minlmg at 37 °C
and the Km was 0.8 ±0. 3 tM.205
Appendix 2
Derivation of Kinetic Mechanisms
A2. 1 Derivation of the Rate Equation for a Di-Iso Ping-Pong Bi-Bi Mechanism for
nNOS Catalyzed Reduction of DCIP
Figure 2.3. shows the kinetic scheme for the di-iso ping-pong bi-bi mechanism proposed
for the nNOS catalyzed reduction of DCIP.The basic features of the proposed
mechanism are as follows: (a) The reaction consists of two-half reactions with NADPH
oxidation reducing the enzyme to three-electron reduced state, E3, followed by reduction
of DCIP which converts the enzyme back to the one-electron reduced state,E1.(b) A
steady-state isomerization step occurs between two forms of the three-electron reduced
state of the enzyme,E3and E3', one that binds NADP and one that binds DCIP. (c) An
alternate form of the free enzyme, E1', exists in the reaction sequence, which is in rapid
equilibrium withE1and is able to bind the NADPH analog, 2'-AMP, but not the substrate
NADPH. The binding of substrates/inhibitors and the release of products is assumed to
occur in rapid equilibrium; thus, the kinetic mechanism is divided into three rapid
equilibrium segments, labeled X, Y, and Z. The derivation of steady-state equation is
according to the method of Cha (302).For the purposes of illustrating how dead-end
inhibition studies with 2'-AMP lead to the proposal of the rapid isomerization ofE1to
E1'in the overall reaction scheme, the enzyme-inhibitor complexes that would form with
the substrate analog, 2'-AMP (1), are also included in Figure 2.3. The fractionation
factors for the mechanism drawn in Figure 2.3 are as follows:E1A A/K
(A2.1)
X1+A/KA +1/K(1+ I/K1 + Q/KIQ + QI/KQKJ)
EPP/K (A2.2)
Yl+P/K
E3 1 (A2.3)
Y 1+P /K
E1 1 (A2.4)
Ill
E3B BIKIB (A2.5)
zl+B/KB
E1Q Q/KQ
(A2.6)
.112x l+A/KA +l/K(l+I/K11+Q/KQ +QI/KQK/)
A, B, P, Q and I represent NADPH, DCIPDX,NADP, DCIPred, and 2'-AMP respectively,
and thevalues refer to their respective dissociation constants.E1and E1' are the one-
electron (FAD/FMNH.) forms of nNOS that exclusively bind NADPH and 2'-AMP,
respectively.E1and E3' are the three-electron (FADH./FMNH2) or (FADH2IFMNH.)
forms of nNOS that exclusively bind NADP and DCIPDX,respectively. K (equal to
E1/E,') is the equilibrium constant for the conversion of the two free enzyme forms,F1
andE1'. X=E1+E1'+E1'I+E1'IQ+E1'Q+E1A;Y=E3P+E3;Z=E3'+E3'B,andE1
= X + V + Z. Using the schemeshown in Figure A2. 1 as the basic King-Altman figure,
the following velocity equation is obtained:
k3k7k1f3f7f11k4k8k12f4f8f12 (A2 7)
Ek4k8f4f8 +k4k11f4f11+k71f7f11+ k3k8f1f8 +k3k11f3f11+ k8k2f8f12 +
k1k7fj7+ k4k12f4f12 + k7k12f7f12
Under initial velocity conditions (P=Q=I=O) substitution of thefractionation factors (eqs
A2.l-A2.6) into equation A2.7 yields the following equation:207
fI/12\k3
/ f8k8
z
f9k9
Figure A2. I The steady-state steps for the nNOS-catalyzed reduction of DCIP. X, Y and
Z refer the rapid equilibrium segments drawn in Figure 2.3. X represents all the enzyme
species that bind NADPH, 2'-AMP and DCIPred; Y represents all the enzyme species that
bind NADP, and Z represents all the enzyme species that bind (i.e. X= E + E1'
+ E1'I + E1'IQ + E1'Q + E1A; Y= E3P + E3; Z = E3' +E1'B. Thefrepresents the
fractional concentration of rapid equilibrium segment involved in the reaction given by
the rate constants(eqs A2.I-A2.6).[A][B]
k3k7k1
(k3k7 +k3k11+k7k11)
E1
[A]{B] + [B]
(KA)(1 + 1 /K)(k7k11)
+ [A]
(KB)(k3k7 + k3k8)
(A2.8)
(k3k7 +k7k11+ k7k11) (k7k7 +k3k11 + k7k11)
The kinetic constants are defined as follows:
k3k7k1 (A2.9) kcat=i
k+k3k11+k7k11) 7
KA(k7kl)(1+ 1/K) (A2.1O) KA
(k7k7 +k3k11 + k7k11)
K
KB(k7k?+k3k8) (A2.11)
B(k3k7 +k7k11+k7k11)
Equation A2.8 simplifies to equation A2.12.
XL.- V[A][B] (A2.12)
E,[A][B]+KB[A1+KA[B]
which has the same form as the rate equation for a ping-pong mechanism, eq. 2.1. Thus,
the proposed mechanism for nNOS reduction of DCIP is consistent with the observed
initial velocity patterns and yields the same patterns expected for a standard ping-pong
mechanism.
The equation describing product inhibition by NADP, P, is derivedletting Q =1 =
0 and substituting the fractionation factors A2.1 to A2.6 into equationA2.7:v[A1[B] (A2.13)
E,
[A][B]{P]
where
KIBKAk4k8(l+l/K) (A2.l4)
(k7k1, + k3k11 +k3k7)
K,B(k3k8 +k4k8)
D2
(k7k1, + k3k11 +k3k7)
(A2.15)
K,Ak4kII(l+ 1/K)
(k7k1, +k1k11+k3k7)
(A2.16)
(k3k, +k4k11)
(k7k11+k31 +k3k7)
(A2.17)
The double reciprocal form of equation A2. 13 predicts noncompetitive inhibition patterns
for P with either A or B as the variable substrate. Thus, the mechanism correctly predicts
the product inhibition patterns which where obtained experimentally.
For dead-end inhibition by the substrate analog, 2'-AMP (I), P=Q=O, substitution
of equations A2.1 to A2.6 into equation A2.7 yields the following velocity equation:
v[A][B]
[I] E
[A][B]+Kfi[A]+KA[B]l+K,1(1+K)
(A2.18)
With A as the varied substrate, the double reciprocal form of the equation A2. 18 is210
Ei( K\K( [i] iI
v,V'B)V K,1(l+K))[A1
(A2. 19)
The equation predicts a competitive pattern for I whenAis the variable substrate,
consistent with the experimental results. Arranging A2. 19 with B as the variable
substrate, the equation becomes
E i(KA( [I]i'K 1 =I 1+I 1+ 11+--
v,V [A] K11(1+K)))V [B]
(A2.2o)
Uncompetitive inhibition is predicted for I whenBis the variable substrate, consistent
with the experimental results. Comparison of equation 2.3 with A2.19 and equation 2.4
with A2.20, show that theand K11 values are both a function of the dissociation
constant,K11and the equilibrium constant, K, betweenE1and E1'.
A2.2 Derivation of Rate Equations of an Iso Two-Site Ping-Pong Mechanism for nNOS-
Catalyzed Reduction of Cytochromec3
Figure 2.4 shows the kinetic scheme for the iso two-site ping-pong mechanism with
NADPH binding in a uni-uni fashion at site 1 and cytochromec3binding in a tert-uni
ping-pong fashion at site 2. Although the reaction consists of two-half reactions, the two
active sites operate independently and formation of a ternary complex is possible. Since
the difference in the apparent affinity for 2'AMP obtained with DCIP compared to
cytochromec3as an electron acceptor led to the proposal that the reaction proceeds via
an iso mechanism, Figure 2.4 also shows 2'AMP forming adead-end complex with E1'.
To simplify the derivation of the rate equation the following assumptions were made: (1)
all ligand binding steps occur in rapid equilibrium; (2) the binding of a ligand at site one211
does not effect of binding of the ligands at second site; and (3) the values of all ligand
dissociation constants are unaffected by the oxidation state of the enzyme. Figure A2A
illustrates the number of different binary and ternary complexes that can form with nNOS
and the various ligands, and Figure A2B shows the additional dead-end complexes that
form withE1'in the presence of 2'-AMP. Equations were derived using the method of
Cha (302) with the fractionation factors defined as follows:
E1A + E1AB + E1AQ A/KIA (A2.21) fA 1+A/KA +P/K+1/K(1+I/K11)
E2B + E2AB + E2PBE3B + E3AB + E1PB B/KB (A2.22) fB
E2 1 + B/KB + Q/KQ
E3P + E3PB + E3PQ
(A2.23)
E3 1+ A/KA +P/K1
E,Q + E2AQ + E2PQ Q/KIQ
(A2.24) fQ E2 1+ B/KIB + Q/KQ
E1Q Q/KKQ
fQE [i+ B/KIB + Q/KQ1[i +A/KA + P/K + 1/K(1 + I/Kg,
)1
(A2.25)
tX212
Figure A2.2 Kinetic scheme showing the various rapid equilibrium enzyme-ligand
complexes that form in the iso (two-site) ping-pong mechanism for the nNOS catalyzed
reduction of cytochrome c3. A, B, P, Q, and I represent the same molecules as in Figure
2.4, and the rate and equilibrium constants are the same as those in Figure 2.4. In Figure
A2.2A,ErepresentsE1,E2, or E3. Figure A2.2B illustrates the equilibrium betweenE1,
the free enzyme form that binds NADPH, but not 2'-AMP and E1', the free enzyme form
that binds 2'-AMP and not NADPH.213
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A, B, P,Qand I represent NADPH, cytochrome c3, NADP, cytochrome c2, and 2'-
AMP respectively, and the K, values refer to their respective dissociation constants. E1
and E1' are the one-electron (FAD/FMNH.) forms of nNOS that exclusively bind
NADPH and 2'-AMP, respectively. E2 is the two-electron (FADIFMNH2) enzyme form
and E1 is the three-electron (FADH.IFMNH2) form of the enzyme. K (equal to E/ E1') is
the equilibrium constant for the conversion of the two free enzyme forms. E2= E2+E2A+
E2B +E2P +E2Q -1-E2AB +E2BP+E2AQ+E2PQ. E3=E3+ E3A +E3B+E3P+E1Q+
E1AB+E3BP+E3AQ+E1PQ. =E1+EA+E1 B,+E1P+E,Q-i- E1AB+E1BP+E1AQ
+ EIPQ + E1'+ E1'I+E1'B+E1'Q+E1'IB+E1'IQ. Using the fractionation factors and
the scheme in Figure A2.3 as the basic King-Altman pattern, one can derivethe
following velocity equation:
v klk9kI5fAfBfB k4k10k16fpfQfQ' (A2.26)
Ek4kI0ffQ+k4k15ff8+ k9Ic5fBfB + k3k9fAfB +k4k6fpfQ'+
k9klofBfQ'+k3kQfAfQ + k3kl5fAfB + kjokl6fQfQ
Under initial velocity conditions (P=Q=I=O), substitution of the fractionation factors
A2.21 to A2.25 simplifies the overall rate equation to the following equation.
k3k9k15 {A][B]
(k1k9+k3k15+k9k15)
E1
[A][B]+[A]
(K18)(k15 k3k9)
+{B](KA)(k9kI5)(l+l/K)
(A2.27)
(k3k9+k1k15+k9k15) (k1k9+k3k5+k9k15)215
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Figure A2.3 The steady-state steps for the nNOS catalyzed reduction of cytochromec3
E1, E1',E2, and E3, the rate constants, and K are the same as in Figure 2.4. The dotted
box labeled X represents the rapid equilibrium segments betweenE1and E1' and the
values for the fractionation factors,f,,are given in equations A2.21 to A2.25.216
Kinetic constants are defined in equation A2.28 to A2.30.
k3k9k15
kcat
(k3k9 +k3k15 +k9k15)
(A2.28)
K
(KA)(k9kI5)(l+l/K) (A2.29)
A(kk +k3k5+k9k15) 39
K
(KB)(k31S+ k3k9) (A2.3o)
B(kk +k3k15+k9k5) 39
Thus the rate equation reduces to the following:
V[A][B] (A2.31)
E,[A][B]+KB[A]+KA[B]
TheKAandKBrefer to the Michaelis constants of NADPH and cytochrome c3,
respectively, and V is the maximal velocity.Equation A2.31 has the same form as
equation 2.1 to which the parallel initial velocity patterns were fit. Thus, the proposed
two-site ping-pong mechanism for nNOS reduction of cytochromec3is consistent with
the observed initialvelocity patterns. However, a hexa-uni one-site ping-pong
mechanism would also generate a rate equation having the same form as the equation for
the two-site ping-pong mechanism under initial velocity conditions. Therefore, product
and dead-end inhibition studies were required to distinguish which mechanism is valid
for nNOS.
In the CPR-catalyzed reduction of cytochrome c NADP + is uncompetitive
versus cytochrome c3.Sem and Kasper accounted for this inhibition pattern by
assuming that electron transfer fromE3to cytochrome c3 is much faster than electron
transfer from E3 to NADP (i.e. k9>>k4; 236). This assumption was supported by the217
absence of pronounced curvature in the double reciprocal plots with cytochromec2 as an
inhibitor.Since NADP is uncompetitiveversuscytochrome c3 and the double-
reciprocal plots with cytochrome c2 as an inhibitor are linear, the same assumptions were
made for the nNOS mechanism. In the presence of P(Q=1O), substitution of the
fractionation factors A2.21-A2.25 into equation A2.26 and omission of terms in equation
A2.26 containing k4 gave the following equation:
v[A][B] (A2.32)
KA E
[A][B] + {B]KA + [AIKB+ [B][PIK(l+
Equation A2.32 predicts competitive inhibition by P when A is the variable substrate.
The corresponding equation describing product inhibition by P with B as thevariable
substrate predicts uncompetitive inhibition. Thus, the mechanism correctly predicts the
product inhibition patterns obtained experimentally.
With product inhibition byQ(P=I=O), substitution of the fractionation factors A2.21 to
A2.25 into equation A2.26 produces the following rate equation:
vi
E
where
[A][B]2+[B]21ç + [A][B]KB + [A][B}[Q]L + [B][Q}L
C2
K) KKQ)
2(C [A]{Q]- + [A]{Q]K,Q2)+[Q}2[K42
J
(A2.33)218
(k3k9 + k3k10 + k3k15
\\
(A2.34) C1= + k9k,5 + k1k15
C2 = KAKB
k
k9k16
(A2.35)
k3 9+k9k15+k1k15
Cl=K,fi2(
k3k10
k1k9 + k9k15 + k3k15J
(A2.36)
C4
k10k16
(A2.37)
3k9 + k9k15 + k1k15
The termsC1andC2predominate overC1andC4in equationA2.33sincek10andk16,
which represent the rate of cytochromec2reduction ofE2and E1, respectively, are
assumed to be much slower then electron transfer to cytochromec3, k9andk15This
assumption is based on the absence of curvature in the initial velocity patterns.
Furthermore, if hydride transfer,k3,is much slower than electron transfer to cytochrome
c3thenC2 >>C1. Both of these assumptions were also made in the derivation of the rate
equation for cytochromec2inhibition studies with CPR(236).Thus, equationA2.33
reduces to the following equation:
v[Aj[B]
(A2.38)
E
[A}[B]+[B]KA+[A]KB+[A][Q}J+[Q]
C2
KK' EQ,)
EquationA2.38predicts product inhibition byQwithBas the variable substrate to be
competitive. The corresponding equation describing productinhibition byQwithA as
the variable substrate predicts noncompetitive inhibition.Therefore, the proposed iso219
two-site ping-pong mechanism is consistent with the cytochromec2product inhibition
patterns obtained experimentally.
In the presence of 2'-AMP, I, (P=Q=O), substitution of the fractionationfactors A2.21 to
A2.25 into equation A2.26 leads to the following equation:
v[AJ[B] (A2.39)
['1 " 1+
I
E,
[A][BI+KB[A]+KA[B][
K,1(1+K))
Equation A2.39 predicts that I will be competitiveversus Aand uncompetitiveversus B.
As with the di-iso ping-pong mechanism described for DCIP as an electron acceptor,the
overall apparent affinity for 2'-AMP is a function of its dissociation constant andthe
equilibrium constant,K(equal toE1/E1'), i.e.K1=K11(l+K)andK1=K11(1+K).
A2.3 Derivation of Rate Equation Describing a Hexa-Uni Ping-Pong Mechanism for
nNOS-Catalyzed Reduction of Cytochromec3
Scheme A2.1 shows the kinetic scheme for the hexa-uni ping-pong mechanism with
NADPH binding in a uni-uni fashion followed by the binding of cytochromec3in a tert-
uni ping-pong fashion.The reaction consists of two-half reactions with only the
formation of binary complexes possible. Using Scheme A2. 1 as the basic King-Altman
figure, the following rate equation is obtained.220
v k1k3k5k7k9k11[A]{B}2k2k4k6k8k10k12[PI[Q12 (A2.4o)
[AI{B]2(k1k5k7k9k11 + k1k1k5k9k11 + k1k3k5k7k9) +
[B]2(k1k5k7k9k1, +k2k5k7k9k1) +
[A][BI(k1k3k7k9k1, + kk3k6k9k1 + k1k1k5k7k11 + k1k1k5k7k10) +
[B][P](k2k4k6k9k1, +k2k4k7k9k1') + [A][B][P](kk4k6k9k11 + k1k4k7k9k1) +
[Q}2(k3k6k8k10k12 + k2k6k8k10k12) + [A][Q](k1k3k6k8k, +k1k3k6k8k10) +
[B][Q]2(k3k5k8k10k2 + k2k5k8k10k12)+[A}{B][Q](k1k3k5k8k1 + /çk3k5k8k10) +
[BJ[Q](k3k5k7k10k12 + k2k5k7k0k12) + [B]2[Q](k3k5k7k9k12 + k2k5k7k9k12) +
[P1[Q](k2k4k7k10k12 + k2k4k6k10k12 +k2k4k6k8k1+k2k4k6k8k0) +
[P}[Q}2(k2k4k8k10k12 + k2k4k6k8k2 + k2k4k8k10k2) +
[A][P][Q](k1k4k6k8k11+kjk4k6k8k10) +{B][P][QJ(k2k4k7k9k12 + k2k4k6k9k12)
k1A
1-jls
kl1kuQ
(E1Q -E2B)
k3
(E1AE3P)
k4P
k6k5B
k10 k8Q
E ' (E3B-EQ)
k9B k7
(Scheme A2. 1)
Equation A2.40 simplifies to the following equation under initial velocity conditions
(P=Q=0).
vi k1k3k5k7k9k11[A][B]
E[A]{B](k1k5k7k9, +k3k5k9k11 +k3k5k7k9) + {B](k3kk7k9, + k2k5k7k9k1
(A2.4 1)
[A](k1k3k7k9k1, +k1k3k6k9k11 + k1k3k5k7k11 +k1k3k5k7k10)The kinetic constants are defined in equations A2.42 to A2.44.
k3k7k11
kcat(k7,+k31+k3k7)
(A2,42)
k7k11(k2+k3)
KA
k1(k7k11 +k1k1 +k3k7)
(A2.43)
KB
k3(k7k9k11+k6k9k11+k5k7k11+k5k7k0) (A2.44)
k5k9(k7k11 +k1k11 +k3k7)
where KA and KB refer to the Michaelis constant of NADPH and cytochromec3,
respectively. Equation A2.41 reduces to the following equation:
vi V[AJ[B]
i;-[A}[B]+KB[A]+KA[B]
(A2.45)
which has the same form as equation 2.1 to which the parallel initial velocity patterns
were fit. Thus, the proposed hexa-uniping-pong mechanism for nNOS reduction of
cytochrome c3 is consistent with the observed initial velocity patterns.
With product inhibition by P (Q=O) the equation A2.40 reduces to the following
equation:
k1k3k5k7k9k11[A][B]
[A][B](k1k5k7k9k11 k1k3k5k9k1 +k1k3k5k7k9)+
[B](k3k5k7k9k1,+k2kk7k9k1)
+kk3k6k9k11+k1k3k5k7k11+k,k1k5k7k10)+
[P}(k2k4k6k9k,+k2k4k7k9k13 + [169, +k1k4k7k9k1')
(A2.46)
221222
Equation A2.46 can be rewritten as
v[A][B]
E [A][BJ + [A]K8 + [B]KA + [P]/G, + [A][P]/G2
(A2.47)
whereKA, KBandkcatare defined as above and
G1
k1kk9(k7k11 +k3k11+k1k7) (A2.48)
k2k4k6k11(k6 + k7)
k5(k7k11+k3k11+k3k7) (A2.49) U2
k4k11(k6+k7)
In double reciprocal form equation A2.47 becomes
=
I I [P1 (A2.5o) I+ll+
v V [BIKAGI)[A]v[ [B] KBG2)]
which shows that P will be noncompetitive with A. as the variable substrate. This
inhibition pattern is inconsistent with the competitive inhibition pattern observed for
NADP (P) versus NADPH(A)with cytochrome c3 as the electron acceptor. Arranging
equation A2.50 withBas the variable substrate gives
=1l+
] [P]
v1V [AIKBGJKBG2)[B]VL [A]
(A2.51)
Equation A2.5 I predicts that P wiI be competitive versusB.This inhibition pattern is
also inconsistent with the uncompetitive inhibition pattern observed forNADP (F)
versus cytochromec3 (B) in Table 2.3. Therefore, the hexa-uni ping-pong mechanism is
not consistent with the basal and CaM-stimulated reductionof cytochrome c3.223
With Q as a product inhibitor (P=O) equation A2.40 becomes
vi kk3k5k7k9k11{A][BI2 (A2.52)
[A][B]2(k1k5k7k9k11 + k1k1k5k9k11 +kk3k5k7k9) +
{B]2(k3k5k7k9kj1+k2k5k7k9kj1) +{A][Q](k1k3k6k8kj, +k1k3k6k8k10) +
[A]{B](k1k3k7k9k,, +kk3k6k9k11+k1k3k5k7k1+kk3k5k7k10) +
[Q]2 (k3k6k8k10k + k2k6k8k10k12) + +[BI[Q12 (k1k5k8k10k12 + k2k5k8k10k1 2)
+[A][B][Q](k1k3k5k8k1, +kk3k5k8k10) +
[BI[Q](k3k5k7k10k12 + k2k5k7kj0k12) + [B]2[Q](k3k5k7k9k12 + k2k5k7k9k12)
Equation A2.52 reduces to the following equation
v[A][Bj2 (A2.53)
E[A][B]2 +KB[A][B]+KA[B12 +
[Q12/J1 + [A][Q]/J2 + [B][QJ2/J3 + [AI[BI{QJ/J4 +[B][Qj/J5 +[B]2[Q]/J6
whereKA, KBandkcatare defined in A2.42 to A2.44.224
k1k5k9(k7k11+k3k11+ k3k7)
(A2.54)
k6k802(k2+k1)
k5k9(k7k11+k1k11+ k1k7)
(A2.55) J2
k1kk8(k10+k11)
k1k9(k7k+k3k1+k3k7)
(A2.56) J3
k8k10k12(k2+ k3)
k9(k7k1+k3k11+k3k7)
(A2.57)
k3k8(0+1)
k1k9(k7k11 +k3k1+k3k7)
(A2.58)
k7k10k12(k2+ k3)
k1k9(k7k11+k3k11+ k1k7)
A2 59
6 k7k12(k2+k1)
In double reciprocal form with A as the variable substrate equation A2.53 becomes.
L_IIK
EQ]22 EQ]22 ±[i+ 112
v,V J1[B]J5[B] J6J3{B]J[A]
+ (A2.6o)
(++[Q] [Q1
V [B]J2[B]2+J4[BIJ
Inhibition byQwould generate a double reciprocal plot in which both the intercept and
slope are affected and are non-linear functions ofQand/or B. Although Table 2.3 shows
that cytochrome c2,Q,is noncompetitive versus NADPH, A, the inhibition patterns did
not exhibit any curvature; therefore, they are not consistent the hexa-uni ping-pong
mechanism. Rearranging equation A2.60 to show B as the variable substrate gives225
1KB
2
-L+1
2
T1+ (A2.61)
vV J3[A] J4J5[A]J[B] J1[A])[B1 J
[Q]
V1 [A]J6[A])
When B is the variable substrate, inhibition by Q is expected to have anaffect on the
intercept and the slope, with the slope a nonlinear function of Q.Asshown in Table 2.3,
cytochromec2', Q,is competitive versus cytochromec3, B;therefore, the product
inhibition pattern is not consistent with the hexa-uni ping-pong mechanism.226
Appendix 3
Derivation of Kinetic Mechanisms with the Charge-transfer Complex
A3. 1 Derivation of the Rate Equation for a Di Iso Ping-Pong Bi-Bi Mechanism for nNOS
Catalyzed Reduction of DCIP Incorporating the Steady-state Isomerization of the
Charge-transfer Complex
Figure 3.2 shows the kinetic scheme for the di-iso ping-pong mechanism with the steady-
state isomerization of the charge-transfer complex with NADPH-FAD proposedfor the
nNOS catalyzed reduction of DCIP. The basic features of the proposed mechanism are
the same as outlined in the Appendix of Woithers and Schimerlik (255). As before, the
binding of substrates/inhibitors and the release of products is assumed to occur in rapid
equilibrium; thus, the kinetic mechanism is divided into four rapid equilibrium segments,
labeled E1A, X, Y, and Z.. The derivation of steady-state equation is according to the
method of Cha (302).
f1k1
X E1A
k2
fi k12
f8k8
Z Y Scheme 3.1
f7k7
The fractionation factors for the mechanism drawn in Figure 3.2 are as follows:227
EA A/KA (A3.1)
X1+ A/KA + 1/K(1 + J/K, +Q/K,Q+QI/K,QKf)
E3PP/K
Y1+P/K
(A3.2)
E3 1
1Y1+P/K,
(A3.3)
E1' 1 (A3.4)
E3'B BIKIB
f;J=Z1+B/K,
(A3.5)
E1Q Q/KQ
(A3.6)
X1+A/K+1/K(1+I/K1 +Q/KQ +QI/KQKIJ)
A, B, P, Q and I represent NADPH, NADP, DCIPred, and 2'-AMP respectively,
and thevalues refer to their respective dissociation constants.E1and E1' are the one-
electron (FAD/FMNH.) forms of nNOS that exclusively bindNADPH and 2'-AMP,
respectively.E1and E3' are the three-electron (FADH./FMNH2) or (FADH2/FMNH.)
forms of nNOS that exclusively bind NADP and respectively. K (equal to
E1/E1') is the equilibrium constant for the conversion of the twofree enzyme forms,E1
andE1'. X=E1+E1'+E1'I+E1'IQ+E1'Qi-E1A;Y=E3P+E3;Z=E1'+E3'B,andE
= X + Y + Z. UsingScheme A3. 1 as the basic King-Altman pattern, the following
velocity equation is obtained:228
vi k1k3k7k11f1f7f11k2k4k8k,2f4f8f12
E, k7k1f7f11(k1+ k2 + k3) +k2k4f4(k8f8 + k11f11) + k4k8f4f8(f1 +k122)
(A3.7)
+k2k8k12f8f12(k2 + k1) +k1k1fj11(k3 + k4f4) +k1k1f1(k7f7 +k8f8)
+k2k7k12f7f12(k2 + k3) +k2k4k12f4f12
Under initial velocity conditions (P=QJ--O) substitution of the fractionationfactors (eqs
A3.1-A3.6)into equationA3.7yields the following equation:
k1k1k7k11
[A][B]
(k1k3k7 + k1k11(k, + k7) +k7k11(k2 +k1))
(A3.8)
(K,A)(l+ 1 /K)(k7k1(k2 +k1)) E,
[AJ[B] +[BJ(
+k11(k3+ k7) + k7k11(k2 +k3))
(KIB)(kk3(k7 + k8))
[A]
(kk3k7 + + k7) +k7k1(k2 +k1))
The kinetic constants are defined as follows:
1ck3k7k11
kcat
(k1k1k7+k1k11(k1 +k7)+k7k11(k2+k1))
(A3.9)
(KIA)(l+ iIK)(k7k11(k2 + k3))
(A3.lO) KA
(k1k3k7 +k11(k, + k7) + k7k11(k2 + k3))
(KB)(klkl(k7 +k8))
KB(k3k7 + + k7)+ k71(k2 +k3))
(A3.1 1)
EquationA3.8simplifies to equationA3.12.
v[A][B] (A3.12)
E[A][B]+KB[A]+KA[B]229
which has the same form as the rate equation for a ping-pong mechanism, eq. 2.1.Thus,
the proposed mechanism for nNOS reduction of DCIP is consistentwith the observed
initial velocity patterns and yields the same patterns expected for a standardping-pong
mechanism.
The equation describing product inhibition by NADP, P, is derived letting Q =1=
0 and substituting the fractionation factors A3. I -A3.6 into equationA3.7:
XL--
V[A][BJ (A3.13)
+I+ E
[
+2-+[AJ[KB
D2P'\
[B]KA
D3P'[P]-'- [A][B} 1
K, ) K, ) K1
where
KBk4k8(k +k2KA(1 + 1/K))
(A3. 14)
k7k11(k2 +k3)+k11(k3 +k7)+k1k3k7
K,Bk8(k2k4+ k1k3)
k7k11(k2+ k3) +k11(k3 + k7) + k1k3k7
(A3.15)
KlAk2k4klI(1 + 1/K)
D3
k7k11(k2+k3)+k11(k3+k7)+k1k3k7
(A3.16)
k11(k2k4+kk4+k1k1)
k7kll(k2+k3)+klkLI(k3+k?)+klk3k7
(A3.17)
WithAas the variable substrate, the double reciprocal form of equation A3. 13 becomes
+ (A18)
v V B)KQ)AV B B))230
which predicts that inhibition by P will produce a noncompetitive inhibition pattern. The
double reciprocal form of equation A3. 13 with B as the variable substrate is the following
D 1 1 1K P "
(A19) + +-I-+ 1
VK A ) Kb B V A A))
which also predicts that inhibition by P will produce a noncompetitive inhibition pattern.
Thus, the mechanism correctly predicts the product inhibition patterns which where
obtained experimentally.
For dead-end inhibition by the substrate analog, 2'-AMP (I), P=Q=O, substitution of
equations A3. 1 -A3.6 into equation A3.7 yields the following velocity equation:
v[A][B]
(A3.2o)
E
[A][BI+KB[A]+KA[B}1+
[I]
J K11(1+K)
WithAas the varied substrate, the double reciprocal form of the equation A3.20 is
LI(1++(1+
II'] 1
v,V B)V K1(1+K)J[A}
(A3.21)
The equation predicts a competitive pattern for I whenAis the variable substrate,
consistent with the experimental results. Arranging A3.20 withBas the variable
substrate, the equation becomes231
['1
vV A K1(l+K))JV [B]
(A3.22)
Uncompetitive inhibition is predicted for I whenBis the variable substrate, consistent
with the experimental results.Jfk3is the isotopically sensitive step, then the observed
isotope effect on V and(V/K)NADPH
A3. 1 Derivation of Rate Equations of an Iso Two-Site Ping-PongMechanism for nNOS-
Catalyzed Reduction of Cytochromec3Incorporating the Charge-Transfer
Complex
Figure 2.4 shows the kinetic scheme for the iso two-site ping-pongmechanism with
NADPH and the formation of a conformationally distinct chargetransfer complex. The
following assumptions were made in the derivation of the rateequation: (1) all ligand
binding steps occur in rapid equilibrium; (2) the binding of a ligand at site onedoes not
effect of binding of the ligands at second site; and (3) the values of all liganddissociation
constants are unaffected by the oxidation state of the enzyme.Scheme A3.2 illustrates
the King-Altman pattern used for the following derivation. Equations werederived using
the method of Cha (62) with the fractionation factors defined asfollows:232
fA =
E1A+EAB+E1AQ A/KIA (A3.25)
1+A/KIA+P/K1P+1 / K(1+I/K,1)
fB=
E,B+E2AB+E2PBE3B+E1AB+E1PB B/K,B (A3.26)
E2 E3 1+B/K,fi+Q/KQ
fP=
E3P+E1PB+E1PQ (A3.27)
E3 1+ A/KIA +
fQ
E2Q+E2AQ+E2PQ Q/K1Q
(A3.28)
E2 1+ B/K18+Q/K1Q
E1Q Q/KKQ
(A3.29)
EtX[i+ B/KB +Q/KIQ][1+ A/KIA + +1/K(1+I/K,)]
A, B, P,Qand I represent NADPH, cytochrome c3, NADP, cytochromec2, and 2'AMP
respectively, and the K1 values refer to their respective dissociation constants.E1 and E1'
are the one-electron (FAD/FMNH.)forms of nNOS that exclusively bind NADPH and
2'AMP, respectively. E2 is the two-electron (FAD/FMNH2) enzymeform and E3 is the
three-electron (FADH./FMNH2) form of the enzyme. K (equal toE1/ E1') is the
equilibrium constant for the conversion of the two free enzyme forms. E2=E2+ E2A +
E2B +E2P+E2Q +E2AB+E2BP+E2AQ+E2PQ. E3 E1+E1A+E3B +E1P+E1Q+
EAB+E3BP+E3AQ+E3PQ. E1+E1A+E1 B,+E1P+E1Q+ E1AB+E1BP+E1AQ
+E1PQ+E1'+ E1'I+E1'B E1'Q+E1'IB+E1'IQ. Using the fractionation factors and
the scheme in Figure 2.7 as the basic King-Altman pattern, one canderive the following
velocity equation:233
fAki
X E1A
k2
fHkfl6kQ' fk k1
fQk1Ø
E3 E Scheme A3.2
fbk9
v. klk3k9kl5fAfBfBk2k4k1ØkI6fpfQfQ'
(A3.3o)
E,k2k4klofpfQ + k9kIsfB2(k2 + k3) + k2k4kl3fBfp + klk4klofAfpfQ +
k4kokI6fpfQfQ'+klk9kl5fAffi2 + klk4klsfAfBfp + kkik9fAfQ +
kOk16fQfQ'(k2 + k3) + kk3fAfB(k9 +
k9k6fBfQ'(k2 + k3) + k2k4k16fpfQ'
Under initial velocity conditions (P=Q=I=O), substitution ofthe fractionation factors
A3.25 to A3.29 simplifies the overall rate equation to thefollowing equation.
k1k3k9k15[A][B]
vi k9k15(kj +k2+k1)+k1k1(k9+k15) (A3.31)
E klk3(K,B)(k9 + k15)
k9k1(K)(k2 + k3)(1 + 1/K)
[BJkk(k+k2+k3)+k1k3(k9+5)234
Kinetic constants are defined in equation A3.32 to A3.34.
V k1k3k9k15
k9k15(k1 + k2 + k3) + k3(k9 + k15)
(A3.32)
kk3k9kj5
KA
kk(k +k2+k3)+k1k3(k9+k15)
(A3.33)
kIk3(KB)(k9+ (A3.34) KB
k (k, +k2 +k3)+k1k3(k9+5) 915
Thus the rate equation reduces to the following:
_i_- v[A][B]
(A3.35)
E,[A][B1+KB[A]+KA[B]
TheKAandKBrefer to the Michaelis constants of NADPH and cytochrome c,
respectively, and V is the maximal velocity.Equation A3.35 has the same form as
equation expected for a ping-pong mechanism. Thus, the proposed two-site ping-pong
mechanism for nNOS reduction of cytochromec3is consistent with the observed initial
velocity patterns.
Since NADP is uncompetitive versus cytochromec3and the double-reciprocal
plots with cytochromec2as an inhibitor are linear the assumptions were made (i.e.
k9>>k4) for the nNOS mechanism. In the presence of P (Q =1 =0), substitution of the
fractionation factors A3.25-A3.29 into equation A3.30 and omission of terms in equation
A30 containingk4gave the following equation:
V[A][B]
(A3.36)
E1
[A][BI+[BIKA+[A]KB+[BI[P][K
KA
+ 1/K))235
Equation A3.36 predicts competitive inhibition by P when A is thevariable substrate.
The corresponding equation describing product inhibition byP with B as the variable
substrate predicts uncompetitive inhibition. Thus, the mechanismcorrectly predicts the
product inhibition patterns obtained experimentally.
With product inhibition by Q (P=I=O), substitution of thefractionation factors
A3.25 to A3.29 into equation A3.30 produces the following rateequation:
V[A][B]2 (A3.37)
c2
1+ E
{A][B]2+[B}2KA + {A]{B]K8 +[A][B][Q][J+ [B][Q}KK)
+[A}[QJ2[2J[Q]2[C4
KQ
where
CK,1k30 (A3.38)
k3k9+k9k15 +k3k15)
I_k9k16(k2+k1) (A3.39) C2 = KZAKiBk3k9 +k9k5+ k3k
C3KB2I k1k3k0 (A3.4o)
k3k9 +k9k15+k3k15
C4KZAKJB[
k105(k2+k3) (A3.41)
k3k9 +k9k15+k3k5}
The termsC1and C2 predominate over C3 andC4in equation A3.37 sincek10and k16,
which represent the rate of cytochromec2reduction ofE2and E1, respectively, are236
assumed to be much slower then electron transfer to cytochrome c3,k9andk15Thus,
equation A3.37 reduces to the following equation:
v[A][B]
(A3.42)
E
[A][B] + [B]KA + [A]KB +[AI[Qj1 +[Q{
C2
KQ) KKiQJ
Equation A3.42 predicts product inhibition by Q with B as the variable substrate to be
competitive. The corresponding equation describing product inhibition by Q with A as
the variable substrate predicts noncompetitive inhibition. Therefore, the proposed iso
two-site ping-pong mechanism is consistent with the cytochromec2product inhibition
patterns obtained experimentally.
In the presence of 2'-AMP, I, (P=Q=O), substitution of the fractionation factors
A3.25 to A3.29 into equation A3.30 leads to the following equation:
v[A][B]
1+
K)J
E1
[AI[B]+KB[A]+KA[BI
[I]
K,1(1+
(A3.43)
Equation A3.43 predicts that I will be competitive versus A and uncompetitive versus B.
As with the di-iso ping-pong mechanism described for DCIP as an electron acceptor, the
overall apparent affinity for 2'-AMP is a function of its dissociation constant and the
equilibrium constant, K (equal toE1/E1'), i.e. K1=K1(1+K) and K1=K11(l4-K).